[
  {
    "question": "Are there microbes in human breast milk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Human breast milk is known to contain a variety of microbes. These include beneficial bacteria that can play a role in the development of the infant's gut microbiome and immune system. The presence of these microbes is a natural and important aspect of breast milk.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can breastfeeding confer protection from type I diabetes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Breastfeeding has been studied for its potential protective effects against various diseases, including type I diabetes. Some research suggests that breastfeeding may lower the risk of developing type I diabetes in children, possibly due to the presence of protective antibodies and other beneficial components in breast milk. However, the evidence is not conclusive, and more research is needed to establish a definitive link. Therefore, while breastfeeding has many known benefits, its role in preventing type I diabetes is not definitively proven.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can pets affect infant microbiomed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether pets can influence the microbiome of infants. The microbiome refers to the collection of microorganisms living in a particular environment, such as the human body. Research has shown that pets can indeed influence the microbiome of household members, including infants. Pets can introduce new bacteria and other microorganisms into the home environment, which can then be transferred to infants through various means, such as direct contact or through the air. This exposure can help diversify the infant's microbiome, which is considered beneficial for developing a healthy immune system.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any association between the human gut microbiome and depression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Research has shown that there is a connection between the human gut microbiome and mental health, including depression. Studies suggest that the gut-brain axis, which is the communication network linking the gut and the brain, plays a role in mood regulation. Changes in the gut microbiome composition have been associated with depressive symptoms, indicating a potential link between the two.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is pembrolizumab effective against Ewing's sarcoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pembrolizumab is an immune checkpoint inhibitor that targets the PD-1 pathway, and it has shown effectiveness in various types of cancers. However, its effectiveness against Ewing's sarcoma, a rare type of cancer, is not well established. Clinical trials and studies are necessary to determine its efficacy in treating Ewing's sarcoma specifically. As of the latest available data, there is no conclusive evidence to support the effectiveness of pembrolizumab against Ewing's sarcoma.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can gene therapy restore auditory function?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Gene therapy has shown promise in restoring auditory function in certain cases. Research and experiments have demonstrated that gene therapy can potentially repair or replace defective genes responsible for hearing loss, leading to restored auditory function. However, the effectiveness and applicability of gene therapy can vary depending on the specific cause and type of hearing loss. While there have been successful cases, gene therapy is still largely in the experimental stages for hearing restoration and is not yet a widely available treatment option.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does vesatolimod inhibit TLR7?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Vesatolimod is a drug that acts as an agonist of Toll-like receptor 7 (TLR7). It is designed to stimulate the immune system by activating TLR7, rather than inhibiting it. Therefore, vesatolimod does not inhibit TLR7; instead, it activates it.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can simvastatin alleviate depressive symptoms?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Simvastatin is primarily a medication used to lower cholesterol and reduce the risk of cardiovascular disease. There is some research suggesting that statins, including simvastatin, may have an impact on mood and depressive symptoms, potentially due to their anti-inflammatory effects. However, the evidence is not conclusive, and simvastatin is not approved or primarily used for treating depression. Therefore, while there might be some potential, it is not a recognized treatment for depressive symptoms.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does gepotidacin activate bacterial topoisomerase?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Gepotidacin is a novel antibiotic that targets bacterial topoisomerase IV and DNA gyrase, which are essential enzymes for bacterial DNA replication. However, it does not activate these enzymes; rather, it inhibits their function, thereby preventing bacterial DNA replication and ultimately leading to bacterial cell death.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is obesity related to cognitive decline?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Obesity has been studied in relation to various health issues, including cognitive decline. Research indicates that there is a connection between obesity and an increased risk of cognitive decline. Factors such as inflammation, insulin resistance, and vascular issues associated with obesity may contribute to this relationship. Therefore, it is generally accepted in the scientific community that obesity is related to cognitive decline.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are whole-genome duplications more divergent than small-scale duplications in yeast?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Whole-genome duplications (WGDs) and small-scale duplications (SSDs) are two different mechanisms of gene duplication. WGDs involve the duplication of the entire genome, leading to the presence of two or more complete sets of chromosomes. This can result in significant genetic divergence over time as the duplicated genes may acquire new functions or be lost. On the other hand, SSDs involve the duplication of individual genes or small segments of the genome, which may lead to less divergence compared to WGDs. In yeast, studies have shown that WGDs can lead to more extensive genetic divergence than SSDs due to the larger scale of duplication and the evolutionary pressures that follow. Therefore, whole-genome duplications are generally considered to be more divergent than small-scale duplications in yeast.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do yeast LTR give rise to circular DNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"LTRs, or Long Terminal Repeats, are sequences found in retrotransposons and retroviruses. In yeast, retrotransposons can be similar to retroviruses in that they can form circular DNA intermediates during their life cycle. This is because the LTRs can facilitate the reverse transcription process, leading to the formation of circular DNA. Therefore, it is possible for yeast LTRs to give rise to circular DNA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Copy Number Variants (CNVs) depleted in regions of low mappability?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Copy Number Variants (CNVs) are segments of DNA that vary in copy number between individuals. Mappability refers to the ability to uniquely map short reads to a reference genome. Regions of low mappability are often repetitive or have high sequence similarity, making it difficult to accurately identify CNVs. Therefore, CNVs are often depleted in these regions because they are harder to detect and analyze accurately.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can mitochondria be inherited by both parents in humans?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"In humans, mitochondria are typically inherited maternally, meaning they are passed down from the mother to the offspring. This is because the mitochondria in the sperm are usually destroyed after fertilization, and only the mitochondria from the egg are retained in the embryo. Therefore, under normal circumstances, mitochondria are not inherited from both parents.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Have machine learning methods been used to predict the severity of major depressive disorder(MDD)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Machine learning methods have been increasingly applied in the field of mental health, including the prediction and diagnosis of major depressive disorder (MDD). Researchers have utilized various machine learning algorithms to analyze data from clinical assessments, neuroimaging, genetic information, and other sources to predict the severity of MDD. These methods aim to improve the accuracy and efficiency of diagnosing and understanding the disorder's progression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any association between suicide and autism in adolescents, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Research indicates that there is an association between autism and an increased risk of suicidal thoughts and behaviors in adolescents. Studies have shown that individuals with autism spectrum disorder (ASD) may experience higher levels of depression, anxiety, and other mental health challenges, which can contribute to an increased risk of suicide. Therefore, there is a recognized link between autism and suicide risk in adolescents.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does allele phasing improve the phylogenetic utility of ultraconserved elements?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Allele phasing is a process that helps in distinguishing between the two alleles of a gene in diploid organisms. Ultraconserved elements (UCEs) are regions of the genome that are highly conserved across different species. Phylogenetic utility refers to the usefulness of genetic data in constructing evolutionary relationships. By phasing alleles, researchers can obtain more accurate genetic information, which can potentially improve the resolution and accuracy of phylogenetic analyses using UCEs. Therefore, allele phasing is likely to enhance the phylogenetic utility of UCEs by providing clearer genetic signals for evolutionary studies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are ultraconserved enhancers important for normal development?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ultraconserved enhancers are DNA sequences that are highly conserved across different species, indicating their importance in biological processes. These enhancers play a crucial role in regulating gene expression during development. Their conservation suggests that they have essential functions that have been maintained through evolution. Therefore, it is likely that ultraconserved enhancers are important for normal development.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Bobble head doll syndrome associated with hydrocephalus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bobble head doll syndrome is a rare neurological disorder characterized by a distinctive bobbing motion of the head. It is often associated with hydrocephalus, particularly with third ventricle enlargement. Hydrocephalus is a condition where there is an accumulation of cerebrospinal fluid within the brain, leading to increased pressure. The connection between bobble head doll syndrome and hydrocephalus is well-documented in medical literature.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tisagenlecleucel effective for B-Cell Lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tisagenlecleucel is a type of CAR T-cell therapy that has been approved for use in certain types of B-cell lymphomas. It has shown effectiveness in treating these conditions, particularly in cases where other treatments have failed. Clinical trials and studies have demonstrated its efficacy in inducing remission in patients with B-cell lymphoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is durvalumab used for lung cancer treatment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Durvalumab is a medication that is used in the treatment of certain types of cancer. It is specifically known for its use in treating non-small cell lung cancer (NSCLC) after chemotherapy and radiation therapy. The drug works as an immune checkpoint inhibitor, targeting the PD-L1 protein to help the immune system attack cancer cells more effectively. Given this information, it is accurate to say that durvalumab is indeed used for lung cancer treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does epidural anesthesia for pain management during labor affect the Apgar score of the the infant?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The Apgar score is a quick test performed on a newborn at 1 and 5 minutes after birth. The 1-minute score determines how well the baby tolerated the birthing process. The 5-minute score tells the healthcare provider how well the baby is doing outside the mother's womb. Epidural anesthesia is commonly used for pain management during labor. There is some debate and research on whether epidural anesthesia affects the Apgar score of the infant. Some studies suggest that there might be a slight impact on the Apgar score, while others find no significant difference. However, the general consensus in the medical community is that epidural anesthesia does not have a clinically significant effect on the Apgar score of the infant.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) been reported to be a plasminogen receptor in pathogenic bacteria?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a well-known enzyme involved in glycolysis. However, beyond its traditional role in metabolism, GAPDH has been reported to have various non-glycolytic functions, including acting as a plasminogen receptor. In pathogenic bacteria, certain proteins can bind plasminogen, which is a precursor to plasmin, an enzyme involved in breaking down fibrin clots. This ability to bind plasminogen can aid bacteria in tissue invasion and immune evasion. There have been studies indicating that GAPDH can serve as a plasminogen receptor in some pathogenic bacteria, facilitating these processes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can exposure to heavy metals like lead(Pb) or cadmium(Cd) cause changes in DNA methylation patterns in Isoetes sinensis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Exposure to heavy metals such as lead (Pb) and cadmium (Cd) is known to cause various biological effects in plants, including changes in DNA methylation patterns. DNA methylation is an epigenetic mechanism that can be influenced by environmental factors, including heavy metal stress. Isoetes sinensis, being a plant species, could potentially exhibit changes in DNA methylation patterns when exposed to heavy metals like lead or cadmium. Therefore, it is plausible that such exposure could lead to alterations in the DNA methylation patterns of Isoetes sinensis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "In clinical trials, the H3 R antagonist CEP-26401 has a positive effect on cognition, yes or no?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if the H3 R antagonist CEP-26401 has a positive effect on cognition in clinical trials, we need to look at the results of those trials. If the trials showed improved cognitive function in participants, then the answer would be 'yes'. If not, then the answer would be 'no'. Without specific trial results or data, it's not possible to definitively say 'yes' or 'no'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Have yeast prions become important models for the study of the basic mechanisms underlying human amyloid diseases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Yeast prions have indeed become important models for studying the basic mechanisms underlying human amyloid diseases. Prions are infectious proteins that can cause other proteins to misfold, and this misfolding is a key feature of amyloid diseases. Yeast prions provide a simpler system to study these processes, allowing researchers to understand the fundamental aspects of protein misfolding and aggregation, which are relevant to human diseases such as Alzheimer's and Parkinson's.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a link between BCL11B haploinsufficiency and syndromic neurodevelopmental delay?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"BCL11B is a gene that plays a role in the development of the brain and other tissues. Haploinsufficiency refers to a condition where a person has only one functional copy of a gene, and this can lead to various developmental issues. Research has shown that BCL11B haploinsufficiency is associated with a range of neurodevelopmental disorders, including intellectual disabilities and developmental delays. Therefore, there is evidence to suggest a link between BCL11B haploinsufficiency and syndromic neurodevelopmental delay.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is the PINES framework being used for the prediction of coding variants?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the PINES framework is utilized for predicting coding variants. To answer this, one must know what the PINES framework is and its applications. If the PINES framework is specifically designed or used for predicting coding variants, the answer would be yes. Otherwise, it would be no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Tecovirimat effective for smallpox?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tecovirimat, also known as TPOXX, is an antiviral medication that has been approved for the treatment of smallpox. It works by inhibiting the activity of the VP37 protein, which is essential for the virus to spread within the body. The approval of Tecovirimat for smallpox treatment is based on studies conducted in animals, as smallpox has been eradicated and human trials are not possible. These studies have shown that Tecovirimat is effective in reducing mortality and viral load in animals infected with viruses similar to smallpox. Therefore, it is considered effective for smallpox treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cabozantinib effective for hepatocellular carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cabozantinib is a medication that has been studied for its effectiveness in treating hepatocellular carcinoma (HCC), which is a common type of liver cancer. Clinical trials and studies have shown that cabozantinib can be effective in treating HCC, particularly in patients who have previously been treated with other therapies. It works by inhibiting certain proteins that promote cancer cell growth and angiogenesis. Based on the available evidence, cabozantinib is considered an effective treatment option for hepatocellular carcinoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Baloxavir effective for influenza?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Baloxavir marboxil is an antiviral medication that is used to treat influenza. It is known to be effective in reducing the duration of flu symptoms if taken within 48 hours of symptom onset. Clinical studies have shown that it can reduce the duration of flu symptoms by about a day compared to placebo. It works by inhibiting the cap-dependent endonuclease activity of the viral polymerase, which is necessary for viral replication. Therefore, it is considered effective for treating influenza.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is ibudilast effective for multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ibudilast is a drug that has been studied for its potential effectiveness in treating multiple sclerosis (MS). Clinical trials have been conducted to evaluate its efficacy and safety for MS patients. Some studies have shown that ibudilast may have a positive impact on slowing the progression of disability in MS, particularly in progressive forms of the disease. However, the overall effectiveness and approval for use in MS treatment may vary based on regulatory decisions and further research outcomes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Adar3 involved in learning and memory?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Adar3, also known as ADAR3, is a member of the adenosine deaminases acting on RNA (ADAR) family, which are enzymes that edit RNA molecules by converting adenosine to inosine. While ADAR1 and ADAR2 have been more extensively studied and are known to play roles in various biological processes, including those related to the nervous system, the specific role of ADAR3 is less well understood. However, there is some evidence suggesting that ADAR3 may be involved in the regulation of processes related to learning and memory, as it is predominantly expressed in the brain and may influence RNA editing in neural tissues. Despite this, the exact mechanisms and extent of its involvement in learning and memory are not fully established.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is deletion at 6q24.2-26 associated with longer survival of patients with high-grade serous ovarian carcinoma (HGSOCs)?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks if a specific genetic deletion, 6q24.2-26, is linked to longer survival in patients with high-grade serous ovarian carcinoma (HGSOCs). To answer this, one would need to refer to scientific studies or clinical data that investigate the relationship between this genetic alteration and patient survival outcomes. Without specific evidence or studies indicating such an association, it is not possible to affirmatively state that the deletion is linked to longer survival.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is  LRP1 interacting with Urokinase receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if LRP1 interacts with the Urokinase receptor, we need to consider existing scientific literature and research studies. LRP1, or Low-Density Lipoprotein Receptor-Related Protein 1, is known to interact with various ligands and receptors. The Urokinase receptor, also known as uPAR, is involved in processes like cell signaling and tissue remodeling. There is evidence in scientific literature suggesting that LRP1 can indeed interact with the Urokinase receptor, facilitating processes such as endocytosis and cell migration. Therefore, based on available research, it is reasonable to conclude that LRP1 does interact with the Urokinase receptor.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is chlorotoxin a peptide?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Chlorotoxin is a peptide derived from the venom of the deathstalker scorpion. It is known for its ability to bind to certain types of cancer cells, making it useful in medical research and treatment. Peptides are short chains of amino acids, and chlorotoxin fits this definition as it is composed of 36 amino acids.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is selenocysteine an aminoacid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Selenocysteine is known as the 21st amino acid. It is similar to cysteine but contains selenium instead of sulfur. It is incorporated into proteins via a unique mechanism during translation and is considered a proteinogenic amino acid. Therefore, it is indeed classified as an amino acid.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is phospholipid hydroperoxide glutathione peroxidase a selenoprotein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Phospholipid hydroperoxide glutathione peroxidase is indeed a selenoprotein. Selenoproteins are proteins that include selenocysteine, an amino acid that contains selenium. This enzyme is known to contain selenocysteine in its active site, which is crucial for its function in reducing lipid hydroperoxides. Therefore, it qualifies as a selenoprotein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is P. gingivalis bacteria found in brain?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"P. gingivalis is a type of bacteria commonly associated with periodontal disease. Recent studies have suggested that P. gingivalis can be found in the brain and may be linked to Alzheimer's disease. This has been a topic of research as scientists explore the potential connection between oral health and neurological conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "There is no drug available to prevent HIV infection, Pre-exposure prophylaxis (PrEP), yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether there is a drug available to prevent HIV infection, specifically referring to Pre-exposure prophylaxis (PrEP). PrEP is indeed a medication that can be taken by HIV-negative individuals to reduce the risk of contracting HIV. Therefore, the statement that there is no drug available to prevent HIV infection is incorrect. PrEP is an effective preventive measure against HIV.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is cariprazine effective for treatment of bipolar disorder?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cariprazine is an atypical antipsychotic that has been studied for its effectiveness in treating bipolar disorder. Clinical trials and studies have shown that cariprazine can be effective in managing symptoms of bipolar disorder, particularly in treating manic or mixed episodes. It is approved by the FDA for this use, indicating that it has been found to be effective and safe for treating bipolar disorder in many patients.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Groucho related gene 5 (GRG5) have a role only in late development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if GRG5 has a role only in late development, we need to consider its functions throughout different stages of development. GRG5, also known as TLE5, is part of the Groucho/TLE family of transcriptional co-repressors, which are involved in various developmental processes. These proteins are known to interact with other transcription factors to regulate gene expression. While specific roles of GRG5 in late development might be documented, it is important to consider that proteins in this family often have roles in multiple stages of development, including early stages. Therefore, it is unlikely that GRG5 is limited to only late developmental roles.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the yeast (Saccharomyces cerevisiae) genome organized into topologically associated domains (TADs)?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Topologically associated domains (TADs) are regions of the genome that interact more frequently with themselves than with other regions. They are a feature of chromatin organization in many eukaryotic organisms, particularly in higher eukaryotes like mammals. In yeast, specifically Saccharomyces cerevisiae, the genome is organized differently. Yeast has a more compact genome and lacks some of the higher-order chromatin structures found in more complex eukaryotes. Studies have shown that yeast does not have TADs in the same way that they are present in higher eukaryotes. Instead, yeast chromatin organization is more influenced by other factors such as transcriptional activity and the presence of nucleosomes. Therefore, the yeast genome is not organized into TADs.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there any role for HUWE1 in MYC signalling?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"HUWE1 is an E3 ubiquitin ligase that has been implicated in various cellular processes, including protein degradation and regulation of transcription factors. MYC is a well-known transcription factor involved in cell growth and proliferation. There is evidence suggesting that HUWE1 can ubiquitinate MYC, leading to its degradation, thereby playing a role in MYC signaling pathways.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is TIAM1 favoring tumor progression in colorectal cancer (CRC)?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"TIAM1, or T-cell lymphoma invasion and metastasis 1, is a guanine nucleotide exchange factor that is involved in the regulation of cell signaling pathways. In the context of colorectal cancer, TIAM1 has been studied for its role in tumor progression. Research indicates that TIAM1 can promote tumor progression by enhancing cell migration, invasion, and metastasis. Therefore, it is generally considered to favor tumor progression in colorectal cancer.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Are de novo mutations in regulatory elements responsible for neurodevelopmental disorders?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"De novo mutations are new genetic mutations that occur in an individual and are not inherited from either parent. Regulatory elements are regions of DNA that control gene expression. Neurodevelopmental disorders are conditions that affect the development of the nervous system, leading to neurological and psychological issues. Research has shown that de novo mutations in regulatory elements can contribute to neurodevelopmental disorders by disrupting the normal regulation of genes important for brain development. Therefore, it is plausible that such mutations could be responsible for some cases of neurodevelopmental disorders.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are recessive coding variants responsible for the majority of undiagnosed nonconsanguineous individuals?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether recessive coding variants are the main cause of undiagnosed conditions in individuals who are not from consanguineous backgrounds. Recessive coding variants require two copies of a mutated gene to manifest a condition, and these are more commonly observed in consanguineous populations due to the higher likelihood of inheriting the same variant from both parents. In nonconsanguineous populations, the likelihood of both parents carrying the same recessive variant is lower, suggesting that recessive coding variants might not be the predominant cause of undiagnosed conditions in these individuals.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the NLM medical text indexer (MTI) still useful and relevant?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The NLM Medical Text Indexer (MTI) is a tool developed by the National Library of Medicine to assist in the indexing of biomedical literature. It uses algorithms to suggest Medical Subject Headings (MeSH) terms for articles, which helps in organizing and retrieving medical information. Given the continuous growth of biomedical literature and the need for efficient information retrieval, tools like MTI remain relevant. However, the relevance of MTI also depends on its ability to adapt to new advancements in natural language processing and machine learning, as well as its integration with current medical databases and indexing practices.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cohesin linked to myeloid differentiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cohesin is a protein complex known for its role in chromosome segregation during cell division. It also plays a role in regulating gene expression and maintaining genome stability. Myeloid differentiation is the process by which hematopoietic stem cells develop into myeloid lineage cells, such as granulocytes, monocytes, and others. Research has suggested that cohesin may be involved in regulating the expression of genes important for myeloid differentiation. Therefore, there is a link between cohesin and myeloid differentiation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is erythropoietin effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Erythropoietin is primarily known for its role in stimulating red blood cell production. It has been studied for various other potential therapeutic effects, including neuroprotection. However, the effectiveness of erythropoietin in treating amyotrophic lateral sclerosis (ALS) is not well-established. Clinical trials and studies have not conclusively shown that erythropoietin is effective for ALS treatment. Therefore, based on current scientific evidence, erythropoietin is not considered an effective treatment for ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mogamulizumab is a monoclonal antibody that targets the CCR4 receptor, which is often expressed on certain types of T-cell lymphomas, including cutaneous T-cell lymphoma (CTCL). It has been approved for use in the treatment of CTCL, particularly for patients who have received prior systemic therapy. Therefore, it is indeed used as a treatment option for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has ivosidenib been FDA approved for use against acute myeloid leukemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ivosidenib is a medication that has been evaluated for its effectiveness in treating acute myeloid leukemia (AML). The FDA approval status of a drug is determined based on clinical trials and evidence of its safety and efficacy. As of the latest information available, ivosidenib has been approved by the FDA for use in treating certain cases of AML, specifically for patients with a susceptible IDH1 mutation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can CPX-351 be used for the treatment of tuberculosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CPX-351, also known as Vyxeos, is a liposomal formulation of daunorubicin and cytarabine used primarily for the treatment of certain types of acute myeloid leukemia (AML). It is not indicated for the treatment of tuberculosis, which is a bacterial infection typically treated with antibiotics such as isoniazid, rifampicin, ethambutol, and pyrazinamide. Therefore, CPX-351 is not used for tuberculosis treatment.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does lucatumumab bind to CD140?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lucatumumab is a monoclonal antibody that targets CD40, not CD140. CD140 is another name for the platelet-derived growth factor receptor (PDGFR). Therefore, lucatumumab does not bind to CD140.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is lucatumumab a polyclonal antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lucatumumab is a monoclonal antibody, not a polyclonal antibody. Monoclonal antibodies are derived from a single clone of cells and are specific to a single epitope, whereas polyclonal antibodies are derived from multiple clones and can bind to multiple epitopes. Therefore, lucatumumab, being a monoclonal antibody, is not a polyclonal antibody.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can midostaurin inhibit angiogenesis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Midostaurin is a multi-targeted kinase inhibitor that is primarily used in the treatment of certain types of cancer, such as acute myeloid leukemia (AML) with FLT3 mutations. It works by inhibiting multiple kinases, including FLT3, KIT, and PDGFR, which are involved in the proliferation and survival of cancer cells. Angiogenesis, the process of new blood vessel formation, is often a target in cancer treatment because tumors require a blood supply to grow and metastasize. While midostaurin is not primarily known as an angiogenesis inhibitor, its ability to inhibit kinases like PDGFR could potentially have an impact on angiogenesis, as PDGFR is involved in the regulation of blood vessel formation. However, midostaurin is not specifically classified or primarily used as an angiogenesis inhibitor.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can enasidenib be used for the treatment of acute myeloid leukemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Enasidenib is a medication that is specifically used for the treatment of acute myeloid leukemia (AML) with an IDH2 mutation. It is an approved therapy for patients with relapsed or refractory AML who have this specific genetic mutation. Therefore, enasidenib can indeed be used for the treatment of acute myeloid leukemia, but it is important to note that its use is limited to cases where the IDH2 mutation is present.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is lithium effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Lithium has been studied as a potential treatment for ALS, but the results have been mixed. Some early studies suggested that lithium might slow the progression of ALS, but subsequent larger and more rigorous studies have not confirmed these findings. As of the latest research, lithium is not considered an effective treatment for ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is celecoxib effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) that is primarily used to treat pain and inflammation. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects nerve cells in the brain and spinal cord. While there have been studies exploring the potential use of anti-inflammatory drugs in ALS treatment, there is no conclusive evidence that celecoxib is effective for treating ALS. Current standard treatments for ALS focus on slowing disease progression and managing symptoms, but celecoxib is not among the commonly recommended treatments for ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is pacritinib effective for treatment of myelofibrosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Pacritinib is a medication that has been studied for its effectiveness in treating myelofibrosis, a type of bone marrow cancer. Clinical trials have shown that pacritinib can be effective in reducing symptoms and improving blood counts in patients with myelofibrosis, particularly in those with low platelet counts. The FDA has approved pacritinib for certain patients with myelofibrosis, indicating that it is considered effective for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do raspberries improve postprandial glucose and acute and chronic inflammation in adults with type 2 Diabetes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether raspberries have a beneficial effect on postprandial glucose levels and inflammation in adults with type 2 diabetes. Postprandial glucose refers to blood sugar levels after eating, and inflammation can be both acute (short-term) and chronic (long-term). Raspberries are known to contain antioxidants and other compounds that might influence blood sugar and inflammation. However, without specific studies or evidence directly linking raspberries to these effects in adults with type 2 diabetes, it is difficult to definitively say 'yes'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Has Hesperidin any role as a Neuroprotective Agent?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Hesperidin is a flavonoid commonly found in citrus fruits and has been studied for its potential health benefits. Research has suggested that hesperidin may have neuroprotective effects due to its antioxidant and anti-inflammatory properties. These properties can help protect nerve cells from damage and may contribute to its role as a neuroprotective agent. However, while there is promising evidence, more research is needed to fully understand its efficacy and mechanisms in humans.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there tools for visualizing and processing long-read sequencing data?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Long-read sequencing data, such as that produced by technologies like PacBio and Oxford Nanopore, requires specialized tools for visualization and processing due to its unique characteristics, such as longer read lengths and higher error rates compared to short-read sequencing. There are indeed tools available that cater specifically to these needs, allowing researchers to effectively analyze and interpret long-read sequencing data.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a deep-learning algorithm for protein solubility prediction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Deep learning algorithms have been increasingly applied in the field of bioinformatics, including protein solubility prediction. These algorithms can analyze large datasets and identify patterns that might not be apparent through traditional methods. Various research studies and projects have developed deep learning models specifically for predicting protein solubility, leveraging neural networks and other advanced techniques to improve accuracy and efficiency.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cabozantinib effective for Hepatocellular Carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cabozantinib is a medication that has been studied and used for the treatment of various cancers, including Hepatocellular Carcinoma (HCC). Clinical trials and studies have shown that cabozantinib can be effective in treating HCC, particularly in patients who have previously been treated with other therapies. It works by inhibiting multiple tyrosine kinases, which are involved in tumor growth and angiogenesis. Therefore, based on the available evidence, cabozantinib is considered an effective treatment option for HCC.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is dupilumab effective for treatment of asthma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Dupilumab is a monoclonal antibody that targets the interleukin-4 receptor alpha subunit, which is involved in the inflammatory response associated with asthma. Clinical studies have shown that dupilumab can reduce asthma exacerbations, improve lung function, and decrease the need for oral corticosteroids in patients with moderate to severe asthma. Therefore, it is considered effective for the treatment of asthma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is verubecestat effective for Alzheimerâ€™s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Verubecestat is a BACE inhibitor that was investigated for its potential to treat Alzheimer's Disease. Clinical trials, however, showed that it was not effective in improving cognitive function or slowing the progression of Alzheimer's Disease. In fact, some studies indicated that it might even worsen cognitive decline. As a result, the development of verubecestat for Alzheimer's treatment was discontinued.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does Eucommia ulmoides leaf extract ameliorates steatosis/fatty liver induced by high-fat diet?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Eucommia ulmoides leaf extract has been studied for its potential health benefits, including its effects on liver health. Some research suggests that it may have a positive impact on reducing liver fat and improving liver function in cases of diet-induced fatty liver. However, the effectiveness can vary based on the specific study, dosage, and methodology used. Overall, there is some evidence supporting its beneficial effects on fatty liver conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there ultraconserved regions in the budding yeast (Saccharomyces cerevisiae)?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ultraconserved regions are sequences of DNA that are highly conserved across different species, often indicating important functional roles. In the context of budding yeast, Saccharomyces cerevisiae, it is known for having a relatively small and well-studied genome. While there are conserved regions within its genome, ultraconserved regions are typically discussed in the context of more complex organisms, such as vertebrates. Therefore, the presence of ultraconserved regions in Saccharomyces cerevisiae is unlikely.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are there graph kernel libraries available implemented in JAVA?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if there are graph kernel libraries available in JAVA, we need to consider the availability of graph kernel implementations in the Java programming language. Graph kernels are algorithms used to measure the similarity between graphs, and they are often used in machine learning tasks involving graph-structured data. Java is a popular programming language, and it is likely that libraries or frameworks have been developed to implement graph kernels. A search for Java-based graph kernel libraries or frameworks would provide a definitive answer.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can you computationally predict Molecular Recognition Features (MoRFs) regions in Intrinsically Disordered Proteins (IDPs)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Molecular Recognition Features (MoRFs) are specific regions within Intrinsically Disordered Proteins (IDPs) that can undergo a disorder-to-order transition upon binding to a partner molecule. Computational methods have been developed to predict these regions by analyzing sequence data and using machine learning algorithms. These methods rely on the identification of patterns and features that are characteristic of MoRFs, such as sequence composition, physicochemical properties, and evolutionary conservation. Therefore, it is possible to computationally predict MoRFs regions in IDPs using these advanced techniques.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there tools for reviewing variant calls?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there are tools available for reviewing variant calls. Variant calling is a process in genomics where variations from a reference genome are identified. There are indeed various tools and software designed for this purpose, such as GATK, FreeBayes, and VarScan, among others. These tools help in analyzing and reviewing the variant calls to ensure accuracy and reliability in genomic studies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is baricitinib effective for rheumatoid arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Baricitinib is a medication that has been studied and used for the treatment of rheumatoid arthritis. It is a Janus kinase (JAK) inhibitor that works by interfering with the signaling pathways that contribute to the inflammatory process in rheumatoid arthritis. Clinical trials and studies have shown that baricitinib can be effective in reducing the symptoms of rheumatoid arthritis, such as joint pain and swelling, and improving physical function. Therefore, it is considered an effective treatment option for rheumatoid arthritis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is galcanezumab effective for treatment of migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Galcanezumab is a monoclonal antibody that targets the calcitonin gene-related peptide (CGRP), which is involved in the pathophysiology of migraines. Clinical trials and studies have shown that galcanezumab is effective in reducing the frequency of migraine attacks and improving the quality of life for individuals suffering from migraines. It is approved by regulatory agencies such as the FDA for the prevention of migraines, indicating its efficacy in treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Lasmiditan effective for migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lasmiditan is a medication that has been studied and used for the treatment of migraines. Clinical trials and research have shown that lasmiditan can be effective in reducing the symptoms of migraines. It is a selective serotonin 5-HT1F receptor agonist, which is a different mechanism of action compared to traditional migraine medications like triptans. The effectiveness of lasmiditan has been demonstrated in various studies, leading to its approval for use in treating acute migraine attacks. Therefore, based on available evidence, lasmiditan is considered effective for migraines.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is pimavanserin effective for Parkinson's disease psychosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Pimavanserin is a medication that has been studied for its effectiveness in treating Parkinson's disease psychosis. Clinical trials and studies have shown that pimavanserin can be effective in reducing the symptoms of psychosis in patients with Parkinson's disease. It is specifically approved for this use, indicating that it has been found to be effective in this context.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does an interferon (IFN) signature exist for SLE patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the body's immune system attacking its own tissues. Research has shown that patients with SLE often exhibit an increased expression of interferon-stimulated genes, which is referred to as an 'interferon signature'. This signature is associated with disease activity and severity in SLE patients. Therefore, the presence of an interferon signature is a recognized feature in SLE.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can Diazepam be beneficial  in the treatment of  traumatic brain injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Diazepam is a medication that is primarily used to treat anxiety, muscle spasms, and seizures. It is a type of benzodiazepine that works by calming the brain and nerves. In the context of traumatic brain injury (TBI), the use of diazepam is not typically considered beneficial for treating the injury itself. While it may be used to manage symptoms such as anxiety or muscle spasms that can occur after a TBI, it does not address the underlying injury or promote healing. In fact, the use of benzodiazepines in TBI patients can be controversial due to potential side effects such as sedation, which may interfere with neurological assessments and recovery. Therefore, diazepam is not generally considered a treatment for traumatic brain injury itself.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are genes that escape X-chromosome inactivation related to mental impairment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether genes that escape X-chromosome inactivation are related to mental impairment. X-chromosome inactivation is a process by which one of the two X chromosomes in females is inactivated to balance the dosage of X-linked genes between males and females. Some genes escape this inactivation and remain active. Research has suggested that these escaping genes can be involved in various biological processes, including those related to brain function and development. Therefore, there is a possibility that they could be linked to mental impairment, as abnormalities in these genes might affect cognitive functions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "As of Feb 2019, are major brain gangliosides a target for the treatment of Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"In February 2019, research into Alzheimer's disease was exploring various targets for treatment, including brain gangliosides. Gangliosides are a group of glycosphingolipids that are abundant in the brain and have been implicated in neurodegenerative diseases. They play a role in cell signaling and neuronal function, and alterations in their metabolism have been associated with Alzheimer's disease. Therefore, targeting brain gangliosides was considered a potential therapeutic strategy for Alzheimer's disease at that time.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is pazopanib an effective treatment of glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pazopanib is a tyrosine kinase inhibitor that targets multiple receptors involved in tumor growth and angiogenesis. It is primarily approved for the treatment of renal cell carcinoma and soft tissue sarcoma. Glioblastoma is a highly aggressive brain tumor with limited treatment options. While there have been studies exploring the use of pazopanib for glioblastoma, the results have been mixed and it is not currently a standard or widely accepted treatment for this type of cancer. Therefore, based on current evidence and approvals, pazopanib is not considered an effective treatment for glioblastoma.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is avelumab effective for bladder cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Avelumab is a type of immunotherapy known as a checkpoint inhibitor. It has been studied for its effectiveness in treating various types of cancer, including bladder cancer. Specifically, avelumab has been approved for use in patients with locally advanced or metastatic urothelial carcinoma, a common type of bladder cancer, particularly after the disease has progressed following platinum-containing chemotherapy. Clinical trials have shown that avelumab can help improve survival rates in some patients with advanced bladder cancer. Therefore, it is considered an effective treatment option for certain cases of bladder cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can pazopanib be used for treatment von Hippel-Lindau disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pazopanib is a medication primarily used to treat certain types of cancer, such as renal cell carcinoma and soft tissue sarcoma. Von Hippel-Lindau (VHL) disease is a genetic disorder characterized by the formation of tumors and cysts in different parts of the body. While pazopanib is not specifically approved for the treatment of VHL disease, there is some research and clinical interest in its potential use for managing certain aspects of the disease, particularly in cases where tumors are present. However, its use for VHL would be considered off-label and should be guided by a healthcare professional.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Miller-Dieker syndrome associated with abnormalities of chromosome 1?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Miller-Dieker syndrome is a genetic disorder that is primarily associated with abnormalities of chromosome 17, specifically a deletion on the short arm of chromosome 17 (17p13.3). It is not associated with abnormalities of chromosome 1.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should dacomitinib be used for treatment of glioblastoma patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Dacomitinib is a medication that is primarily used to treat non-small cell lung cancer (NSCLC) with specific genetic mutations. Glioblastoma is a type of brain cancer, and the treatment for glioblastoma typically involves a combination of surgery, radiation therapy, and chemotherapy with drugs like temozolomide. While there is ongoing research into various treatments for glioblastoma, including targeted therapies, dacomitinib is not currently a standard or approved treatment for glioblastoma patients. Therefore, based on current medical guidelines and approvals, dacomitinib should not be used for the treatment of glioblastoma patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is inositol effective for trichotillomania?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Inositol is a type of sugar that influences the insulin response and several hormones associated with mood and cognition. Some studies have suggested that inositol may have beneficial effects on certain mental health conditions, including anxiety and depression. Trichotillomania, a condition characterized by an irresistible urge to pull out one's hair, is often considered a type of obsessive-compulsive disorder. There is limited research specifically on the effectiveness of inositol for trichotillomania. While some anecdotal evidence and small studies might suggest potential benefits, there is not enough robust scientific evidence to definitively conclude that inositol is effective for treating trichotillomania.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is eculizumab used for treatment of myasthenia gravis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Eculizumab is a medication that is known to be used in the treatment of certain conditions. Myasthenia gravis is an autoimmune disorder that affects the neuromuscular junction, leading to muscle weakness. Eculizumab has been approved for the treatment of generalized myasthenia gravis in patients who are anti-acetylcholine receptor antibody-positive. Therefore, it is indeed used in the treatment of myasthenia gravis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Semagacestat effective for treatment of Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Semagacestat was a drug developed as a gamma-secretase inhibitor for the treatment of Alzheimer's disease. However, clinical trials showed that it was not effective and even worsened cognitive function in patients. As a result, the development of Semagacestat was discontinued.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does simvastatin improve outcomes of aneurysmal subarachnoid hemorrhage?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Simvastatin is a medication primarily used to control high cholesterol and reduce the risk of cardiovascular disease. There has been research into its potential neuroprotective effects, including its use in patients with aneurysmal subarachnoid hemorrhage (aSAH). Some studies suggest that statins like simvastatin may have beneficial effects in improving outcomes after aSAH, potentially due to their anti-inflammatory and vasodilatory properties. However, the evidence is not conclusive, and more research is needed to definitively determine its efficacy in this context.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does tremelimumab improve survival of mesothelioma patients?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tremelimumab is an immunotherapy drug that has been studied for its potential to improve survival in patients with mesothelioma, a type of cancer. Clinical trials have been conducted to evaluate its efficacy. Some studies have shown that tremelimumab can have a positive impact on survival rates, while others have not demonstrated a significant improvement. Therefore, the effectiveness of tremelimumab in improving survival for mesothelioma patients may vary depending on individual cases and specific study results.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Axitinib is a tyrosine kinase inhibitor that primarily targets vascular endothelial growth factor receptors. It is primarily used in the treatment of renal cell carcinoma. While there have been studies exploring the use of Axitinib in various cancers, including pancreatic cancer, it is not a standard treatment for pancreatic cancer. The effectiveness of Axitinib in prolonging survival in pancreatic cancer patients has not been conclusively demonstrated in clinical trials. Therefore, based on the current evidence, Axitinib is not recognized as a treatment that prolongs survival in pancreatic cancer patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does Panitumumab prolong survival of biliary tract cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Panitumumab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is primarily used in the treatment of metastatic colorectal cancer. While there have been studies exploring the use of EGFR inhibitors in biliary tract cancers, the evidence supporting the use of Panitumumab specifically for prolonging survival in biliary tract cancer patients is limited and not well-established. Therefore, based on current knowledge and available data, it is not confirmed that Panitumumab prolongs survival in biliary tract cancer patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the enzyme ERAP2 associated with the disease birdshot chorioretinopathy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Birdshot chorioretinopathy is a rare eye disease characterized by inflammation of the retina and choroid. It is known to have a strong association with the HLA-A29 gene. ERAP2, or Endoplasmic Reticulum Aminopeptidase 2, is an enzyme involved in the processing of peptide antigens for presentation by MHC class I molecules. While ERAP2 has been studied in the context of various autoimmune and inflammatory diseases, there is no direct evidence or widely recognized association between ERAP2 and birdshot chorioretinopathy specifically. The primary genetic association for birdshot chorioretinopathy remains with HLA-A29.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is ADP-ribosylation a PTM?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ADP-ribosylation is a type of post-translational modification (PTM) where an ADP-ribose moiety is transferred to a target protein. This modification can affect the function, activity, or localization of the protein. PTMs are chemical modifications that occur to proteins after they have been synthesized, and they play crucial roles in regulating protein function and cellular processes. Therefore, ADP-ribosylation is indeed considered a post-translational modification.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is collagen the most abundant human protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Collagen is a structural protein that is a major component of connective tissues in the body, including skin, tendons, ligaments, and bones. It is indeed the most abundant protein in the human body, making up about 30% of the total protein content. This makes it more prevalent than other proteins such as keratin or elastin.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Mesenchymal stem cells (MSC) multipotent cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mesenchymal stem cells (MSCs) are a type of stem cell that can differentiate into a variety of cell types. They are known for their ability to develop into cells that make up bone, cartilage, muscle, and fat. This ability to differentiate into multiple types of cells is what defines them as multipotent. Therefore, MSCs are indeed considered multipotent cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is TIM-3 a target for cancer immunotherapy in NSCLC?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"TIM-3 is a protein that is expressed on immune cells and has been identified as a potential target for cancer immunotherapy. In the context of non-small cell lung cancer (NSCLC), targeting TIM-3 is being explored as a strategy to enhance the immune response against cancer cells. Research and clinical trials are ongoing to determine the efficacy of TIM-3 inhibitors in NSCLC treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are phagosomal proteins ubiquitinated?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Phagosomal proteins can indeed undergo ubiquitination. Ubiquitination is a process where ubiquitin molecules are attached to a substrate protein, often marking it for degradation by the proteasome, altering its cellular location, affecting its activity, or promoting or preventing protein interactions. In the context of phagosomes, ubiquitination can play a role in regulating the maturation and function of these organelles, as well as in the degradation of engulfed pathogens or cellular debris. Therefore, it is accurate to say that phagosomal proteins can be ubiquitinated.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any approved treatment for NAFLD?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"NAFLD, or non-alcoholic fatty liver disease, currently does not have any specific medications approved by regulatory agencies like the FDA for its treatment. Management typically focuses on lifestyle changes such as diet, exercise, and weight loss. Some medications may be used to manage associated conditions like diabetes or high cholesterol, but there is no specific approved treatment for NAFLD itself.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are tumour specific antigens originating from known protein coding genes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tumour specific antigens can originate from various sources, including known protein coding genes. These antigens are often derived from proteins that are abnormally expressed or mutated in cancer cells. Therefore, it is possible for tumour specific antigens to originate from known protein coding genes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is treatment with Bacillus Calmette Guerin used for bladder cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bacillus Calmette Guerin (BCG) is a type of immunotherapy that is commonly used as a treatment for bladder cancer, particularly non-muscle invasive bladder cancer. It is administered directly into the bladder to help stimulate the immune system to attack cancer cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Rhamnose have any effect on aging?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Rhamnose is a naturally occurring sugar that is found in many plants. It is often used in skincare products due to its potential benefits for the skin. Some studies suggest that rhamnose may have anti-aging effects, particularly in terms of improving skin elasticity and reducing wrinkles. However, the evidence is not definitive, and more research is needed to fully understand its impact on aging.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are apoE mimetics being considered as a treatment against Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ApoE mimetics are being researched as potential treatments for Alzheimer's disease due to their ability to mimic the functions of the apolipoprotein E, which is involved in lipid metabolism and has been linked to Alzheimer's pathology. Researchers are exploring their therapeutic potential in modulating amyloid-beta aggregation and neuroinflammation, which are key factors in Alzheimer's disease progression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is L-4F an apoE mimetic peptide?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"L-4F is a synthetic peptide designed to mimic the structure and function of apolipoprotein A-I, not apolipoprotein E (apoE). Therefore, it is not considered an apoE mimetic peptide.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can oleuropein aglycone interfere with amyloid aggregation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Oleuropein aglycone is a compound found in olive oil that has been studied for its potential health benefits, including its effects on amyloid aggregation. Amyloid aggregation is a process involved in the development of diseases such as Alzheimer's. Research has suggested that oleuropein aglycone may have the ability to interfere with amyloid aggregation, potentially reducing the formation of amyloid plaques.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Crocus sativus compounds being considered against Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Crocus sativus, commonly known as saffron, has been studied for its potential therapeutic effects on various conditions, including Alzheimer's disease. Research has indicated that certain compounds in saffron, such as crocin and safranal, may have neuroprotective properties and could be beneficial in the treatment or management of Alzheimer's disease. Therefore, it is reasonable to conclude that Crocus sativus compounds are being considered in the context of Alzheimer's disease research.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do Crocus sativus extracts loosen the blood-brain barrier?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Crocus sativus, commonly known as saffron, is a plant whose extracts have been studied for various health benefits. However, there is limited scientific evidence to suggest that Crocus sativus extracts have the ability to loosen or affect the blood-brain barrier. The blood-brain barrier is a selective permeability barrier that protects the brain from potentially harmful substances in the bloodstream. While some studies may explore the effects of different compounds on the blood-brain barrier, there is no well-documented evidence that specifically supports the claim that Crocus sativus extracts can loosen it.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Netrin-1 a secreted protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Netrin-1 is a protein that is known to be secreted. It belongs to a family of proteins that are involved in axon guidance and cell migration. These proteins are typically secreted into the extracellular space where they can interact with receptors on the surface of cells to influence their behavior. Therefore, based on this information, Netrin-1 is indeed a secreted protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Have apolipoprotein mimetics been used in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Apolipoprotein mimetics are synthetic peptides designed to mimic the structure and function of natural apolipoproteins. They have been studied for their potential therapeutic effects, particularly in cardiovascular diseases. Clinical trials are a key step in evaluating the safety and efficacy of new treatments. To determine if apolipoprotein mimetics have been used in clinical trials, one would need to review scientific literature and clinical trial registries. Based on available information, apolipoprotein mimetics have indeed been the subject of clinical trials.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has strimvelis been approved by the European Medicines Agency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Strimvelis is a gene therapy used to treat ADA-SCID, a rare genetic disorder. It was developed by GlaxoSmithKline and was approved by the European Medicines Agency (EMA) in 2016. This approval allows it to be marketed and used within the European Union.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein Asporin related to disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Asporin is a protein that is part of the small leucine-rich proteoglycan family and is involved in the regulation of extracellular matrix assembly. Research has shown that Asporin is associated with various diseases, particularly osteoarthritis. Genetic variations in the Asporin gene have been linked to an increased risk of developing osteoarthritis. Additionally, Asporin may play a role in other conditions related to tissue remodeling and fibrosis. Therefore, there is evidence that Asporin is related to disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is lactotransferrin a tumour suppressor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lactotransferrin, also known as lactoferrin, is a multifunctional protein that is part of the transferrin family. It is known for its role in the immune system, particularly in its antimicrobial and anti-inflammatory properties. There is some research suggesting that lactoferrin may have tumor-suppressing properties. Studies have indicated that lactoferrin can inhibit the growth of cancer cells and may play a role in preventing cancer development. However, the classification of lactoferrin as a definitive tumor suppressor is still under investigation, and more research is needed to fully understand its role in cancer biology.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has the protein SIRT2 been associated to cervical cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if SIRT2 has been associated with cervical cancer, we need to look at scientific research and studies that have investigated this connection. SIRT2 is a member of the sirtuin family of proteins, which are involved in various cellular processes, including aging and cancer. There have been studies that suggest a role for SIRT2 in different types of cancer, including cervical cancer. Research has indicated that SIRT2 may be involved in the progression or suppression of cervical cancer, depending on the context and cellular environment. Therefore, based on available scientific literature, SIRT2 has been associated with cervical cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does RUNX2 inhibit astrocyte differentiation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"RUNX2 is a transcription factor that is primarily known for its role in osteoblast differentiation and bone development. Its role in astrocyte differentiation is not well-documented, and there is no strong evidence suggesting that RUNX2 inhibits astrocyte differentiation. Therefore, the answer is likely no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can miR-122 target RUNX2?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if miR-122 can target RUNX2, we need to consider the biological interactions between microRNAs and genes. MicroRNAs (miRNAs) are small non-coding RNA molecules that can regulate gene expression by binding to complementary sequences on target messenger RNAs (mRNAs), usually resulting in gene silencing. RUNX2 is a transcription factor that plays a crucial role in bone development and osteoblast differentiation. The targeting of RUNX2 by miR-122 would depend on the presence of complementary binding sites for miR-122 on the RUNX2 mRNA. This information is typically determined through experimental studies or bioinformatics predictions. Without specific evidence or studies indicating that miR-122 targets RUNX2, we cannot definitively say that it does. Therefore, based on the information available, the answer is likely 'no'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can antisense threapy be used for Huntington's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Antisense therapy is a treatment approach that involves using antisense oligonucleotides (ASOs) to target and degrade specific RNA molecules, thereby reducing the production of harmful proteins. Huntington's disease is a genetic disorder caused by a mutation in the huntingtin gene, leading to the production of a toxic protein. Antisense therapy has been explored as a potential treatment for Huntington's disease by targeting the mutant huntingtin mRNA to reduce the levels of the toxic protein. Clinical trials have been conducted to evaluate the efficacy and safety of antisense therapy for Huntington's disease, indicating that it is a viable approach for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can prevnar 13 be used in children?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Prevnar 13 is a pneumococcal conjugate vaccine that is commonly used to protect against pneumococcal disease. It is approved for use in children, typically starting from 6 weeks of age. The vaccine is part of the routine immunization schedule for children in many countries, as it helps prevent infections caused by Streptococcus pneumoniae, such as pneumonia, meningitis, and sepsis. Therefore, it is indeed used in children as part of their vaccination regimen.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Was stelara developed by Amgen?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Stelara is a medication used to treat certain autoimmune conditions. It was developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, not by Amgen.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is ustekinumab a polyclonal antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ustekinumab is a monoclonal antibody, not a polyclonal antibody. Monoclonal antibodies are derived from a single cell line and are specific to a single epitope, whereas polyclonal antibodies are a mixture of antibodies that target multiple epitopes. Ustekinumab is specifically designed to target interleukin-12 and interleukin-23, making it a monoclonal antibody.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do tumour-associated macrophages have a prognostic role in gliomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tumour-associated macrophages (TAMs) are known to play a significant role in the tumor microenvironment, influencing tumor progression and the immune response. In gliomas, which are a type of brain tumor, research has shown that TAMs can affect the prognosis of the disease. They can contribute to tumor growth, invasion, and resistance to therapy. Studies have indicated that the presence and characteristics of TAMs in gliomas can be associated with patient outcomes, making them a potential prognostic factor.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can cardiospheres be produced from skin fibroblasts?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cardiospheres are a type of cardiac progenitor cell that can be derived from heart tissue. However, recent advancements in regenerative medicine and cellular reprogramming have shown that it is possible to convert skin fibroblasts into cardiac-like cells through a process called direct reprogramming. This involves the use of specific transcription factors to reprogram fibroblasts into induced cardiac progenitor cells, which can then form cardiospheres. Therefore, it is feasible to produce cardiospheres from skin fibroblasts through reprogramming techniques.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does the interaction of MOV10 and RNASEH2 promote L1 retrotransposition?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the interaction between MOV10 and RNASEH2 promotes L1 retrotransposition. L1 retrotransposition is a process involving the replication and insertion of LINE-1 elements into new locations in the genome. MOV10 is a helicase that has been reported to inhibit L1 retrotransposition, while RNASEH2 is involved in RNA processing and DNA repair. The interaction between these two proteins and their effect on L1 retrotransposition is not well-documented as promoting it. In fact, MOV10 is known to suppress L1 activity, suggesting that their interaction would not promote L1 retrotransposition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Tocilizumab is an anti-TNF antibody, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tocilizumab is not an anti-TNF antibody. It is actually an interleukin-6 (IL-6) receptor antagonist. Anti-TNF antibodies target tumor necrosis factor (TNF), whereas tocilizumab targets the IL-6 receptor, which is a different mechanism of action. Therefore, the statement that tocilizumab is an anti-TNF antibody is incorrect.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Velocardial facial syndrome, otherwise known as Di George syndrome  is caused by a deletion in chromosome 21, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Velocardial facial syndrome, also known as DiGeorge syndrome, is actually caused by a deletion in chromosome 22, specifically 22q11.2, not chromosome 21.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Anaplasma phagocytophilum is an obligate gram-negative, intracellular bacterium, yes  or no",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Anaplasma phagocytophilum is indeed an obligate intracellular bacterium that is gram-negative. It infects white blood cells and is transmitted by ticks. The question asks to confirm whether it is an obligate gram-negative, intracellular bacterium, which aligns with the known characteristics of Anaplasma phagocytophilum.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are cardenolides inhibitors of Na+/K+ ATPase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cardenolides are a class of chemical compounds that are known to inhibit the Na+/K+ ATPase enzyme. This enzyme is crucial for maintaining the electrochemical gradient across the cell membrane by pumping sodium out of and potassium into the cell. Cardenolides, such as digoxin and ouabain, bind to the Na+/K+ ATPase and inhibit its activity, which can lead to increased intracellular sodium levels and subsequent effects on cardiac muscle contraction. Therefore, cardenolides are indeed inhibitors of Na+/K+ ATPase.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is it possible to analyze exosomes with FACS?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Exosomes are small extracellular vesicles that can be analyzed using various techniques, including flow cytometry, also known as fluorescence-activated cell sorting (FACS). FACS can be used to analyze and sort exosomes based on their size and surface markers, although it may require specialized protocols and equipment due to the small size of exosomes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can mitochondria transfer from cell to cell?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mitochondria are known to transfer between cells through various mechanisms such as tunneling nanotubes, extracellular vesicles, and cell fusion. This intercellular transfer can play a role in cellular repair and communication.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can mitochondria pass through membrane nanotubes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mitochondria are known to be able to transfer between cells through structures called tunneling nanotubes (TNTs), which are a type of membrane nanotube. This process has been observed in various studies, indicating that mitochondria can indeed pass through these nanotubes to move from one cell to another.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is TNF-Î± an activator of pancreatic stellate cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"TNF-Î±, or Tumor Necrosis Factor-alpha, is a cytokine involved in systemic inflammation and is part of the body's immune response. Pancreatic stellate cells (PSCs) are known to play a significant role in pancreatic fibrosis and inflammation, particularly in conditions like chronic pancreatitis and pancreatic cancer. TNF-Î± is known to activate various cell types, including stellate cells in the liver. There is evidence suggesting that TNF-Î± can also activate pancreatic stellate cells, contributing to their role in inflammation and fibrosis in the pancreas.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are protamines ubiquitously expressed?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Protamines are small, arginine-rich proteins that are primarily associated with the packaging of DNA in the sperm of many animal species. They replace histones during the final stages of spermatogenesis and are crucial for the condensation of sperm chromatin. Protamines are not ubiquitously expressed in all cell types or tissues; their expression is largely restricted to the testes, where they play a role in sperm development. Therefore, protamines are not expressed in all cells or tissues throughout the body.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can therapeutic levels of  Vedolizumab be found in the breast milk of nursing mothers following treatment for Inflammatory bowel disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Vedolizumab is a medication used to treat inflammatory bowel disease, and there is interest in understanding its presence in breast milk. Studies have shown that vedolizumab can be detected in breast milk, but typically at low levels. The question asks if therapeutic levels can be found, which implies levels high enough to have a clinical effect. Current evidence suggests that while vedolizumab is present in breast milk, the levels are not high enough to be considered therapeutic.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if there are any anti-amyloid antibodies approved as drugs for Alzheimer's disease treatment, we need to consider the current state of medical approvals. Anti-amyloid antibodies are a class of drugs designed to target amyloid plaques in the brain, which are characteristic of Alzheimer's disease. As of the latest updates, there have been approvals for certain anti-amyloid antibodies for the treatment of Alzheimer's disease. These approvals indicate that such drugs are indeed available for clinical use in treating the disease.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is subdural empyema a complication of sinusitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Subdural empyema is a collection of pus between the dura mater and the arachnoid mater of the brain. It can occur as a complication of infections, including sinusitis. Sinusitis, particularly when it involves the frontal or ethmoid sinuses, can lead to the spread of infection to the brain, resulting in subdural empyema. Therefore, subdural empyema can indeed be a complication of sinusitis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are artificial blood cells available?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Artificial blood cells, also known as synthetic or artificial red blood cells, are being researched and developed, but they are not yet widely available for clinical use. Scientists have been working on creating artificial blood substitutes for various medical applications, such as transfusions, but these are still largely in the experimental stages. Some products have been tested in clinical trials, but they have not been approved for general use by regulatory bodies like the FDA. Therefore, as of now, artificial blood cells are not available for routine medical use.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is actin present in the nucleus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Actin is a well-known cytoskeletal protein primarily found in the cytoplasm, where it plays a crucial role in maintaining cell shape, motility, and division. However, research has shown that actin is also present in the nucleus, where it is involved in various nuclear processes such as chromatin remodeling, transcription regulation, and nuclear structure maintenance. Although its nuclear functions are not as well understood as its cytoplasmic roles, the presence of actin in the nucleus is well-documented in scientific literature.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Philadelphia chromosome a fusion between parts of chromosomes 1 and 9?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The Philadelphia chromosome is not a fusion between parts of chromosomes 1 and 9. It is actually a specific genetic abnormality in chromosome 22, where a part of chromosome 9 is translocated to it. This results in a fusion between the BCR gene on chromosome 22 and the ABL1 gene on chromosome 9, which is associated with chronic myeloid leukemia (CML). Therefore, the Philadelphia chromosome involves chromosomes 9 and 22, not 1 and 9.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is collagen matrix of human articular cartilage changing with disease?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether the collagen matrix in human articular cartilage undergoes changes when affected by disease. Articular cartilage is a smooth tissue that covers the ends of bones in joints, and it is crucial for smooth movement and cushioning. The collagen matrix is a key structural component of this cartilage. In diseases such as osteoarthritis, the integrity of the cartilage is compromised, and changes in the collagen matrix are often observed. These changes can include degradation, altered synthesis, and disorganization of collagen fibers, which contribute to the deterioration of cartilage function. Therefore, it is reasonable to conclude that the collagen matrix does change with disease.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can TAD disruption lead to disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"TADs, or Topologically Associating Domains, are regions of the genome that interact more frequently with each other than with other regions. Disruption of TADs can lead to misregulation of gene expression, which has been associated with various diseases, including cancer and developmental disorders. Therefore, TAD disruption can indeed lead to disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Estrogen lead to forkhead FoxA1 activation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Estrogen is a hormone that can influence various cellular processes. Forkhead FoxA1 is a transcription factor that can be activated by certain pathways. Estrogen can lead to the activation of FoxA1 through its interaction with estrogen receptors, which then can bind to DNA and activate transcription factors like FoxA1. Therefore, estrogen can indeed lead to the activation of FoxA1.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Apelin usually decreased in diabetes?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Apelin is a peptide that plays a role in various physiological processes, including glucose metabolism. Research has shown that levels of Apelin can be altered in metabolic disorders such as diabetes. In many studies, it has been observed that Apelin levels are decreased in individuals with diabetes, particularly type 2 diabetes. This decrease in Apelin may contribute to the impaired glucose metabolism and insulin resistance observed in diabetic patients. Therefore, it is generally accepted that Apelin is usually decreased in diabetes.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is Pim-1 a protein phosphatase?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pim-1 is not a protein phosphatase. It is actually a serine/threonine kinase, which means it adds phosphate groups to proteins rather than removing them. Protein phosphatases, on the other hand, are enzymes that remove phosphate groups from proteins. Therefore, Pim-1 does not function as a protein phosphatase.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the crystal structure of Pim-1 available?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the crystal structure of Pim-1 is available, one would typically check scientific databases such as the Protein Data Bank (PDB). Pim-1 is a kinase, and many kinases have had their structures resolved and deposited in such databases. Given the common interest in kinases for drug development, it is likely that the crystal structure of Pim-1 has been studied and made available.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is myc a tumour suppressor gene?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether 'myc' is a tumor suppressor gene. Myc is actually known as an oncogene, not a tumor suppressor gene. Oncogenes are genes that have the potential to cause cancer when mutated or expressed at high levels. Tumor suppressor genes, on the other hand, are genes that protect a cell from one step on the path to cancer. When these genes are mutated, they lose their ability to control cell growth and division, which can lead to cancer. Since myc is associated with promoting cell proliferation and is considered an oncogene, it is not classified as a tumor suppressor gene.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is CD63 an exosomal marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CD63 is a tetraspanin protein that is commonly used as a marker for exosomes. Exosomes are small extracellular vesicles that are released by cells and play a role in cell communication. CD63 is one of the proteins that is enriched in the membrane of exosomes, making it a useful marker for identifying and studying these vesicles.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does association with the nuclear pore promote gene silencing?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the association with the nuclear pore promotes gene silencing. The nuclear pore is a complex that regulates the transport of molecules between the nucleus and the cytoplasm. Gene silencing refers to the regulation of gene expression in a way that prevents the expression of a gene. The association with the nuclear pore can influence gene expression, but it does not inherently promote gene silencing. In some contexts, association with the nuclear pore can actually facilitate gene expression rather than silence it.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the process of DNA loop-extrusion independent of ATP?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The process of DNA loop-extrusion involves the active movement of cohesin and condensin complexes along DNA to form loops. This process is generally considered to be ATP-dependent because these complexes require energy to translocate along the DNA and form loops. ATP hydrolysis provides the necessary energy for these molecular motors to function. Therefore, DNA loop-extrusion is not independent of ATP.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are lamina-associated domains (LADs) associated with transcriptional activation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lamina-associated domains (LADs) are regions of the genome that are associated with the nuclear lamina. These regions are generally considered to be transcriptionally inactive or repressive. They are often associated with heterochromatin, which is a tightly packed form of DNA that is not actively transcribed. Therefore, LADs are not typically associated with transcriptional activation.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are the members of the KRAB-ZNF  gene family promoting gene repression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The KRAB-ZNF gene family is known for its role in gene repression. KRAB (KrÃ¼ppel-associated box) is a transcriptional repression domain found in many zinc finger proteins (ZNFs). These proteins are involved in regulating gene expression by binding to specific DNA sequences and recruiting other proteins that modify chromatin structure, leading to gene silencing. Therefore, the members of the KRAB-ZNF gene family are indeed associated with promoting gene repression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does deletion of cohesin change gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cohesin is a protein complex that plays a crucial role in chromosome segregation during cell division, as well as in the regulation of gene expression. It helps in the organization of chromatin structure and facilitates interactions between different regions of the genome. Deletion of cohesin can disrupt these processes, potentially leading to changes in gene expression. Studies have shown that cohesin is involved in the regulation of transcription by influencing the three-dimensional structure of the genome, which can affect the accessibility of transcription factors and other regulatory proteins to DNA. Therefore, it is reasonable to conclude that deletion of cohesin can indeed change gene expression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SATB1 expressed in thymocytes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SATB1 is a protein that is known to be expressed in thymocytes. Thymocytes are the precursors to T-cells and are found in the thymus. SATB1 plays a crucial role in the development and differentiation of these cells. Therefore, the expression of SATB1 in thymocytes is well-documented in scientific literature.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there negative enhancers?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether there are enhancers that have a negative effect. Enhancers are typically DNA sequences that increase the transcription of a gene. However, the term 'negative enhancers' is not commonly used in genetics. Instead, elements that decrease transcription are usually referred to as silencers or repressors. Therefore, the concept of 'negative enhancers' does not align with standard genetic terminology.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is SATB1 necessary for T-cell maturation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SATB1 is a chromatin organizer that plays a crucial role in the development and function of T-cells. It is involved in the regulation of gene expression necessary for T-cell maturation. Studies have shown that SATB1 is required for the proper development of T-cells, indicating its necessity in the maturation process.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does SATB1 regulate the RAG1 and RAG2 genes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SATB1 is a global chromatin organizer and transcription factor that has been shown to regulate various genes involved in immune system development and function. RAG1 and RAG2 are critical for V(D)J recombination in lymphocyte development. There is evidence that SATB1 can influence the expression of RAG1 and RAG2, suggesting a regulatory role.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is CTCF bound at nucleosome free regions?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CTCF, or CCCTC-binding factor, is a transcription factor known to play a role in the organization of chromatin structure. It is often associated with insulator regions and is known to bind to specific DNA sequences. Nucleosome-free regions are areas of the genome where nucleosomes, which are complexes of DNA and histone proteins, are not present, allowing for easier access by transcription factors and other DNA-binding proteins. CTCF is known to bind to these nucleosome-free regions, as they provide the accessibility required for CTCF to interact with its target DNA sequences. Therefore, it is accurate to say that CTCF is bound at nucleosome-free regions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does metformin alleviate atherosclerosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Metformin is a medication primarily used to treat type 2 diabetes. There is some research suggesting that metformin may have beneficial effects on cardiovascular health, including the potential to alleviate atherosclerosis. However, the evidence is not conclusive, and more studies are needed to confirm these effects. Therefore, while there is some indication that metformin might help with atherosclerosis, it is not definitively proven.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does GRHL2 over-expression lead to EMT?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"GRHL2 is a transcription factor that is known to play a role in epithelial cell differentiation and maintenance. Over-expression of GRHL2 has been shown to inhibit epithelial-mesenchymal transition (EMT), which is a process where epithelial cells lose their characteristics and gain mesenchymal features. Therefore, over-expression of GRHL2 does not lead to EMT; instead, it suppresses it.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is PRDM9 essential for meiosis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"PRDM9 is a gene that encodes a protein involved in the regulation of meiotic recombination. It is known to play a crucial role in the process of meiosis, particularly in the formation of double-strand breaks and the determination of recombination hotspots. However, while PRDM9 is important for the proper functioning of meiosis in many organisms, there are some species that do not have PRDM9 and still undergo meiosis successfully. This suggests that while PRDM9 is essential for meiosis in certain species, it is not universally essential across all species.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does the chromatin remodeling complex, RSC target H2A.Z nucleosomes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the chromatin remodeling complex, RSC, specifically targets H2A.Z nucleosomes. RSC is known to be involved in chromatin remodeling, which includes repositioning, ejecting, or restructuring nucleosomes. H2A.Z is a variant of the histone H2A and is incorporated into nucleosomes, influencing chromatin structure and function. Research has shown that RSC does interact with H2A.Z nucleosomes, suggesting that it targets them for remodeling activities.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the tyrosine kinase BTK implicated in autoimmunity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the tyrosine kinase BTK is implicated in autoimmunity, we need to consider its role in the immune system. BTK, or Bruton's tyrosine kinase, is a crucial enzyme in the signaling pathways of B cells, which are a type of white blood cell involved in the immune response. Dysregulation of B cell signaling can lead to autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. Therefore, if BTK plays a role in B cell signaling, it could be implicated in autoimmunity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is induction of interferon by TLR7 higher in males?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the induction of interferon by TLR7 is higher in males. TLR7 is a Toll-like receptor that plays a role in the immune response, and interferon is a type of protein that is part of the immune system's response to pathogens. There is evidence suggesting that there are sex differences in immune responses, including those involving TLR7 and interferon production. Some studies indicate that females may have a stronger TLR7-mediated response, potentially leading to higher interferon production compared to males. Therefore, the induction of interferon by TLR7 is not typically higher in males.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does CXorf21 escape X chromosome inactivation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if CXorf21 escapes X chromosome inactivation, we need to consider whether this gene is expressed from both the active and inactive X chromosomes. Genes that escape X inactivation are typically expressed from both X chromosomes in females, unlike most X-linked genes which are silenced on the inactive X. Research indicates that CXorf21 is one of the genes that escape X inactivation, meaning it is expressed from both X chromosomes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SATB1 positioned close to AT-rich sequences?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SATB1 is a protein that binds to specific DNA sequences, often associated with AT-rich regions. It is known to interact with matrix attachment regions (MARs), which are typically AT-rich. Therefore, it is likely that SATB1 is positioned close to AT-rich sequences.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Niraparib effective for ovarian cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Niraparib is a PARP inhibitor that has been approved for the treatment of ovarian cancer. It is used as maintenance therapy for patients with recurrent ovarian cancer who are in response to platinum-based chemotherapy. Clinical trials have shown that Niraparib can significantly prolong progression-free survival in patients with ovarian cancer, making it an effective treatment option for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is palbociclib effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Palbociclib is a drug that is primarily used to treat certain types of breast cancer. It works as a CDK4/6 inhibitor, which helps to stop cancer cells from growing. Glioblastoma is a type of brain cancer that is known for being particularly aggressive and difficult to treat. While palbociclib has shown promise in preclinical studies for various cancers, its effectiveness for glioblastoma specifically is still under investigation. As of the latest research, there is no conclusive evidence that palbociclib is effective for treating glioblastoma.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can LB-100 sensitize ovarian carcinoma to cisplatin?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"LB-100 is a protein phosphatase 2A (PP2A) inhibitor that has been studied for its potential to enhance the efficacy of chemotherapy drugs like cisplatin. Research has shown that LB-100 can sensitize various types of cancer cells, including ovarian carcinoma, to cisplatin by inhibiting PP2A, which is involved in cell survival pathways. This sensitization can lead to increased cancer cell death when used in combination with cisplatin.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has LB-100 been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"LB-100 is a compound that has been under investigation for its potential therapeutic effects. Clinical trials are a critical step in the development of new drugs, as they help determine the safety and efficacy of a compound in humans. To answer the question, we need to verify if LB-100 has been subjected to such trials.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can LB-100 downregulate miR-33?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if LB-100 can downregulate miR-33, we need to look into scientific studies or research articles that specifically investigate the interaction between LB-100 and miR-33. LB-100 is a small molecule inhibitor of protein phosphatase 2A (PP2A), and miR-33 is a microRNA involved in lipid metabolism and other cellular processes. The question is whether there is evidence that LB-100 affects the expression levels of miR-33. Without specific research evidence or studies indicating this interaction, it is not possible to definitively say that LB-100 downregulates miR-33.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can PRL3-zumab inhibit PRL3+ cancer cells in vitro and in vivo?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether PRL3-zumab, a therapeutic agent, can inhibit PRL3+ cancer cells both in vitro (in a controlled lab environment) and in vivo (within a living organism). To answer this, we need to consider existing research and studies on PRL3-zumab's effectiveness against PRL3+ cancer cells. If studies have shown that PRL3-zumab can successfully inhibit these cancer cells in both settings, the answer would be 'yes'. If not, the answer would be 'no'.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Can discharge destinations be accurately predicted using the Risk Assessment and Prediction Tool (RAPT)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the Risk Assessment and Prediction Tool (RAPT) can accurately predict discharge destinations. To answer this, we need to consider the effectiveness and accuracy of RAPT in predicting discharge outcomes. If RAPT has been validated through studies and shown to have a high level of accuracy in predicting discharge destinations, the answer would be 'yes'. However, if there is insufficient evidence or if studies have shown that RAPT is not reliable in this regard, the answer would be 'no'.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is AZD5153 active in prostate cancer?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if AZD5153 is active in prostate cancer, we need to consider available research and clinical trial data. AZD5153 is a BET bromodomain inhibitor, which has shown promise in preclinical studies for various cancers. However, its specific activity in prostate cancer would depend on clinical trial results or specific studies targeting this cancer type. Without specific evidence or data indicating its efficacy in prostate cancer, we cannot conclusively say it is active in this context.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is GRG5 involved only in late embryonic mouse development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether GRG5 is involved exclusively in late embryonic mouse development. To answer this, we need to consider if GRG5 has roles in other stages of development or in other biological processes. If GRG5 is known to be involved in other stages or processes, the answer would be 'no'. If it is only involved in late embryonic development, the answer would be 'yes'.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does BNN27 promote memory loss?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"BNN27 is a synthetic derivative of the neurosteroid dehydroepiandrosterone (DHEA). It has been studied for its neuroprotective effects and potential benefits in neurodegenerative diseases. There is no evidence to suggest that BNN27 promotes memory loss. In fact, it is being researched for its potential to protect against cognitive decline. Therefore, the answer to the question is no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is BNN20 involved in Parkinson's disease?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"BNN20 is a synthetic neurosteroid that has been studied for its potential neuroprotective effects. It is not directly involved in Parkinson's disease, but it has been researched for its potential therapeutic benefits in neurodegenerative diseases, including Parkinson's. Therefore, BNN20 itself is not a factor in the disease, but it may be relevant in the context of treatment research.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Has istadefylline been considered as a treatment for Parkinson's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Istradefylline is a medication that has been considered as a treatment for Parkinson's disease. It is an adenosine A2A receptor antagonist and has been used to help manage the symptoms of Parkinson's disease, particularly in patients experiencing 'off' episodes while on levodopa therapy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is amantadine ER the first approved treatment for akinesia?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Amantadine ER is an extended-release formulation of amantadine, which is used to treat symptoms of Parkinson's disease, including akinesia. However, it is not the first approved treatment for akinesia. Other treatments, such as levodopa, have been used for this purpose before amantadine ER was approved.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has amantadine ER been approved by the FDA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Amantadine ER, or extended-release amantadine, is a medication that has been evaluated by the FDA for its efficacy and safety. The FDA approval status of a drug can be checked through official FDA announcements or databases. As of the latest information, amantadine ER has been approved by the FDA for certain uses, such as the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adult patients.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is pimavanserin a typical antipsychotic?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pimavanserin is not a typical antipsychotic. It is classified as an atypical antipsychotic, specifically used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Typical antipsychotics, also known as first-generation antipsychotics, primarily work by blocking dopamine receptors, whereas atypical antipsychotics, like pimavanserin, have a different mechanism of action and are often used for different indications.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has ProSavin undergone phase IV clinical trials by 2018?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"ProSavin is a gene therapy product developed for the treatment of Parkinson's disease. It underwent phase I/II clinical trials, but there is no evidence or records indicating that it advanced to phase IV clinical trials by 2018. Phase IV trials are post-marketing studies conducted after a drug has been approved for consumer sale, and ProSavin had not reached that stage by 2018.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does ProSavin use an adenoviral vector?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"ProSavin is a gene therapy product developed for the treatment of Parkinson's disease. It uses a lentiviral vector, not an adenoviral vector, to deliver genes that encode for enzymes involved in dopamine synthesis. Lentiviral vectors are derived from viruses like HIV, whereas adenoviral vectors are derived from adenoviruses. Therefore, ProSavin does not use an adenoviral vector.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is BCL11B involved in schizophrenia?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"BCL11B is a gene that has been studied in relation to various neurological and psychiatric conditions. Research has suggested that it may play a role in brain development and function. Some studies have explored the potential involvement of BCL11B in schizophrenia, a complex mental health disorder characterized by symptoms such as hallucinations, delusions, and cognitive impairments. While there is ongoing research, the evidence is not yet conclusive. Therefore, it is not definitively established that BCL11B is involved in schizophrenia.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are CD8+ (cytotoxic) T cells and  CD4+ Helper T cells generated in the thyroid and express the T-cell receptor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CD8+ (cytotoxic) T cells and CD4+ Helper T cells are not generated in the thyroid. They are generated in the bone marrow and mature in the thymus. Both types of T cells express the T-cell receptor, which is crucial for their function in the immune response.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do MAIT cells have a role in multiple myeloma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"MAIT cells, or mucosal-associated invariant T cells, are a type of immune cell that have been studied in various diseases, including cancers. Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow. Research has been conducted to understand the role of different immune cells in the progression and treatment of multiple myeloma. Some studies suggest that MAIT cells may have a role in the immune response against multiple myeloma, but the extent and nature of their involvement are still being investigated. Therefore, while there is some evidence of their involvement, it is not yet fully understood or confirmed.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the BAGEL algorithm used for arrayed CRISPR screens?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The BAGEL algorithm is indeed used in the context of CRISPR screens. It is specifically designed for analyzing CRISPR knockout screens to identify essential genes. BAGEL stands for Bayesian Analysis of Gene Essentiality, and it is used to determine which genes are essential for cell survival based on the data from CRISPR screens. Therefore, the answer to the question is yes.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is Ubrogepant effective for migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ubrogepant is a medication used for the acute treatment of migraine with or without aura in adults. It is a CGRP receptor antagonist and has been shown in clinical trials to be effective in reducing migraine pain and associated symptoms. The effectiveness of Ubrogepant has been supported by research and it is approved by regulatory agencies for this use.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is modified vaccinia Ankara effective for smallpox?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Modified vaccinia Ankara (MVA) is a highly attenuated strain of the vaccinia virus, which is used as a vaccine. It has been developed as a safer alternative to the traditional smallpox vaccine, particularly for individuals with weakened immune systems. MVA has shown to be effective in generating an immune response against smallpox, making it a viable option for vaccination against the disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Apremilast effective for BehÃ§etâ€™s Syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Apremilast is a medication that has been studied for its effectiveness in treating BehÃ§etâ€™s Syndrome, particularly for oral ulcers associated with the condition. Clinical trials and studies have shown that Apremilast can be effective in reducing the frequency and severity of oral ulcers in patients with BehÃ§etâ€™s Syndrome. Therefore, it is considered an effective treatment option for managing certain symptoms of the syndrome.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Selinexor effective for multiple myeloma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Selinexor is a drug that has been studied and used in the treatment of multiple myeloma. It works as a selective inhibitor of nuclear export and has shown efficacy in clinical trials for patients with relapsed or refractory multiple myeloma. The FDA has approved Selinexor for use in combination with other therapies for certain patients with multiple myeloma, indicating its effectiveness in this context.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does teplizumab hold promise for diabetes prevention?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Teplizumab is a monoclonal antibody that has been studied for its potential to delay the onset of type 1 diabetes in individuals at high risk. Clinical trials have shown that teplizumab can delay the progression to clinical diabetes in some patients, suggesting it holds promise for diabetes prevention.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does nintedanib hold promise for lung disease associated with systemic sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Nintedanib is a medication that has been studied for its effectiveness in treating lung disease associated with systemic sclerosis. Clinical trials and research have shown that nintedanib can slow the progression of lung disease in patients with systemic sclerosis, indicating that it holds promise as a treatment option for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is mesothelioma caused by asbestos exposure?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mesothelioma is a type of cancer that is primarily associated with asbestos exposure. Asbestos is a group of minerals that are found in the environment as bundles of fibers, and when these fibers are inhaled, they can become lodged in the lining of the lungs, abdomen, or heart, leading to inflammation and scarring that may eventually cause mesothelioma. The link between asbestos exposure and mesothelioma is well-established, and it is considered the primary cause of the disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Hemochromatosis type 4 is caused by a mutation in a recessive gene?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Hemochromatosis type 4, also known as ferroportin disease, is caused by mutations in the SLC40A1 gene. Unlike other types of hemochromatosis, type 4 is inherited in an autosomal dominant manner, meaning it is not caused by a mutation in a recessive gene.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Huntington's disease is caused by expansion of a CTG repeat in the HTT gene on Chromosome 4?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Huntington's disease is a genetic disorder caused by a mutation in the HTT gene on chromosome 4. However, the specific mutation involves the expansion of a CAG repeat, not a CTG repeat. Therefore, the statement in the question is incorrect regarding the type of repeat expansion involved in Huntington's disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can radiation induced meningiomas be treated with radiosurgery?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Radiation induced meningiomas are a type of brain tumor that can develop after exposure to radiation. Radiosurgery, such as Gamma Knife or CyberKnife, is a non-invasive treatment option that uses focused radiation to target and treat tumors. It is often used for treating meningiomas, including those induced by radiation, depending on their size, location, and other factors. Therefore, radiosurgery can be a viable treatment option for radiation induced meningiomas.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an increased risk of meningiomas in atomic bomb survivors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Atomic bomb survivors were exposed to high levels of ionizing radiation, which is known to increase the risk of various types of cancer, including brain tumors such as meningiomas. Studies have shown that there is indeed an increased risk of developing meningiomas among atomic bomb survivors due to their exposure to radiation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiation for tinea capitis increases brain tumor risk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tinea capitis is a fungal infection of the scalp, and radiation is not a standard treatment for it. Historically, X-ray therapy was used to treat tinea capitis, but this practice has been discontinued due to the risks associated with radiation exposure. Studies have shown that radiation exposure, particularly in children, can increase the risk of developing brain tumors later in life. Therefore, if radiation was used to treat tinea capitis, it could potentially increase the risk of brain tumors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can secondary glioblastoma be caused by brain irradiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Secondary glioblastoma can develop as a result of previous brain irradiation. Radiation therapy, while used to treat various brain conditions, can sometimes lead to the development of secondary tumors, including glioblastomas, as a long-term side effect. This is a known risk associated with radiation treatment to the brain.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does head ct increase brain tumor risk?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether a head CT scan increases the risk of developing a brain tumor. CT scans involve exposure to ionizing radiation, which in high doses has been linked to an increased risk of cancer. However, the radiation dose from a single head CT scan is relatively low, and the risk of developing a brain tumor from a single scan is considered to be very small. Medical professionals generally weigh the benefits of obtaining important diagnostic information from a CT scan against the potential risks. Therefore, while there is a theoretical risk, it is not significant enough to be a major concern for most patients.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there an increased risk for meningiomas in childhood leukemia survivors?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\n  \"draft\": \"To determine if there is an increased risk for meningiomas in childhood leukemia survivors, we need to consider the long-term effects of leukemia treatments such as radiation therapy and chemotherapy. These treatments can potentially increase the risk of developing secondary cancers, including meningiomas. Studies have shown that survivors of childhood leukemia who have undergone cranial radiation therapy may have a higher risk of developing meningiomas later in life. Therefore, it is reasonable to conclude that there is an increased risk for meningiomas in childhood leukemia survivors, particularly those who received radiation therapy.\",\n  \"answer\": \"yes\"\n}",
    "correct": true
  },
  {
    "question": "Can radiotherapy cause radiation induced osteosarcoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Radiotherapy is a treatment that uses high doses of radiation to kill cancer cells and shrink tumors. However, one of the potential long-term side effects of radiotherapy is the development of secondary cancers, including radiation-induced osteosarcoma. Osteosarcoma is a type of bone cancer, and while it is rare, it can occur as a result of radiation exposure. The risk of developing radiation-induced osteosarcoma depends on various factors, including the dose of radiation received and the area of the body that was treated.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Chernobyl survivors at increased risk for breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether individuals who survived the Chernobyl nuclear disaster have a higher likelihood of developing breast cancer compared to the general population. Exposure to radiation is a known risk factor for various types of cancer, including breast cancer. The Chernobyl disaster released a significant amount of radioactive material, which could potentially increase the risk of cancer among those exposed. Studies have shown that survivors of nuclear disasters, such as Chernobyl, may indeed have an elevated risk of developing certain cancers due to radiation exposure. Therefore, it is reasonable to conclude that Chernobyl survivors could be at increased risk for breast cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for Hodgkin disease increases risk for lung cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Radiotherapy is a common treatment for Hodgkin disease, and there is evidence suggesting that it can increase the risk of developing secondary cancers, including lung cancer. This is particularly true for patients who have received high doses of radiation or have other risk factors such as smoking. Therefore, it is generally accepted in the medical community that radiotherapy for Hodgkin disease can increase the risk of lung cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for cervical cancer increases risk of colon cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Radiotherapy for cervical cancer can increase the risk of developing secondary cancers, including colon cancer. Studies have shown that radiation exposure can lead to DNA damage in surrounding tissues, potentially increasing the risk of cancer in those areas. Therefore, it is possible that radiotherapy for cervical cancer could increase the risk of colon cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does radiotherapy for prostate cancer increase bladder cancer risk?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Radiotherapy for prostate cancer has been associated with an increased risk of developing secondary cancers, including bladder cancer. This is due to the exposure of surrounding tissues to radiation during treatment. Studies have shown that patients who undergo radiotherapy for prostate cancer may have a higher incidence of bladder cancer compared to those who do not receive such treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a role for MRPL53 in cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"MRPL53 is a mitochondrial ribosomal protein that is part of the large subunit of the mitochondrial ribosome. While mitochondrial ribosomal proteins are primarily involved in mitochondrial protein synthesis, recent research has suggested that alterations in mitochondrial function and biogenesis can be linked to cancer development and progression. However, specific information about the role of MRPL53 in cancer is limited and not well-documented in the current scientific literature. Therefore, based on the available information, it is not clear if MRPL53 has a direct or significant role in cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a role for TET proteins in invariant natural killer T cells (iNKT) cell fate?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether TET proteins have a role in the fate of invariant natural killer T cells (iNKT). TET proteins are known to be involved in DNA demethylation and can influence gene expression. iNKT cells are a subset of T cells with unique functions and development pathways. Research has shown that TET proteins can play a role in the development and function of various immune cells, including T cells. Therefore, it is plausible that TET proteins could influence iNKT cell fate through epigenetic regulation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Uc.63+ promote sensitivity to treatment in prostate cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To answer this question, we need to determine if Uc.63+ has been shown to enhance the effectiveness of treatments for prostate cancer. This would involve looking at scientific studies or clinical trials that have investigated the role of Uc.63+ in prostate cancer treatment. If such studies exist and show that Uc.63+ does indeed increase sensitivity to treatment, the answer would be 'yes'. Otherwise, it would be 'no'.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do de novo truncating mutations in WASF1 cause cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"De novo truncating mutations in WASF1 are not commonly associated with causing cancer. WASF1 is a gene that encodes a protein involved in actin cytoskeleton organization, and mutations in this gene have been linked to neurological disorders rather than cancer. While mutations in various genes can contribute to cancer development, there is no strong evidence or established link between WASF1 truncating mutations and cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does the Mcm2-Ctf4-PolÎ± axis play a role in transfer of histones to leading strand DNA at the replication forks?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the Mcm2-Ctf4-PolÎ± axis is involved in the transfer of histones to the leading strand DNA at replication forks. The Mcm2-Ctf4-PolÎ± axis is known to be involved in DNA replication processes. Mcm2 is part of the helicase complex that unwinds DNA, Ctf4 acts as a scaffold protein connecting the helicase to DNA polymerase alpha (PolÎ±), which is responsible for initiating DNA synthesis. Histone transfer is a crucial part of chromatin assembly during DNA replication. While the Mcm2-Ctf4-PolÎ± axis is involved in replication, the specific role of histone transfer to the leading strand is not clearly established in the context of this axis. Therefore, based on current knowledge, the answer is likely 'no'.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is AND-1/Ctf4 essential for proliferation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether AND-1/Ctf4 is essential for proliferation. AND-1/Ctf4 is a protein involved in DNA replication and cell cycle progression. Its role is crucial in the stabilization of replication forks and the recruitment of other proteins necessary for DNA synthesis. If AND-1/Ctf4 is essential for these processes, then it would be considered essential for cell proliferation, as proliferation depends on successful DNA replication and cell cycle progression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a BRCA mutation analysis in the Greek population?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\n  \"draft\": \"The question asks whether there is a BRCA mutation analysis conducted specifically within the Greek population. BRCA mutation analysis is a genetic test that identifies mutations in the BRCA1 and BRCA2 genes, which are linked to an increased risk of breast and ovarian cancer. Such analyses are commonly conducted in various populations to understand the prevalence and implications of these mutations. Given the global interest in genetic research and the importance of understanding BRCA mutations for cancer prevention and treatment, it is likely that such studies have been conducted in the Greek population as well.\",\n  \"answer\": \"yes\"\n}",
    "correct": true
  },
  {
    "question": "Can Patient-derived organoids (PDOs) recapitulate patient responses in the clinic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Patient-derived organoids (PDOs) are three-dimensional cell culture systems derived from a patient's own tissues. They are used in research to model diseases and test drug responses. The question asks whether PDOs can mimic or replicate the responses that patients exhibit in clinical settings. PDOs have been shown to closely mimic the genetic and phenotypic characteristics of the original tumor or tissue, allowing researchers to study disease progression and treatment responses in a controlled environment. There is evidence that PDOs can reflect patient-specific responses to treatments, making them a valuable tool for personalized medicine. However, while PDOs can provide insights into how a patient might respond to a treatment, they are not perfect replicas of the complex interactions that occur in a living organism. Despite these limitations, the current scientific consensus supports the idea that PDOs can indeed recapitulate patient responses to a significant extent.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Verubecestat effective for Alzheimer's Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Verubecestat is a BACE1 inhibitor that was investigated for the treatment of Alzheimer's Disease. Clinical trials, however, showed that it was not effective in improving cognitive function or slowing the progression of the disease. In fact, some trials were halted early due to lack of efficacy and potential safety concerns. Therefore, based on the available evidence, Verubecestat is not considered effective for Alzheimer's Disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "The LINCS L1000 data set contains gene expression data for drug treated human cells, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The LINCS L1000 data set is known for containing gene expression data. It is a part of the Library of Integrated Network-based Cellular Signatures (LINCS) project, which aims to catalog how human cells respond to various perturbations, including drug treatments. The data set includes information on gene expression changes in human cells after being treated with different drugs. Therefore, the statement that the LINCS L1000 data set contains gene expression data for drug treated human cells is accurate.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is bortezomib a Proteasome inhibitor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bortezomib is a medication that is classified as a proteasome inhibitor. It works by inhibiting the proteasome, which is a complex that degrades unneeded or damaged proteins in cells. This inhibition can lead to cell cycle arrest and apoptosis, particularly in cancer cells, making bortezomib an effective treatment for certain types of cancer, such as multiple myeloma and mantle cell lymphoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are breaks in double stranded DNA associated with ionizing radiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ionizing radiation is known to cause damage to DNA, including breaks in the double-stranded structure. This type of radiation has enough energy to remove tightly bound electrons from atoms, creating ions. When it interacts with DNA, it can cause breaks in one or both strands of the DNA helix. Double-strand breaks are particularly serious because they can lead to mutations, cancer, or cell death if not properly repaired. Therefore, there is a well-established association between ionizing radiation and double-strand breaks in DNA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Thymoquinone is ineffective against radiation induced enteritis, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if thymoquinone is ineffective against radiation-induced enteritis, we need to consider scientific studies and evidence. Thymoquinone is a compound found in black seed oil and has been studied for various therapeutic effects, including anti-inflammatory and antioxidant properties. Some studies suggest that thymoquinone may have protective effects against radiation-induced damage, including enteritis. However, the effectiveness can vary based on dosage, study design, and specific conditions. Without specific evidence stating its ineffectiveness, it is not accurate to claim that thymoquinone is ineffective against radiation-induced enteritis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Autophagy is a cellular process where cells degrade and recycle their own components. It is not a process where a virus obtains nutrients from its host. Instead, viruses may exploit the host's cellular machinery for their replication, but this is not termed autophagy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are stretch enhancers transcribed more than super-enhancers?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether stretch enhancers are transcribed more than super-enhancers. Stretch enhancers and super-enhancers are both types of regulatory DNA sequences that can influence gene expression. Super-enhancers are typically characterized by a high density of transcription factor binding sites and are associated with genes that are highly expressed. Stretch enhancers are longer regions of DNA with enhancer activity. The transcriptional activity of these enhancers can vary depending on the context and the specific genes they regulate. Generally, super-enhancers are known for their strong transcriptional activity, often more so than typical enhancers, but the question specifically compares them to stretch enhancers. Without specific data comparing the transcription levels of stretch enhancers to super-enhancers, it is difficult to definitively say which is transcribed more. However, super-enhancers are typically associated with higher transcriptional activity due to their role in regulating key genes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the FIP virus thought to be a mutated strain for the Feline enteric Coronavirus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Feline Infectious Peritonitis (FIP) is indeed caused by a mutated strain of the Feline Enteric Coronavirus (FECV). The FECV is a common virus in cats that typically causes mild intestinal symptoms. However, in some cases, the virus mutates within the host cat, leading to the development of FIP, which is a more severe and often fatal disease. This understanding is widely accepted in veterinary medicine.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is poliosis circumscripta another term for a white or unpigmented patch of hair or skin?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Poliosis circumscripta is a condition characterized by a lack of melanin in the hair, leading to a white or unpigmented patch of hair. It can also refer to similar depigmentation in the skin. Therefore, poliosis circumscripta can indeed be another term for a white or unpigmented patch of hair or skin.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are stem cell transplants used to treat acute kidney injury?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Stem cell transplants are primarily used for treating certain types of cancers and blood disorders. While research is ongoing into the potential of stem cells for treating acute kidney injury, it is not a standard or widely accepted treatment for this condition as of now.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Do circular exons increase gene expression?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Circular exons, also known as circular RNAs (circRNAs), are a type of RNA which, unlike linear RNAs, form a covalently closed continuous loop. They have been found to play various roles in gene regulation, including acting as microRNA sponges, interacting with RNA-binding proteins, and potentially influencing transcription and splicing. However, the direct effect of circular exons on increasing gene expression is not straightforward. While they may have regulatory roles that could indirectly influence gene expression, they do not inherently increase gene expression by themselves. Therefore, the answer to whether circular exons increase gene expression is generally 'no'.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are there lncRNAs that control the extent of neuronal outgrowth?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Long non-coding RNAs (lncRNAs) are known to play various roles in gene regulation, including in the nervous system. Research has shown that certain lncRNAs are involved in the regulation of neuronal development and outgrowth. These lncRNAs can influence the expression of genes that are critical for neuronal differentiation and the growth of neuronal processes. Therefore, it is plausible that lncRNAs can control the extent of neuronal outgrowth.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Selumetinib effective for low-grade glioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Selumetinib is a MEK inhibitor that has been studied for its effectiveness in treating low-grade glioma, particularly in pediatric patients. Clinical trials and studies have shown that Selumetinib can be effective in shrinking tumors and managing the disease in some patients with low-grade glioma. Therefore, it is considered an effective treatment option for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does gavestinel improve outcomes of stroke patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if gavestinel improves outcomes of stroke patients, we need to consider clinical trial data and scientific studies. Gavestinel is a glycine site antagonist of the NMDA receptor that was investigated for its potential neuroprotective effects in stroke patients. However, clinical trials, such as the GAIN trials, did not show significant improvement in outcomes for stroke patients treated with gavestinel compared to placebo. Therefore, based on available evidence, gavestinel does not improve outcomes for stroke patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Enlimomab improve stroke outcomes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Enlimomab is a monoclonal antibody that was investigated for its potential to improve outcomes in stroke patients. However, clinical trials have shown that Enlimomab did not improve stroke outcomes and was associated with adverse effects. Therefore, it is not considered an effective treatment for improving stroke outcomes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should tirilazad be used for treatment of ischemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tirilazad is a drug that was investigated for its potential use in treating ischemic stroke. However, clinical trials have not shown it to be effective for this purpose. Therefore, it is not recommended for the treatment of ischemic stroke.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Aptiganel effective for treatment of stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Aptiganel was investigated as a potential treatment for stroke due to its properties as an NMDA receptor antagonist. However, clinical trials did not demonstrate sufficient efficacy, and development was discontinued. Therefore, Aptiganel is not considered an effective treatment for stroke.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should Lubeluzole be used for treatment of ischemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lubeluzole was initially investigated as a potential treatment for ischemic stroke due to its neuroprotective properties. However, clinical trials did not demonstrate significant efficacy in improving outcomes for stroke patients. As a result, Lubeluzole is not approved or recommended for the treatment of ischemic stroke.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a vaccine for peanut allergy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Peanut allergies are a significant concern for many individuals, and researchers have been working on various treatments and potential vaccines. However, as of the latest information available, there is no approved vaccine specifically for peanut allergies. Treatments such as oral immunotherapy exist, but they are not vaccines. Therefore, the answer to whether there is a vaccine for peanut allergy is no.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Have toll-like receptor 2 activators been found in food?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Toll-like receptor 2 (TLR2) is part of the immune system and recognizes pathogens. Some studies have identified certain food components that can activate TLR2. These activators are often microbial components or derived from fermented foods, which contain microbial products that can interact with TLR2. Therefore, it is plausible that TLR2 activators have been found in food.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Rad4/XPC a DNA damage sensing protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Rad4/XPC is known to be involved in the DNA damage recognition process, particularly in nucleotide excision repair (NER). It plays a crucial role in detecting DNA damage and initiating the repair process. Therefore, it can be considered a DNA damage sensing protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there interactions between short and long noncoding RNAs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Short and long noncoding RNAs can interact with each other in various biological processes. These interactions can play roles in gene regulation, chromatin remodeling, and other cellular functions. For example, short noncoding RNAs like microRNAs can regulate the expression of long noncoding RNAs, and vice versa. Additionally, both types of RNAs can be involved in complex networks that influence cellular pathways.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is indinavir effective for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Indinavir is an antiretroviral drug used primarily in the treatment of HIV/AIDS. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects nerve cells in the brain and spinal cord. There is no known cure for ALS, and treatments focus on managing symptoms and slowing disease progression. Indinavir is not known to be used for ALS treatment, and there is no evidence supporting its effectiveness for this condition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is golimumab effective for sarcoidosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Golimumab is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-alpha), and it is primarily used for conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Sarcoidosis is an inflammatory disease that affects multiple organs, particularly the lungs and lymph glands. While TNF-alpha inhibitors like infliximab have been used off-label for sarcoidosis, the effectiveness of golimumab specifically for sarcoidosis is not well-established in the medical literature. There are limited studies and clinical trials directly assessing golimumab's efficacy for sarcoidosis, so it is not a standard treatment for this condition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is marimastat effective for small-cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Marimastat is a matrix metalloproteinase inhibitor that has been studied for various types of cancer. However, its effectiveness for small-cell lung cancer specifically has not been established as a standard treatment. Clinical trials have not shown significant benefits for this type of cancer, and it is not commonly used in treatment protocols for small-cell lung cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are astronauts in higher risk for developing cancer?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Astronauts are exposed to higher levels of cosmic radiation in space compared to people on Earth. This increased exposure to radiation is known to elevate the risk of developing cancer. Studies have shown that astronauts may indeed face a higher risk of cancer due to their time spent in space, especially during long-duration missions. Therefore, it is reasonable to conclude that astronauts are at a higher risk for developing cancer compared to the general population.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is g-H2AX a marker for double strand breaks?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether g-H2AX is a marker for double strand breaks. g-H2AX is a phosphorylated form of the histone protein H2AX. When DNA double strand breaks occur, H2AX is rapidly phosphorylated at the site of the break, forming g-H2AX. This modification serves as a signal for the recruitment of DNA repair proteins to the site of damage. Therefore, g-H2AX is widely used as a marker for the presence of DNA double strand breaks in cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does natalizumab improve disease course of secondary progressive multiple sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Natalizumab is a monoclonal antibody used primarily in the treatment of relapsing forms of multiple sclerosis (MS). It is known to be effective in reducing the frequency of relapses and slowing the progression of physical disability in relapsing-remitting MS. However, its effectiveness in secondary progressive multiple sclerosis (SPMS) is less clear. While some studies suggest potential benefits in certain subgroups of SPMS, particularly those with active inflammation, natalizumab is not generally considered a standard treatment for SPMS without relapses. Therefore, it is not typically used to improve the disease course of SPMS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are multipotent adult progenitor cells effective for treatment of stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Multipotent adult progenitor cells (MAPCs) are a type of stem cell that have the ability to differentiate into various cell types. They have been studied for their potential in regenerative medicine, including the treatment of stroke. Research has shown that MAPCs can potentially aid in the recovery of stroke by promoting neurogenesis, reducing inflammation, and enhancing repair mechanisms in the brain. However, while preclinical studies and some early clinical trials have shown promising results, the effectiveness of MAPCs for stroke treatment is still under investigation. More extensive clinical trials are needed to conclusively determine their efficacy and safety for this purpose.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is ozanezumab effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ozanezumab is a monoclonal antibody that was investigated for the treatment of amyotrophic lateral sclerosis (ALS). However, clinical trials did not demonstrate significant efficacy in improving the condition of ALS patients. Therefore, it is not considered an effective treatment for ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are gut microbiota profiles altered by irradiation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether irradiation can change the profiles of gut microbiota. Gut microbiota refers to the community of microorganisms living in the digestive tracts of humans and other animals. Irradiation is a process that involves exposing objects to radiation. Scientific studies have shown that irradiation can indeed affect the composition and diversity of gut microbiota. Therefore, the answer to the question is yes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are genomic regulatory blocks (GRBs) any different than TADs?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Genomic regulatory blocks (GRBs) and topologically associating domains (TADs) are both structural features of the genome, but they are distinct concepts. GRBs are regions of the genome that contain a gene and its regulatory elements, often conserved across species, and are involved in regulating gene expression. TADs, on the other hand, are regions of the genome that interact more frequently with themselves than with other regions, forming a three-dimensional structure that helps organize the genome within the nucleus. While both GRBs and TADs are involved in gene regulation, they are defined by different criteria and serve different roles in genomic organization.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is Nivolumab (Opdivo) a PD-L1 inhibitor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nivolumab, also known by the brand name Opdivo, is a medication used in cancer treatment. It is an immune checkpoint inhibitor, but it specifically targets the PD-1 receptor, not PD-L1. PD-1 is a protein on the surface of T cells, and by inhibiting it, Nivolumab helps to boost the immune response against cancer cells. PD-L1 inhibitors, on the other hand, target the PD-L1 protein, which is often expressed on the surface of cancer cells. Therefore, Nivolumab is not classified as a PD-L1 inhibitor.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is PF-05190457 an inverse agonist of the ghrelin receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\n  \"draft\": \"PF-05190457 is a compound that has been studied in relation to the ghrelin receptor. The ghrelin receptor, also known as the growth hormone secretagogue receptor (GHS-R1a), is a target for various compounds that can act as agonists, antagonists, or inverse agonists. An inverse agonist is a substance that binds to the same receptor as an agonist but induces a pharmacological response opposite to that agonist. To determine if PF-05190457 is an inverse agonist, one would need to look at specific scientific studies or pharmacological data that describe its action on the ghrelin receptor. Based on available information, PF-05190457 is indeed described as an inverse agonist of the ghrelin receptor.\",\n  \"answer\": \"yes\"\n}",
    "correct": true
  },
  {
    "question": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"LY6K overexpression is generally associated with poor prognosis in non-small cell lung cancer patients. Studies have shown that high levels of LY6K are linked to increased tumor aggressiveness and worse outcomes. Therefore, overexpression of LY6K is not associated with a better prognosis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does the BRAFV600E mutation have an effect on clinical response to radioiodine therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The BRAFV600E mutation is known to be associated with various cancers, including thyroid cancer. In the context of thyroid cancer, particularly papillary thyroid carcinoma, the presence of the BRAFV600E mutation has been studied for its impact on treatment outcomes. Radioiodine therapy is a common treatment for thyroid cancer, and the BRAFV600E mutation has been reported to affect the clinical response to this therapy. Studies suggest that the mutation may lead to a poorer response to radioiodine therapy, potentially due to its role in altering the expression of genes involved in iodine metabolism. Therefore, the presence of the BRAFV600E mutation is considered to have an effect on the clinical response to radioiodine therapy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does metformin has as an antitumor effect?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Metformin is primarily known as a medication for managing type 2 diabetes. However, research has suggested that metformin may have potential antitumor effects. Some studies have shown that metformin can inhibit the growth of certain cancer cells and may have a role in cancer prevention and treatment. Despite these findings, the evidence is not yet conclusive, and more research is needed to fully understand the antitumor effects of metformin and its mechanisms. Therefore, while there is some evidence supporting the antitumor effects of metformin, it is not yet definitive.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Xaliproden is a drug that has been investigated for its potential effects on amyotrophic lateral sclerosis (ALS). However, clinical trials have not shown significant improvement in the prognosis of ALS patients treated with xaliproden. Therefore, it is not considered an effective treatment for improving the prognosis of ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is celecoxib effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Celecoxib is a nonsteroidal anti-inflammatory drug (NSAID) primarily used to treat pain and inflammation. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects nerve cells in the brain and spinal cord. While there have been studies exploring the potential of various drugs for ALS, celecoxib is not widely recognized or approved as an effective treatment for ALS. The primary treatments for ALS focus on slowing the progression of the disease and managing symptoms, and celecoxib is not typically included in these treatment protocols.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should Pentoxifylline be used for treatment of amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Pentoxifylline is a drug that is primarily used to improve blood flow in patients with circulation problems. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects nerve cells in the brain and spinal cord. There is no known cure for ALS, and treatment options are limited. While some studies have explored the potential of various drugs to treat ALS, Pentoxifylline is not commonly recognized or approved as a treatment for this condition. Therefore, based on current medical guidelines and available treatments, Pentoxifylline should not be used for the treatment of amyotrophic lateral sclerosis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does clinical trial data support the use of minocycline for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if clinical trial data supports the use of minocycline for amyotrophic lateral sclerosis (ALS), we need to look at the results of relevant studies. Historically, some studies have been conducted to evaluate the efficacy of minocycline in ALS patients. However, the outcomes of these studies have generally not shown a significant benefit of minocycline in treating ALS. In fact, some trials have suggested that minocycline might even have a negative impact on ALS progression. Therefore, based on the available clinical trial data, minocycline is not supported as an effective treatment for ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Dexmecamylamine effective for depression?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Dexmecamylamine is a nicotinic acetylcholine receptor antagonist that has been studied for various uses, including as a potential treatment for depression. However, its effectiveness for depression is not well-established in the medical community. There is limited clinical evidence supporting its use for this condition, and it is not commonly prescribed for depression. Therefore, based on current knowledge and available evidence, it is not considered an effective treatment for depression.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is NicVAX vaccine effective for smoking cessation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"NicVAX is a nicotine conjugate vaccine that was developed to help with smoking cessation by inducing the production of antibodies that bind to nicotine, preventing it from reaching the brain and reducing its addictive effects. However, clinical trials have shown that NicVAX did not demonstrate significant efficacy in helping individuals quit smoking compared to a placebo. Therefore, it is not considered an effective treatment for smoking cessation.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Figitumumab effective for non-small cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Figitumumab is a monoclonal antibody that targets the insulin-like growth factor 1 receptor (IGF-1R). It has been studied for its potential use in treating various cancers, including non-small cell lung cancer (NSCLC). However, clinical trials have shown mixed results, and some trials were terminated due to lack of efficacy or safety concerns. As of the latest data, figitumumab is not considered an effective treatment for non-small cell lung cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Semagacestat effective for Alzheimer's Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Semagacestat is a gamma-secretase inhibitor that was investigated for the treatment of Alzheimer's Disease. However, clinical trials showed that it was not effective in improving cognitive symptoms and was associated with adverse effects. As a result, its development for Alzheimer's treatment was discontinued.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Systemic Lupus Erythematosus cause seizures?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect multiple organs and systems in the body. One of the potential complications of SLE is its impact on the central nervous system, which can lead to neurological symptoms. Seizures are one of the neurological manifestations that can occur in individuals with SLE. This is due to the inflammation and other immune system-related changes that SLE can cause in the brain. Therefore, it is possible for SLE to cause seizures in some patients.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is MAGE-A3 immunotherapeutic effective for non-small-cell lung cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"MAGE-A3 immunotherapy was developed as a potential treatment for non-small-cell lung cancer (NSCLC) by targeting the MAGE-A3 antigen, which is expressed in some cancer cells. However, clinical trials, such as the MAGRIT trial, have shown that MAGE-A3 immunotherapy did not significantly improve outcomes for patients with NSCLC compared to placebo. Therefore, based on current evidence, MAGE-A3 immunotherapy is not considered effective for treating non-small-cell lung cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Impetigo a viral infection that affects the skin?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Impetigo is a common and highly contagious skin infection that mainly affects infants and children. It is caused by bacteria, not a virus. The two types of bacteria that cause impetigo are Staphylococcus aureus and Streptococcus pyogenes. Therefore, impetigo is not a viral infection but a bacterial one.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Î±CGRP a member of the CGRP family?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Î±CGRP, also known as alpha calcitonin gene-related peptide, is indeed a member of the CGRP family. The CGRP family consists of peptides that are related in structure and function, including Î±CGRP and Î²CGRP. These peptides are involved in various physiological processes, including vasodilation and pain transmission. Therefore, Î±CGRP is classified within this family of peptides.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do genes with monoallelic expression contribute proportionally to genetic diversity in humans?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Monoallelic expression refers to the phenomenon where only one allele of a gene is expressed while the other is silenced. This can occur randomly or be imprinted, where the expression is parent-of-origin specific. Genetic diversity in humans is influenced by the variation in alleles present in the population. While monoallelic expression can contribute to phenotypic diversity by allowing different alleles to be expressed in different cells or tissues, it does not directly increase genetic diversity at the population level. Genetic diversity is more about the variety of alleles present in the gene pool rather than their expression patterns. Therefore, monoallelic expression does not contribute proportionally to genetic diversity in the sense of increasing the number of different alleles in the population.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is deletion at 6q24.2-26 associated with shorter survival for ovarian cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether a specific genetic deletion, 6q24.2-26, is linked to shorter survival in ovarian cancer patients. To answer this, one would need to refer to scientific studies or clinical data that investigate the impact of this genetic alteration on survival outcomes in ovarian cancer. Without specific data or studies provided in the question, it is not possible to definitively say 'yes' or 'no'.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does promoter shape vary across populations?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if promoter shape varies across populations, we need to consider genetic and epigenetic factors that influence promoter regions. Promoter regions are sequences of DNA that initiate transcription of a particular gene. These regions can be subject to variations due to genetic diversity among populations. Additionally, epigenetic modifications, which can differ between populations due to environmental factors, can also influence promoter shape. Therefore, it is plausible that promoter shape could vary across different populations due to these genetic and epigenetic influences.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the CADM2 gene associated with differences in information processing speed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The CADM2 gene has been studied in relation to cognitive functions, including information processing speed. Research suggests that there is an association between variations in the CADM2 gene and differences in information processing speed, indicating that this gene may play a role in cognitive performance.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is KAT2A involved in Acute myeloid leukemia (AML)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"KAT2A, also known as GCN5, is a histone acetyltransferase that plays a role in gene expression regulation. Research has shown that KAT2A is involved in various cancers, including leukemia. Specifically, KAT2A has been implicated in the regulation of genes associated with Acute Myeloid Leukemia (AML). Therefore, it can be concluded that KAT2A is involved in AML.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "AhR ligands are attractive drug targets for pharmaceutical development due to their induction of Cyp1a1, yes or no?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question is asking whether AhR ligands are considered attractive drug targets in pharmaceutical development because they induce Cyp1a1. AhR (Aryl hydrocarbon Receptor) ligands are known to bind to the AhR, which can lead to the induction of various enzymes, including Cyp1a1. Cyp1a1 is involved in the metabolism of xenobiotics and can play a role in drug metabolism. The induction of Cyp1a1 by AhR ligands can be seen as a beneficial property in drug development because it can enhance the metabolism and clearance of drugs, potentially reducing toxicity and improving efficacy. However, the attractiveness of AhR ligands as drug targets would depend on the specific context and desired outcomes in pharmaceutical development. Generally, the induction of Cyp1a1 is considered a positive attribute in this context, making AhR ligands attractive targets.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Glucoraphanin from broccoli can help reduce obesity , yes or no?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Glucoraphanin is a compound found in broccoli that has been studied for its potential health benefits, including its role in reducing obesity. Some research suggests that glucoraphanin may help in weight management by improving metabolism and reducing fat accumulation. However, while there is some evidence supporting these claims, it is not definitive, and more research is needed to establish a clear link between glucoraphanin and obesity reduction. Therefore, the answer to whether glucoraphanin from broccoli can help reduce obesity is not straightforward and depends on the interpretation of existing studies.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Has saracatinib been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Saracatinib is a drug that has been investigated for its potential therapeutic effects. To determine if it has been tested in clinical trials, one would need to look at scientific literature or clinical trial registries. Based on available information, saracatinib has indeed been tested in clinical trials for various conditions, including cancer and Alzheimer's disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does saracatinib promote oncogenesis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Saracatinib is a Src kinase inhibitor that has been studied for its potential use in cancer treatment. Src kinases are involved in signaling pathways that regulate various cellular processes, including proliferation, survival, and migration. In the context of cancer, Src kinases can contribute to oncogenesis by promoting these processes. Therefore, inhibiting Src kinases with drugs like saracatinib is generally aimed at reducing oncogenic activity rather than promoting it. Based on this understanding, saracatinib is not known to promote oncogenesis; rather, it is being investigated for its potential to inhibit cancer progression.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has MLE4901 been tested in phase III clinical trials?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\n  \"draft\": \"To determine if MLE4901 has been tested in phase III clinical trials, we need to check the latest clinical trial records or scientific publications. MLE4901, also known as AZD4901, is a drug that has been investigated for various conditions, including polycystic ovary syndrome (PCOS). As of the latest updates, MLE4901 has been tested in phase II clinical trials, but there is no publicly available information indicating that it has progressed to phase III trials. Therefore, based on the current information, the answer is no.\",\n  \"answer\": \"no\"\n}",
    "correct": true
  },
  {
    "question": "Does ESN364 activate the hypothalamic-pituitary-gonadal axis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if ESN364 activates the hypothalamic-pituitary-gonadal axis, we need to understand the mechanism of action of ESN364. ESN364 is known as a selective neurokinin-3 receptor antagonist. It is used in the treatment of conditions like polycystic ovary syndrome (PCOS) and menopausal symptoms. The hypothalamic-pituitary-gonadal (HPG) axis is a critical endocrine system that regulates reproductive function and hormone production. Activation of this axis typically involves stimulating the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which then stimulates the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), ultimately affecting the gonads. However, ESN364, as a neurokinin-3 receptor antagonist, is more likely to inhibit certain pathways rather than activate them. Therefore, it is unlikely that ESN364 activates the HPG axis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is traditional Chinese medicine associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether traditional Chinese medicine is linked to a reduced risk of heart failure in breast cancer patients who are undergoing treatment with doxorubicin. Doxorubicin is a chemotherapy drug known to have cardiotoxic effects, which can lead to heart failure. Traditional Chinese medicine encompasses a variety of practices, including herbal remedies, acupuncture, and other therapies. Some studies suggest that certain components of traditional Chinese medicine may have cardioprotective effects, potentially reducing the risk of heart failure. However, the evidence is not conclusive, and more research is needed to establish a definitive link. Therefore, based on the current evidence, it is not possible to definitively say that traditional Chinese medicine is associated with a decreased risk of heart failure in this context.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the protein ABCG2 (ATP-Binding Cassette, subfamily G, member 2, transporter) excreting uric acid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ABCG2 is a protein that functions as a transporter and is known to play a role in the excretion of uric acid. It is part of the ATP-binding cassette (ABC) family of transporters, which are involved in the transport of various molecules across cellular membranes. ABCG2 specifically has been identified as a urate transporter, contributing to the excretion of uric acid from the body.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein ABCG2 transmembrane?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ABCG2, also known as the breast cancer resistance protein (BCRP), is a member of the ATP-binding cassette (ABC) transporter family. Proteins in this family are known to be transmembrane proteins that transport various molecules across cellular membranes. ABCG2 is specifically known to be a transmembrane protein that plays a role in multidrug resistance by transporting drugs out of cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can brain derived exosomes carry APP molecules?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Brain-derived exosomes are small vesicles that can carry various types of molecules, including proteins, lipids, and RNA. APP, or amyloid precursor protein, is a protein that is expressed in the brain and is associated with Alzheimer's disease. Research has shown that exosomes can indeed carry APP molecules, as they are involved in the transport and processing of proteins within the brain. Therefore, it is possible for brain-derived exosomes to carry APP molecules.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can Flotillin be used as exosomal marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Flotillin is a protein that has been identified as a component of lipid rafts and is often associated with exosomes. It is commonly used as a marker for exosomes in research studies. Therefore, it is generally accepted that Flotillin can be used as an exosomal marker.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has the Spanich flu virus been reconstructed?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The Spanish flu virus, which caused a pandemic in 1918, has indeed been reconstructed by scientists. In 2005, researchers successfully reconstructed the virus using samples from preserved tissues of victims and genetic sequencing techniques. This reconstruction was done to better understand the virus and its characteristics, which could help in preparing for future pandemics.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Liâ€“Fraumeni syndrome a rare, autosomal recessive, hereditary disorder that predisposes carriers to cancer development?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Liâ€“Fraumeni syndrome is a hereditary disorder that predisposes individuals to cancer development. However, it is not an autosomal recessive disorder; it is actually an autosomal dominant disorder. This means that only one copy of the altered gene is sufficient to increase the risk of developing cancer. Therefore, the statement that Liâ€“Fraumeni syndrome is an autosomal recessive disorder is incorrect.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are ICAMS, Intracellular Adhesion Molecules, part of the immunoglobulin superfamily?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ICAMs, or Intracellular Adhesion Molecules, are indeed part of the immunoglobulin superfamily. This family is characterized by the presence of immunoglobulin-like domains, which are found in a variety of proteins involved in the immune system, including ICAMs. These molecules play a crucial role in the immune response by facilitating the adhesion and interaction between cells, such as leukocytes and endothelial cells. Therefore, the classification of ICAMs within the immunoglobulin superfamily is accurate.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The Paramyxovirus genome is a single, non-segmented, negative-sense RNA. It is not segmented, which means it is a single continuous strand of RNA rather than being divided into separate segments.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a vaccine for rotavirus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Rotavirus is a highly contagious virus that causes gastroenteritis, primarily in infants and young children. Vaccines have been developed to prevent rotavirus infections. These vaccines are administered orally and are included in the immunization schedules of many countries. The availability of rotavirus vaccines has significantly reduced the incidence of severe rotavirus infections and hospitalizations in children.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors(MPNST) rare in neurofibromatosis patients?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumors (MPNST) are indeed considered rare, even among patients with neurofibromatosis. Neurofibromatosis is a genetic disorder that increases the risk of developing various types of tumors, including MPNST. However, the occurrence of MPNST specifically within the spinal intradural space is not common. Therefore, it can be concluded that these tumors are rare in neurofibromatosis patients.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does AZD3759 cross the blood brain barrier?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"AZD3759 is a drug that has been studied for its ability to cross the blood-brain barrier. It was specifically designed to penetrate the central nervous system and has shown effectiveness in doing so in preclinical and clinical studies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is PTEN a tumour suppressor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"PTEN is a well-known tumor suppressor gene. It is involved in regulating cell growth by inhibiting the PI3K/AKT signaling pathway, which is crucial for cell survival and proliferation. Mutations or deletions in the PTEN gene can lead to uncontrolled cell growth and contribute to the development of various cancers. Therefore, PTEN is classified as a tumor suppressor.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is MLL3 part of the ASCOM complex?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if MLL3 is part of the ASCOM complex, we need to understand the components of the ASCOM complex and the role of MLL3. The ASCOM complex, also known as the ASC-2 complex, is involved in transcriptional regulation and includes various proteins. MLL3, on the other hand, is a histone methyltransferase that is part of the COMPASS-like complex, which is involved in histone modification. While MLL3 is associated with transcriptional regulation, it is not typically listed as a component of the ASCOM complex. Therefore, MLL3 is not part of the ASCOM complex.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are astrocytes part of the blood brain barrier?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Astrocytes are a type of glial cell in the brain and spinal cord. They play a crucial role in the functioning of the blood-brain barrier (BBB) by supporting and maintaining the barrier's integrity. However, they are not a structural component of the BBB itself. The blood-brain barrier is primarily composed of endothelial cells that line the blood vessels in the brain, along with tight junctions that connect these cells. Astrocytes contribute to the BBB by releasing signaling molecules that influence the permeability and function of the endothelial cells. Therefore, while astrocytes are closely associated with the blood-brain barrier and are essential for its function, they are not part of the barrier's physical structure.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the protein MCL-1 anti-apoptotic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"MCL-1 is a member of the Bcl-2 family of proteins, which are known to regulate apoptosis. Specifically, MCL-1 is known to have anti-apoptotic properties. It functions by inhibiting the pro-apoptotic proteins, thereby preventing the initiation of the apoptotic process. This role is crucial in cell survival and is often implicated in cancer, where overexpression of MCL-1 can lead to resistance to apoptosis and contribute to tumorigenesis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are bacteria in the genus Clostridium facultative anaerobes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Bacteria in the genus Clostridium are known to be obligate anaerobes, meaning they cannot survive in the presence of oxygen. Facultative anaerobes, on the other hand, can survive with or without oxygen. Therefore, Clostridium bacteria are not facultative anaerobes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has ORMD-0801 been tested in patients?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ORMD-0801 is an oral insulin capsule developed by Oramed Pharmaceuticals. Clinical trials are typically conducted to test new drugs in patients. To determine if ORMD-0801 has been tested in patients, we would need to check if it has undergone any clinical trials involving human participants.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Was vivotif licensed in Europe and the US at the same time?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Vivotif, an oral typhoid vaccine, was licensed in Europe and the US, but not necessarily at the same time. Licensing processes can vary by region and depend on regulatory approvals specific to each area.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can AGY be used as antidiuretic replacement therapy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"AGY is not a recognized abbreviation or name for any known antidiuretic or medication used in replacement therapy. Antidiuretic replacement therapy typically involves the use of medications like desmopressin, which is a synthetic analog of vasopressin. Without further information on what AGY specifically refers to, it cannot be confirmed as a suitable antidiuretic replacement therapy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Have the rotavirus vaccines changed the predominant rotavirus genotypes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The introduction of rotavirus vaccines has been associated with changes in the prevalence of certain rotavirus genotypes. Vaccination can lead to a reduction in the circulation of vaccine-targeted genotypes, potentially allowing other genotypes to become more prevalent. This phenomenon has been observed in various regions where rotavirus vaccination programs have been implemented. Therefore, it is reasonable to conclude that rotavirus vaccines have influenced the distribution of rotavirus genotypes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can leuprorelin acetate be used as androgen deprivation therapy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Leuprorelin acetate is a medication that is commonly used as part of androgen deprivation therapy (ADT). It is a type of gonadotropin-releasing hormone (GnRH) agonist, which works by reducing the production of testosterone in the body. This reduction in testosterone is beneficial in treating conditions like prostate cancer, where lowering androgen levels can help slow the growth of cancer cells. Therefore, leuprorelin acetate is indeed used as androgen deprivation therapy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can MVA85A confer immunity against smallpox?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"MVA85A is a vaccine candidate designed to enhance the immune response to the BCG vaccine against tuberculosis. It is not developed or intended for use against smallpox. Smallpox is caused by the variola virus, and the vaccine used for smallpox is based on the vaccinia virus, which is different from MVA85A. Therefore, MVA85A would not confer immunity against smallpox.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the drug Exubera currently (March 2020) available?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Exubera was an inhaled form of insulin that was approved by the FDA in 2006 but was withdrawn from the market by Pfizer in 2007 due to poor sales and acceptance. Since it was withdrawn, it has not been reintroduced to the market. Therefore, as of March 2020, Exubera is not available.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has the drug Afrezza been approved by the FDA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Afrezza is an inhalable insulin used to control blood sugar levels in adults with diabetes. It was developed by MannKind Corporation and has been a subject of interest due to its unique delivery method. The FDA approval status of a drug is crucial for its availability and use in the United States. To determine if Afrezza has been approved by the FDA, one would need to check the FDA's records or reliable sources that track drug approvals.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the Fluzone intradermal and the Fluzone intradermal quadrivalent vaccine produced by different companies?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The Fluzone intradermal and Fluzone intradermal quadrivalent vaccines are both produced by the same company, Sanofi Pasteur. Fluzone is a brand name for influenza vaccines manufactured by Sanofi Pasteur, and the intradermal versions are part of their product line. Therefore, they are not produced by different companies.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Daptacel be used instead of IPOL?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Daptacel and IPOL are both vaccines, but they are used for different purposes. Daptacel is a combination vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough), while IPOL is a vaccine that protects against poliovirus. Since they target different diseases, Daptacel cannot be used as a substitute for IPOL.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can CMB305 be used against sarcomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if CMB305 can be used against sarcomas, we need to consider the nature of CMB305 and its intended applications. CMB305 is a cancer vaccine that targets the NY-ESO-1 antigen, which is expressed in various types of tumors, including some sarcomas. Clinical trials have been conducted to evaluate its efficacy in treating cancers that express this antigen. Therefore, if sarcomas express the NY-ESO-1 antigen, CMB305 could potentially be used against them. However, the effectiveness and approval for use would depend on clinical trial results and regulatory approvals.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has ZP-PTH been tested in a phase II clinical trial?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ZP-PTH is a drug that may have undergone various stages of clinical trials. To determine if it has been tested in a phase II clinical trial, one would need to check clinical trial registries or scientific publications for evidence of such a trial. If there is documentation or reports confirming a phase II trial for ZP-PTH, then the answer would be yes. Otherwise, it would be no.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SARS virus interacting with ACE2 encoded protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The SARS virus, specifically SARS-CoV, is known to interact with the ACE2 encoded protein. The spike protein of the SARS virus binds to the ACE2 receptor on the surface of human cells, facilitating viral entry and infection. This interaction is a well-documented mechanism of how the virus infects host cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is ACE2 expressed on cell surfaces?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ACE2, or angiotensin-converting enzyme 2, is a protein that is expressed on the surface of various cell types, including epithelial cells in the lungs, intestines, kidneys, and blood vessels. It serves as a receptor for the SARS-CoV-2 virus, allowing the virus to enter cells and cause infection. The expression of ACE2 on cell surfaces is a key factor in the pathogenesis of COVID-19.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cathepsin L active in endosomes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cathepsin L is a cysteine protease that is typically active in the acidic environment of lysosomes. However, it can also be active in endosomes, which are part of the endocytic pathway and have a slightly acidic pH that can support the activity of cathepsin L. Therefore, it is possible for cathepsin L to be active in endosomes under certain conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is endotrophin derived from collagen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Endotrophin is a cleavage product of collagen VI, specifically derived from the C5 domain of the collagen VI alpha 3 chain. It is associated with various biological processes and has been studied for its role in fibrosis and cancer. Since endotrophin is a fragment that results from the processing of collagen VI, it can be considered as being derived from collagen.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Protoporphyrinogen oxidase localized to the mitochondrium?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Protoporphyrinogen oxidase is an enzyme involved in the heme biosynthesis pathway. It is known to be localized in the mitochondria as well as in the cytosol, depending on the organism. In humans, it is primarily found in the mitochondria, where it catalyzes the oxidation of protoporphyrinogen IX to protoporphyrin IX, a precursor to heme. Therefore, in the context of human biology, protoporphyrinogen oxidase is indeed localized to the mitochondria.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is aggrephagy a variant of autophagy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Aggrephagy is a specific type of autophagy that involves the selective degradation of protein aggregates. Autophagy is a broader cellular process that involves the degradation and recycling of cellular components, and aggrephagy is one of its specialized forms. Therefore, aggrephagy can be considered a variant of autophagy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does protein ALEX1 contain armadillo repeats?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\n  \"draft\": \"To determine if protein ALEX1 contains armadillo repeats, we need to look at the protein's structure and sequence information. Armadillo repeats are a type of protein motif characterized by a series of tandemly repeated sequences that form a superhelix. These repeats are found in a variety of proteins and are involved in protein-protein interactions. Without specific structural or sequence data on ALEX1, it is not possible to definitively say whether it contains armadillo repeats.\",\n  \"answer\": \"no\"\n}",
    "correct": false
  },
  {
    "question": "Is Bcl-2-like protein 1 an pro apoptotic protein?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Bcl-2-like protein 1, also known as Bcl-xL, is part of the Bcl-2 family of proteins. The Bcl-2 family includes both pro-apoptotic and anti-apoptotic proteins. Bcl-xL is known for its role in inhibiting apoptosis, thus it is classified as an anti-apoptotic protein.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do nematodes contain a CTCF gene?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CTCF (CCCTC-binding factor) is a transcriptional regulator protein that is known to be present in many eukaryotic organisms, including vertebrates and some invertebrates. Nematodes, such as Caenorhabditis elegans, are a type of invertebrate. Research has shown that CTCF is not present in C. elegans, which is a model organism for nematodes. Therefore, it is unlikely that nematodes contain a CTCF gene.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does steroid 5A-Reductase deficiency lead to hermaphroditism?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Steroid 5A-Reductase deficiency is a condition that affects male sexual development. It is caused by a deficiency in the enzyme 5-alpha-reductase, which is necessary for the conversion of testosterone to dihydrotestosterone (DHT). DHT is crucial for the development of male external genitalia. Individuals with this deficiency are genetically male (46,XY) but may have ambiguous genitalia or female-appearing genitalia at birth. This condition can lead to a form of intersex variation, where the individual has characteristics of both male and female genitalia, which is sometimes referred to as pseudohermaphroditism. However, the term 'hermaphroditism' is outdated and not typically used in modern medical contexts. The condition does not lead to true hermaphroditism, where both ovarian and testicular tissue are present.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the TFR1 gene dispensable for erythropoiesis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The TFR1 gene, also known as transferrin receptor 1, is crucial for iron uptake in cells. Erythropoiesis, the process of producing red blood cells, requires iron for hemoglobin synthesis. Therefore, TFR1 is generally considered essential for erythropoiesis because it facilitates the iron uptake necessary for this process.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are somatic mutations positioned towards the nuclear periphery?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Somatic mutations are changes in the DNA that occur after conception and can be found in any of the body's cells except the germ cells. The positioning of somatic mutations in relation to the nuclear periphery is a topic of scientific research. Some studies suggest that certain mutations may be more prevalent in specific nuclear regions, but this is not a definitive rule for all somatic mutations. Therefore, the statement that somatic mutations are positioned towards the nuclear periphery is not universally true.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Mediator present at super enhancers?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if the Mediator complex is present at super enhancers, we need to understand the roles of both. Super enhancers are large clusters of transcriptional enhancers that drive the expression of genes involved in cell identity. The Mediator complex is a multi-protein complex that functions as a transcriptional coactivator in all eukaryotes. It serves as a bridge conveying information from gene-specific regulatory proteins to the RNA polymerase II transcription machinery. Research has shown that the Mediator complex is indeed associated with super enhancers, as it is recruited to these regions to facilitate high levels of transcription. Therefore, the answer is yes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tcf3 associated with the Wnt pathway?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tcf3 is a transcription factor that is indeed associated with the Wnt signaling pathway. It is part of the TCF/LEF family of transcription factors that mediate Wnt signaling by interacting with beta-catenin. When Wnt signaling is active, beta-catenin accumulates in the nucleus and binds to TCF/LEF transcription factors, including Tcf3, to regulate the expression of Wnt target genes. Therefore, Tcf3 is associated with the Wnt pathway.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Nanog repressed in pluripotent stem cells?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nanog is a transcription factor that is crucial for maintaining the pluripotency of stem cells. It is typically expressed in pluripotent stem cells to help maintain their undifferentiated state. Repression of Nanog would lead to differentiation, which is not the usual state for pluripotent stem cells. Therefore, Nanog is not repressed in pluripotent stem cells; rather, it is actively expressed to maintain their pluripotency.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do nematodes contain architectural proteins like CTCF?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CTCF is a well-known architectural protein involved in the organization of chromatin structure in eukaryotic cells. Nematodes, such as C. elegans, are eukaryotic organisms and have been studied extensively for their genetic and molecular biology. While CTCF is a common architectural protein in many eukaryotes, it is not universally present in all species. In the case of nematodes, specifically C. elegans, research indicates that they do not have a direct ortholog of CTCF. Therefore, it is unlikely that nematodes contain CTCF or similar architectural proteins in the same way as other organisms like mammals or flies.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do polycomb group proteins (PcG) mediate the formation of chromatin loops?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Polycomb group proteins (PcG) are known to play a role in the regulation of gene expression through chromatin modification. They are involved in the formation of repressive chromatin structures, which can include the formation of chromatin loops. These loops can bring distant regions of DNA into close proximity, facilitating or inhibiting interactions necessary for gene regulation. Therefore, PcG proteins do mediate the formation of chromatin loops as part of their function in gene regulation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are super enhancers structurally insulated in chromatin loops?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Super enhancers are regions of the genome that are densely occupied by transcription factors and coactivators, playing a crucial role in regulating gene expression. They are often found in chromatin loops, which are structures that bring distant parts of the genome into close proximity. These loops can create insulated neighborhoods that help regulate the activity of super enhancers by limiting their interaction with other genomic regions. Therefore, super enhancers can be structurally insulated within these chromatin loops, allowing them to specifically interact with their target genes.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Are there negative enhancers?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks if there are negative enhancers. In biology, enhancers are DNA sequences that increase the transcription of a gene. Typically, enhancers are positive regulators of gene expression. However, there are regulatory elements known as silencers that decrease transcription. These are not called enhancers, but they serve a similar regulatory function in the opposite direction. Therefore, the term 'negative enhancer' is not commonly used or recognized in the field of genetics.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are enhancers directional in their targeting of gene promoters?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Enhancers are DNA sequences that can increase the transcription of genes. They are known to interact with gene promoters to enhance gene expression. However, enhancers are generally considered to be non-directional in their targeting. This means that they can enhance the transcription of genes regardless of their orientation relative to the gene promoter. Enhancers can work over long distances and can be located upstream, downstream, or even within the genes they regulate. Therefore, the directionality of enhancers in targeting gene promoters is not a defining characteristic of their function.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is the zelda transcription factor a chromatin remodeller?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the Zelda transcription factor functions as a chromatin remodeler. Transcription factors are proteins that help regulate the expression of genes by binding to specific DNA sequences. Chromatin remodelers, on the other hand, are proteins that modify the structure of chromatin to allow access to DNA for transcription. While transcription factors and chromatin remodelers can interact and influence each other's functions, they are distinct in their primary roles. Zelda is known as a pioneer transcription factor that binds to DNA and helps activate zygotic genome activation in early embryonic development. It is not primarily characterized as a chromatin remodeler, although it may influence chromatin structure indirectly through its role in gene activation.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is methotrexate used for the treatment of Rheumatoid Arthritis (RA)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Methotrexate is a medication that is commonly used in the treatment of Rheumatoid Arthritis (RA). It is considered a disease-modifying antirheumatic drug (DMARD) and is often prescribed to help reduce inflammation and slow the progression of the disease. Methotrexate is one of the most widely used and effective treatments for RA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can ATAC-Seq be employed in single-cell mode?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"ATAC-Seq, which stands for Assay for Transposase-Accessible Chromatin using sequencing, is a technique used to study chromatin accessibility. It can indeed be adapted for single-cell analysis, allowing researchers to investigate chromatin accessibility at the level of individual cells. This adaptation is known as single-cell ATAC-Seq (scATAC-Seq).\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is yeast fbp1 affected by glucose starvation stress?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the yeast fbp1 gene is affected by glucose starvation stress. In yeast, fbp1 is known to be involved in gluconeogenesis, a process that is upregulated when glucose is scarce. Therefore, it is likely that fbp1 is affected by glucose starvation as the organism shifts its metabolism to adapt to the lack of glucose.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does an antiphlogistic promotes inflammation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"An antiphlogistic is a substance or treatment that reduces inflammation or fever. The term 'antiphlogistic' is derived from 'anti-' meaning against, and 'phlogistic' relating to inflammation. Therefore, an antiphlogistic does not promote inflammation; rather, it works to reduce or counteract it.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can SMAD6 variants cause craniosynostosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SMAD6 is a gene that has been associated with craniosynostosis, a condition where the bones in a baby's skull join together too early. Variants in the SMAD6 gene can disrupt its normal function, which is involved in bone development and growth. Research has shown that mutations in SMAD6 can lead to craniosynostosis, making it one of the genetic factors contributing to this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can propofol cause green urine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Propofol is a medication commonly used for anesthesia and sedation. One of the rare side effects of propofol is the discoloration of urine, which can sometimes appear green. This is due to the presence of phenolic metabolites in the urine after the administration of propofol. Therefore, it is possible for propofol to cause green urine, although it is not a common occurrence.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can radiosurgery be used for the DNET tumors?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"DNET (Dysembryoplastic Neuroepithelial Tumor) is a type of brain tumor that is generally considered benign and often associated with epilepsy. Treatment options for DNETs typically include surgical resection, especially if they are causing symptoms like seizures. Radiosurgery, which is a form of radiation therapy that precisely targets tumors, is sometimes considered for brain tumors, particularly when surgery is not feasible or if the tumor is in a difficult-to-access location. However, the primary treatment for DNETs is usually surgical removal, and radiosurgery might not be the first line of treatment. The decision to use radiosurgery would depend on various factors including the tumor's size, location, and the patient's overall health. Therefore, while radiosurgery can be used for certain brain tumors, it is not typically the standard treatment for DNETs.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Was golimumab tested for diabetes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Golimumab is a monoclonal antibody primarily used for the treatment of autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is not typically associated with the treatment of diabetes. Clinical trials and studies for golimumab have focused on its efficacy and safety in treating these autoimmune diseases rather than diabetes. Therefore, it is unlikely that golimumab has been specifically tested for diabetes.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nelson's syndrome is a condition that can occur in patients who have had their adrenal glands removed, typically due to Cushing's disease. It is characterized by the growth of a pituitary tumor and increased production of ACTH. Cabergoline is a dopamine agonist that is sometimes used to treat pituitary tumors, particularly those that secrete prolactin. However, its use in Nelson's syndrome is not standard and is not commonly mentioned in the treatment guidelines for this condition. Therefore, it is unlikely that cabergoline is a primary treatment for Nelson's syndrome.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is proton beam therapy used for treatment of craniopharyngioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Proton beam therapy is a type of radiation treatment that uses protons rather than x-rays to treat cancer. It is known for its precision and ability to minimize damage to surrounding healthy tissue. Craniopharyngioma is a type of brain tumor that can be challenging to treat due to its location near critical structures in the brain. Proton beam therapy is often considered for such tumors because it can target the tumor more precisely and reduce the risk of side effects compared to conventional radiation therapy. Therefore, it is used in the treatment of craniopharyngioma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can Panitumumab cause trichomegaly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Panitumumab is a monoclonal antibody used in cancer treatment, specifically for colorectal cancer. It works by targeting the epidermal growth factor receptor (EGFR). One of the known side effects of EGFR inhibitors, like Panitumumab, is changes in hair growth, including trichomegaly, which is the excessive growth of eyelashes. Therefore, it is possible for Panitumumab to cause trichomegaly as a side effect.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do exon 38 or 39 KMT2D missense variants cause Kabuki syndrome type 1 (KS1)?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Kabuki syndrome type 1 (KS1) is a genetic disorder caused by mutations in the KMT2D gene. Missense variants in this gene can lead to KS1. Exons 38 and 39 are parts of the KMT2D gene, and missense variants in these exons could potentially cause KS1. However, the specific impact of variants in these exons would depend on the nature of the mutation and its effect on the protein function. Generally, missense mutations in KMT2D are known to be associated with KS1, so it is plausible that variants in exons 38 or 39 could contribute to the condition.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is tirabrutinib effective for lymphoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tirabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor that has been studied for its effectiveness in treating certain types of lymphoma. Clinical trials and studies have shown that tirabrutinib can be effective in treating some forms of lymphoma, particularly those that are dependent on the BTK pathway. However, the effectiveness can vary depending on the specific type of lymphoma and the individual patient's condition. Overall, there is evidence supporting its use in certain cases of lymphoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is fusobacterium associated with Lemierre's syndrome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Fusobacterium, particularly Fusobacterium necrophorum, is a type of bacteria that is commonly associated with Lemierre's syndrome. This syndrome is a rare condition that typically begins with a throat infection and can lead to serious complications, including septicemia and thrombophlebitis of the internal jugular vein. The association between Fusobacterium and Lemierre's syndrome is well-documented in medical literature.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is progeria caused by an autosomal recessive gene?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS), is a rare genetic condition characterized by rapid aging in children. It is caused by a mutation in the LMNA gene, which is located on chromosome 1. This mutation is not inherited in an autosomal recessive manner. Instead, it typically arises as a de novo mutation, meaning it occurs spontaneously and is not passed down from parents to children. Therefore, progeria is not caused by an autosomal recessive gene.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there a genetic cause of craniostenosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Craniostenosis, also known as craniosynostosis, is a condition where one or more of the sutures in a baby's skull close prematurely, affecting the shape of the head and potentially the brain's development. There are various causes of craniosynostosis, and genetics can play a significant role. Some cases are associated with genetic syndromes caused by mutations in specific genes, such as FGFR2, FGFR3, and TWIST1. Therefore, there is a genetic component to some forms of craniosynostosis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is acupotomy used to treat muscle stiffness?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Acupotomy is a form of acupuncture that involves using a small needle-like instrument to perform a minimally invasive procedure. It is often used to treat various musculoskeletal conditions, including muscle stiffness. By targeting specific points in the body, acupotomy aims to relieve tension and improve mobility, making it a suitable treatment for muscle stiffness.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is carpal tunnel syndrome a type of nerve entrapment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Carpal tunnel syndrome is a condition that occurs when the median nerve, which runs from the forearm into the palm of the hand, becomes pressed or squeezed at the wrist. This condition is indeed a type of nerve entrapment, as it involves the compression of a nerve within a confined space, leading to symptoms such as pain, numbness, and tingling in the hand and arm.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any role of genotoxic pks + E. coli in cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks if there is a role of genotoxic pks+ E. coli in cancer. Genotoxic pks+ E. coli refers to a strain of E. coli bacteria that carries the pks genomic island, which is known to produce colibactin, a genotoxin. Research has shown that colibactin can cause DNA damage in host cells, which may contribute to the development of cancer. Therefore, there is scientific evidence suggesting a potential role of genotoxic pks+ E. coli in cancer development.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is avelumab effective for urothelial carcinoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Avelumab is a monoclonal antibody that has been studied for its effectiveness in treating urothelial carcinoma, particularly in patients who have already undergone platinum-based chemotherapy. Clinical trials have shown that avelumab can be effective in this context, leading to its approval for use in certain cases of urothelial carcinoma. Therefore, based on available evidence, avelumab is considered effective for urothelial carcinoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does a comet assay measure radiation induced mutations?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The comet assay, also known as single cell gel electrophoresis, is a sensitive technique for measuring DNA damage in individual cells. It is commonly used to detect DNA strand breaks and repair in cells exposed to various agents, including radiation. However, it does not directly measure mutations, but rather the extent of DNA damage, which can be a precursor to mutations. Therefore, while it can indicate potential for mutations due to DNA damage, it does not measure mutations themselves.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is MIS-C or Multisystem  Inflammatory syndrome in children a complication of Covid-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"MIS-C, or Multisystem Inflammatory Syndrome in Children, is a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. It has been observed in children who have been infected with the virus that causes COVID-19 or have been in contact with someone with COVID-19. The Centers for Disease Control and Prevention (CDC) and other health organizations have recognized MIS-C as a complication associated with COVID-19 in children.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SLIC-CAGE used for quantification of translation?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"SLIC-CAGE (Start Labeled Inverted Capped RNA sequencing) is a technique primarily used to map transcription start sites (TSS) and to study promoter usage and gene expression at the transcriptional level. It is not specifically designed for quantifying translation, which involves the process of protein synthesis from mRNA. Techniques like ribosome profiling are more suited for studying translation. Therefore, SLIC-CAGE is not used for quantification of translation.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is adenosine signaling prognostic for cancer outcome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Adenosine signaling is involved in various physiological processes and has been studied in the context of cancer. It is known to play a role in tumor progression and immune evasion. Research has suggested that adenosine signaling can influence cancer outcomes, making it a potential prognostic factor. However, the prognostic value may vary depending on the type of cancer and other factors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does bleomycin cause lung toxicity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bleomycin is a chemotherapy drug that is known to cause lung toxicity as a side effect. This condition is often referred to as bleomycin-induced pneumonitis or pulmonary fibrosis. The risk of lung toxicity increases with higher cumulative doses of bleomycin and can lead to serious respiratory complications. Therefore, it is important for healthcare providers to monitor patients receiving bleomycin for any signs of lung toxicity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there sex differences in oncogenic mutational processes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there are differences between sexes in the processes that lead to mutations causing cancer. Oncogenic mutational processes refer to the mechanisms by which genetic mutations occur that can lead to cancer. Research has shown that there can be differences in cancer incidence and progression between males and females, which may be due to biological differences, including hormonal influences and genetic factors. Studies have indicated that there are indeed sex differences in the mutational processes that lead to cancer, suggesting that the answer to the question is likely 'yes'.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is co-loss of BRCA2-RB1 associated with better prognosis for prostate cancer patients?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the co-loss of BRCA2 and RB1 genes is linked to a better prognosis in prostate cancer patients. BRCA2 and RB1 are both tumor suppressor genes, and their loss is generally associated with more aggressive cancer and poorer outcomes. Therefore, it is unlikely that the co-loss of these genes would be associated with a better prognosis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a role for Dickkopf-1 (DKK1) in prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Dickkopf-1 (DKK1) is a protein that is known to play a role in the regulation of the Wnt signaling pathway, which is involved in various cellular processes including cell proliferation and differentiation. Abnormal Wnt signaling has been implicated in the development and progression of several types of cancer, including prostate cancer. Research has shown that DKK1 can be overexpressed in prostate cancer and may contribute to tumor growth and metastasis. Therefore, there is a role for DKK1 in prostate cancer, particularly in the context of its involvement in cancer progression and as a potential therapeutic target.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Benralizumab effective for Chronic Spontaneous Urticaria?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Benralizumab is a monoclonal antibody that is primarily used for the treatment of severe eosinophilic asthma. It works by targeting the interleukin-5 receptor on the surface of eosinophils, leading to their depletion. Chronic Spontaneous Urticaria (CSU) is a condition characterized by the spontaneous appearance of hives and/or angioedema without an identifiable trigger. The standard treatment for CSU includes antihistamines and, in some cases, omalizumab, another monoclonal antibody. While there is ongoing research into the use of various biologics for CSU, Benralizumab is not currently approved or widely recognized as an effective treatment for this condition. Therefore, based on the current evidence and approvals, Benralizumab is not considered effective for Chronic Spontaneous Urticaria.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is belimumab effective for the lupus nephritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Belimumab is a monoclonal antibody that targets and inhibits the activity of the B-lymphocyte stimulator (BLyS) protein, which is involved in the survival and activity of B cells. It is used in the treatment of systemic lupus erythematosus (SLE). Recent studies and clinical trials have shown that belimumab can be effective in treating lupus nephritis, which is a severe kidney inflammation caused by SLE. The FDA has approved belimumab for use in adult patients with active lupus nephritis, indicating its effectiveness in this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is liraglutide effective for weight reduction?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Liraglutide is a medication that is commonly used for the treatment of type 2 diabetes and obesity. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that has been shown in clinical studies to aid in weight loss. The effectiveness of liraglutide for weight reduction has been supported by various research studies and clinical trials, which have demonstrated significant weight loss in individuals using the medication compared to those on a placebo. Therefore, based on the available evidence, liraglutide is considered effective for weight reduction.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Eflornithine and Sulindac are effective for prevention of progression in Familial Adenomatous Polyposis?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Familial Adenomatous Polyposis (FAP) is a hereditary condition that causes cancer predisposition due to the development of numerous polyps in the colon and rectum. Eflornithine and Sulindac are drugs that have been studied for their potential to prevent the progression of polyps in FAP patients. Clinical trials have been conducted to evaluate their effectiveness. Some studies have shown that the combination of Eflornithine and Sulindac can reduce the number of polyps in FAP patients, suggesting they may be effective in preventing progression. However, the results can vary, and not all studies may show the same level of effectiveness. Therefore, while there is some evidence supporting their use, it is not definitive for all cases.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is ofatumumab effective for multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ofatumumab is a medication that has been studied and used for the treatment of multiple sclerosis (MS). It is a monoclonal antibody that targets CD20, a protein found on the surface of certain immune cells. Clinical trials have shown that ofatumumab is effective in reducing the frequency of relapses and slowing the progression of disability in patients with relapsing forms of multiple sclerosis. It has been approved by regulatory agencies for this use, indicating its effectiveness in treating MS.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Olaparib effective for prostate cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Olaparib is a medication that has been studied for its effectiveness in treating prostate cancer, particularly in cases where the cancer has specific genetic mutations such as BRCA1 or BRCA2. Clinical trials have shown that Olaparib can be effective in treating prostate cancer with these mutations, leading to its approval for use in certain cases of metastatic castration-resistant prostate cancer. Therefore, Olaparib is considered effective for prostate cancer with specific genetic profiles.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has tocilizumab been assessed against Covid-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tocilizumab is a medication that has been studied for its potential use in treating Covid-19. It is an immunosuppressive drug, typically used to treat rheumatoid arthritis, and works by blocking the interleukin-6 (IL-6) receptor. During the Covid-19 pandemic, researchers investigated its effectiveness in managing severe cases of Covid-19, particularly in patients experiencing a cytokine storm, which is an overreaction of the body's immune system. Various clinical trials and studies have been conducted to assess its efficacy and safety in this context.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is tocilizumab a tumor necrosis factor inhibitor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tocilizumab is a medication that acts as an interleukin-6 (IL-6) receptor antagonist. It is primarily used to treat rheumatoid arthritis and certain other inflammatory conditions. Tumor necrosis factor (TNF) inhibitors, on the other hand, are a different class of medications that specifically target and inhibit the activity of TNF, a pro-inflammatory cytokine. Since tocilizumab targets IL-6 receptors and not TNF, it is not classified as a TNF inhibitor.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is tofacitinib a JAK inhibitor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tofacitinib is a medication that is classified as a Janus kinase (JAK) inhibitor. It is used to treat certain autoimmune conditions by inhibiting the activity of JAK enzymes, which play a role in the inflammatory process. Therefore, the answer to the question is yes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does the use of bDMARDs during pregnancy impact neonatal development?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the use of biologic disease-modifying antirheumatic drugs (bDMARDs) during pregnancy affects the development of newborns. bDMARDs are used to treat autoimmune conditions and their safety during pregnancy is a concern. Research indicates that some bDMARDs can cross the placenta, potentially impacting the fetus. However, the extent of impact on neonatal development varies depending on the specific bDMARD and the timing of exposure during pregnancy. Some studies suggest potential risks, while others indicate minimal impact. Overall, the answer depends on the specific circumstances and bDMARDs involved.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is tocilizumab a csDMARD?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if tocilizumab is a csDMARD, we need to understand what csDMARDs are. csDMARD stands for conventional synthetic Disease-Modifying Anti-Rheumatic Drug. These are traditional drugs used to treat rheumatic diseases by modifying the underlying disease process. Tocilizumab, on the other hand, is a biologic drug that targets the interleukin-6 receptor and is classified as a biologic DMARD (bDMARD), not a conventional synthetic one. Therefore, tocilizumab is not a csDMARD.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is vocimagene amiretrorepvec effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Vocimagene amiretrorepvec, also known as Toca 511, is an investigational gene therapy designed to treat glioblastoma. Clinical trials have been conducted to assess its efficacy. However, as of the latest updates, the results have not demonstrated a significant improvement in overall survival or progression-free survival compared to standard treatments. Therefore, it is not considered effective for glioblastoma based on current evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does addition of valproic acid improve survival of patients with diffuse intrinsic pontine glioma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the addition of valproic acid improves the survival of patients with diffuse intrinsic pontine glioma (DIPG). DIPG is a highly aggressive and difficult-to-treat brain tumor found in the pons of the brainstem. Treatment options are limited, and the prognosis is generally poor. Valproic acid is a medication primarily used to treat epilepsy and bipolar disorder, but it has also been studied for its potential anti-cancer properties. However, there is limited and inconclusive evidence regarding its effectiveness in improving survival rates for DIPG patients. Clinical trials and studies would be necessary to provide a definitive answer. Based on the current knowledge and available data, it is not clear that valproic acid significantly improves survival in DIPG patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is capmatinib effective for glioblastoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Capmatinib is a drug that is primarily used to target MET exon 14 skipping mutations in non-small cell lung cancer. Glioblastoma is a type of brain cancer, and while there is ongoing research into various treatments for glioblastoma, capmatinib is not currently recognized as an effective treatment for this type of cancer. The effectiveness of a drug can vary based on the specific mutations and characteristics of the cancer, and as of the latest available information, capmatinib is not a standard or widely accepted treatment for glioblastoma.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should cerebrolysin be used for aneurysmal subarachnoid hemorrhage?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Cerebrolysin is a neuroprotective agent that is sometimes used in the treatment of various neurological conditions. Aneurysmal subarachnoid hemorrhage (SAH) is a serious condition that requires careful management. The use of cerebrolysin for SAH is not widely established or recommended in standard treatment guidelines. The primary treatments for aneurysmal SAH typically involve surgical interventions and management of complications such as vasospasm. Therefore, the use of cerebrolysin in this context is not standard practice and lacks strong evidence supporting its efficacy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Tranexamic acid effective for intracerebral haemorrhage?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tranexamic acid is an antifibrinolytic agent that helps to reduce bleeding by inhibiting the breakdown of blood clots. It has been studied for its potential use in various bleeding conditions, including intracerebral hemorrhage (ICH). However, the effectiveness of tranexamic acid specifically for ICH is still under investigation. Some studies suggest it may reduce hematoma expansion, but there is no conclusive evidence that it improves functional outcomes or mortality rates in ICH patients. Therefore, while it may have some effect on bleeding, its overall effectiveness for intracerebral hemorrhage remains uncertain.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can thiotepa be recommended for treatment of osteosarcoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Thiotepa is a chemotherapy drug that is primarily used to treat certain types of cancers such as breast cancer, ovarian cancer, and bladder cancer. It is also used in bone marrow transplantation conditioning regimens. However, it is not commonly recommended or used as a standard treatment for osteosarcoma, which is a type of bone cancer. The standard treatment for osteosarcoma typically involves a combination of surgery and chemotherapy with drugs like methotrexate, doxorubicin, and cisplatin. Therefore, thiotepa is not typically recommended for osteosarcoma treatment.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does hypofractionated radiotherapy offers any benefit for DIPG?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Hypofractionated radiotherapy is a treatment approach where radiation doses are delivered in larger fractions over a shorter period of time. Diffuse Intrinsic Pontine Glioma (DIPG) is a highly aggressive and difficult-to-treat brain tumor found in children. Traditional radiotherapy is often used to manage DIPG symptoms and potentially extend survival, but the prognosis remains poor. Hypofractionated radiotherapy could potentially offer benefits such as reduced treatment time and improved convenience, but the overall impact on survival or quality of life for DIPG patients is not well-established. Current research and clinical trials are needed to determine if there are any significant benefits of hypofractionated radiotherapy for DIPG patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is isradipine effective for Parkinson's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Isradipine is a calcium channel blocker that has been investigated for its potential neuroprotective effects in Parkinson's disease. Some preclinical studies suggested that it might have benefits, but clinical trials, such as the STEADY-PD III trial, did not show significant efficacy in slowing the progression of Parkinson's disease. Therefore, based on current evidence, isradipine is not considered effective for Parkinson's disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should nerinetide be used for treatment of ischaemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nerinetide is a neuroprotective agent that has been studied for its potential use in treating ischemic stroke. Clinical trials, such as the ESCAPE-NA1 trial, have investigated its efficacy. However, the results have been mixed, with some studies showing no significant benefit when used alongside standard treatments like thrombolysis or thrombectomy. Therefore, as of the latest available data, nerinetide is not widely recommended or approved for the treatment of ischemic stroke outside of clinical trials.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Lanabecestat effective for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Lanabecestat is a drug that was developed as a potential treatment for Alzheimer's disease. It is an oral beta-secretase cleaving enzyme (BACE) inhibitor, which was intended to reduce the production of amyloid-beta, a protein that accumulates in the brains of people with Alzheimer's disease. However, clinical trials, including the AMARANTH and DAYBREAK-ALZ studies, were halted because lanabecestat did not show efficacy in slowing the progression of Alzheimer's disease. Therefore, based on the available evidence from these trials, lanabecestat is not considered effective for treating Alzheimer's disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should minocycline be used for mild Alzheimer disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Minocycline is an antibiotic that has been studied for its potential neuroprotective effects in various neurological conditions, including Alzheimer's disease. However, current clinical guidelines and research do not support the routine use of minocycline for mild Alzheimer's disease due to insufficient evidence of its efficacy and safety in this context. Therefore, it is not recommended as a standard treatment for mild Alzheimer's disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is MK-1602 a CGRP antagonist?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"MK-1602 is a drug that has been identified as a CGRP antagonist. CGRP antagonists are a class of medications that block the action of the calcitonin gene-related peptide, which is involved in the transmission of pain and is a target for migraine treatment. Therefore, MK-1602 is indeed a CGRP antagonist.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has ubrogepant entered clinical phase III trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ubrogepant is a medication developed for the treatment of migraine. It is a CGRP receptor antagonist. Clinical trials are conducted in phases, with Phase III being one of the later stages before a drug can be approved for use. To determine if ubrogepant has entered Phase III trials, we need to check the clinical trial records or scientific publications. Based on available information, ubrogepant has indeed been through Phase III clinical trials, as it has been approved by the FDA for the treatment of migraine.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there small molecule CGRPs under development for the treatment of migraine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CGRP (Calcitonin Gene-Related Peptide) antagonists are a class of drugs that have been developed for the treatment of migraines. These drugs work by blocking the action of CGRP, a neuropeptide involved in the pathophysiology of migraines. There are both monoclonal antibodies and small molecule CGRP receptor antagonists that have been developed or are under development. Small molecule CGRP receptor antagonists, also known as gepants, are being researched and developed by various pharmaceutical companies as a treatment option for migraines. Therefore, it is accurate to say that small molecule CGRPs are under development for the treatment of migraine.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is eptinezumab a small molecule?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Eptinezumab is a monoclonal antibody used for the prevention of migraine. Monoclonal antibodies are large, complex proteins, not small molecules. Small molecules are typically low molecular weight compounds that can easily diffuse across cell membranes, unlike large proteins such as monoclonal antibodies.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is gabapentin effective for chronic pelvic pain?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Gabapentin is a medication that is often used to treat nerve pain and certain types of seizures. It is sometimes prescribed off-label for chronic pelvic pain, which can be a complex condition with various underlying causes. The effectiveness of gabapentin for chronic pelvic pain can vary from person to person. Some studies and clinical experiences suggest that it may provide relief for some individuals, particularly if the pain has a neuropathic component. However, it may not be effective for everyone, and its use should be evaluated on a case-by-case basis by a healthcare professional. Therefore, the answer to whether gabapentin is effective for chronic pelvic pain is not definitive and depends on individual circumstances.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does trimetazidine protect from myocardial injury after percutaneous coronary intervention?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Trimetazidine is a drug that has been studied for its potential protective effects on the heart, particularly in the context of myocardial injury. Percutaneous coronary intervention (PCI) is a procedure used to treat narrowed coronary arteries of the heart found in coronary artery disease. Some studies suggest that trimetazidine may have a protective effect against myocardial injury following PCI by improving cardiac metabolism and reducing oxidative stress. However, the evidence is not entirely conclusive, and more research may be needed to fully establish its efficacy in this context.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does inactivation of CYLD help in colorectal cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if inactivation of CYLD helps in colorectal cancer, we need to consider the role of CYLD in cancer biology. CYLD is a tumor suppressor gene that negatively regulates various signaling pathways, including NF-kB and JNK, which are involved in cell proliferation, survival, and inflammation. Inactivation of CYLD could potentially lead to increased tumor growth and progression due to the lack of regulation of these pathways. Therefore, inactivation of CYLD is generally not considered beneficial in the context of colorectal cancer, as it may promote cancer development and progression.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a role for TFII-I in megakaryopoiesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\n  \"draft\": \"To determine if there is a role for TFII-I in megakaryopoiesis, we need to consider the biological processes involved. Megakaryopoiesis is the process by which megakaryocytes develop from hematopoietic stem cells, eventually leading to the production of platelets. TFII-I is a transcription factor known to be involved in various cellular processes, including gene expression regulation. If TFII-I has been shown to influence genes or pathways critical to megakaryocyte development or function, then it could be said to have a role in megakaryopoiesis. However, without specific evidence or studies linking TFII-I directly to megakaryopoiesis, it would be difficult to definitively state its involvement.\",\n  \"answer\": \"no\"\n}",
    "correct": false
  },
  {
    "question": "Is istiratumab effective for pancreatic cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Istiratumab is a drug that has been studied for its potential effectiveness in treating pancreatic cancer. However, as of the latest available data, there is no conclusive evidence to support its effectiveness for this specific type of cancer. Clinical trials and studies are necessary to determine its efficacy and safety. Without definitive results from such studies, it cannot be confirmed as an effective treatment for pancreatic cancer.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does erenumab target the calcitonin gene-related peptide?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Erenumab is a medication used for the prevention of migraines. It is known to target the calcitonin gene-related peptide (CGRP) pathway. However, it does not directly target the CGRP itself. Instead, erenumab is a monoclonal antibody that targets the CGRP receptor, thereby inhibiting the binding of CGRP to its receptor. This action helps in preventing migraines. Therefore, while erenumab is associated with the CGRP pathway, it does not directly target the CGRP peptide itself.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a link between rare variants in PPARG and type 1 diabetes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"PPARG is a gene that encodes a protein involved in the regulation of fatty acid storage and glucose metabolism. It is more commonly associated with type 2 diabetes due to its role in insulin sensitivity. Type 1 diabetes is primarily an autoimmune condition where the immune system attacks insulin-producing cells in the pancreas. While genetic factors do play a role in type 1 diabetes, they are typically related to immune function rather than metabolic regulation. Therefore, rare variants in PPARG are not typically linked to type 1 diabetes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there an association of alterations in ADCY7 and ulcerative colitis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\n  \"draft\": \"To determine if there is an association between alterations in ADCY7 and ulcerative colitis, one would need to look at scientific studies or genetic research that investigates the role of the ADCY7 gene in the context of ulcerative colitis. ADCY7 is a gene that encodes a member of the adenylyl cyclase family, which is involved in the conversion of ATP to cyclic AMP. Ulcerative colitis is a chronic inflammatory bowel disease. While genetic factors do play a role in the susceptibility to ulcerative colitis, specific associations with ADCY7 would need to be confirmed through research studies. As of the latest data available, there is no widely recognized direct association between alterations in ADCY7 and ulcerative colitis. Therefore, based on current knowledge, the answer would be no.\",\n  \"answer\": \"no\"\n}",
    "correct": false
  },
  {
    "question": "Is there high nucleotide diversity in the Drosophila suzukii species?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if there is high nucleotide diversity in Drosophila suzukii, we need to consider genetic studies and research that have analyzed the genetic variation within this species. Nucleotide diversity is a measure of genetic variation at the nucleotide level within a population. High nucleotide diversity indicates a large amount of genetic variation, which can be influenced by factors such as population size, mutation rates, and evolutionary history. Studies on Drosophila suzukii have shown that it has a relatively high level of genetic diversity compared to other species, which is consistent with its invasive nature and adaptability to different environments.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Î‘re plants from the genus Strychnos the original source of curare?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Curare is a term used to describe various plant-derived alkaloid poisons traditionally used by indigenous South American tribes for hunting. The primary plants associated with curare are from the genera Strychnos and Chondrodendron. Strychnos species, such as Strychnos toxifera, are indeed one of the original sources of curare. Therefore, the genus Strychnos is considered an original source of curare.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Curare function by stimulating the acetylcholine receptor?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Curare is a known muscle relaxant that works by blocking the acetylcholine receptors at the neuromuscular junction. It does not stimulate these receptors; instead, it prevents acetylcholine from binding to them, thereby inhibiting muscle contraction.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is AZD9668 a VEGF mRNA drug?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"AZD9668 is not a VEGF mRNA drug. It is an oral inhibitor of neutrophil elastase, which is an enzyme involved in the inflammatory process. VEGF mRNA drugs are related to vascular endothelial growth factor, which is involved in angiogenesis and not related to neutrophil elastase inhibition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has AZD9668 been tested in clinical trials?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"AZD9668, also known as Alvelestat, is a drug that has been investigated for its potential therapeutic effects. To determine if it has been tested in clinical trials, we need to check if there have been any registered studies involving this compound. Clinical trials are typically registered in databases such as ClinicalTrials.gov, where information about the trial phases, conditions studied, and outcomes are documented. Based on available information, AZD9668 has indeed been tested in clinical trials, as it has been studied for conditions like chronic obstructive pulmonary disease (COPD) and other inflammatory diseases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are TAMs good anticancer therapeutic targets?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"TAMs, or tumor-associated macrophages, are a type of immune cell found in the tumor microenvironment. They can have both pro-tumor and anti-tumor functions, depending on their polarization state. In many cancers, TAMs are associated with tumor progression, angiogenesis, and suppression of anti-tumor immunity. Targeting TAMs to reprogram them towards an anti-tumor phenotype or to reduce their pro-tumor activities is a promising strategy in cancer therapy. Therefore, TAMs are considered good anticancer therapeutic targets.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Tocilizumab (Actemra) used to block/antagonize the  IL-6 receptor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tocilizumab, also known by the brand name Actemra, is a medication that is used to block or antagonize the interleukin-6 (IL-6) receptor. It is a monoclonal antibody that specifically targets the IL-6 receptor, thereby inhibiting the pro-inflammatory effects of IL-6. This mechanism of action is utilized in the treatment of various inflammatory conditions, such as rheumatoid arthritis and cytokine release syndrome.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are PDXK mutations linked to polyneuropathy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"PDXK mutations have been studied in relation to their potential link to polyneuropathy. Research has shown that mutations in the PDXK gene, which encodes pyridoxal kinase, can lead to a deficiency in pyridoxal-5'-phosphate (PLP), the active form of vitamin B6. PLP is crucial for numerous enzymatic processes in the body, including those involved in nerve function. Deficiency in PLP due to PDXK mutations can result in neurological issues, including polyneuropathy. Therefore, there is evidence supporting the link between PDXK mutations and polyneuropathy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do bacteria release extracellular vesicles?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bacteria are known to release extracellular vesicles, which are small, membrane-bound particles that can carry proteins, lipids, and genetic material. These vesicles play roles in communication, pathogenesis, and environmental interactions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Gram positive bacteria able to release extracellular vesicles?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Gram positive bacteria have a thick peptidoglycan layer which was initially thought to prevent the release of extracellular vesicles. However, recent studies have shown that Gram positive bacteria can indeed release extracellular vesicles, although the mechanisms may differ from those in Gram negative bacteria.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the apilimod inhibitor effective against SARS-CoV-2?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Apilimod is a small molecule inhibitor that has been studied for its potential antiviral effects, including against SARS-CoV-2, the virus responsible for COVID-19. Research has shown that apilimod can inhibit the replication of SARS-CoV-2 in vitro, meaning in a controlled laboratory setting. However, the effectiveness of apilimod in clinical settings, such as in human patients, requires more extensive clinical trials to determine its safety and efficacy. As of the latest updates, there is no conclusive evidence from large-scale clinical trials confirming its effectiveness against SARS-CoV-2 in humans.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Hunter's disease is associated with the X Chromosome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Hunter's disease, also known as Hunter syndrome or mucopolysaccharidosis type II (MPS II), is a genetic disorder. It is caused by a deficiency of the enzyme iduronate-2-sulfatase. This enzyme deficiency leads to the accumulation of certain complex molecules in the body, causing various symptoms. Hunter syndrome is inherited in an X-linked recessive pattern, which means the gene responsible for the condition is located on the X chromosome. Males, having only one X chromosome, are more frequently affected by X-linked recessive disorders. Females, with two X chromosomes, are typically carriers unless they have mutations on both X chromosomes, which is rare. Therefore, Hunter's disease is indeed associated with the X chromosome.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Toll-like receptors (TLRs) induced by microbes?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Toll-like receptors (TLRs) are a class of proteins that play a key role in the innate immune system. They are usually expressed on sentinel cells such as macrophages and dendritic cells, and they recognize structurally conserved molecules derived from microbes. When these microbial molecules bind to TLRs, they activate immune cell responses. Therefore, TLRs are not induced by microbes, but rather they are activated by them. TLRs are always present and ready to detect microbial components, so they are not induced in the sense of being produced or expressed in response to microbes.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can Freund's complete adjuvant induce arthritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Freund's complete adjuvant is known to induce arthritis in certain experimental animal models, particularly in rats. This is a well-established method used in research to study arthritis and test anti-inflammatory drugs. The adjuvant contains inactivated mycobacteria, which triggers an immune response leading to arthritis-like symptoms in these models.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can saponins be used as adjuvant?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Saponins are a class of chemical compounds found in various plant species. They have been studied for their potential use as adjuvants in vaccines. Adjuvants are substances that enhance the body's immune response to an antigen. Saponins, particularly those derived from the bark of the Quillaja saponaria tree, have been used in some vaccine formulations as adjuvants. Therefore, saponins can indeed be used as adjuvants in certain contexts.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is phosphoenolpyruvate carboxykinase 1 (PCK1) the rate-limiting enzyme in gluconeogenesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Phosphoenolpyruvate carboxykinase 1 (PCK1) is an important enzyme in the gluconeogenesis pathway. It catalyzes the conversion of oxaloacetate to phosphoenolpyruvate. While it plays a crucial role, the rate-limiting step in gluconeogenesis is generally considered to be the conversion of fructose-1,6-bisphosphate to fructose-6-phosphate, which is catalyzed by fructose-1,6-bisphosphatase. Therefore, PCK1 is not typically regarded as the rate-limiting enzyme in gluconeogenesis.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is histone variant H3.3K27M associated with gliomas?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the histone variant H3.3K27M is associated with gliomas. Gliomas are a type of tumor that occurs in the brain and spinal cord. The histone variant H3.3K27M is known to be a mutation that is associated with certain types of gliomas, particularly diffuse intrinsic pontine gliomas (DIPG) and other midline gliomas. This mutation is a hallmark of these tumors and is used in their diagnosis and study. Therefore, the answer to the question is yes, H3.3K27M is associated with gliomas.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do honey contain diastases/amylases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Honey does contain diastases, also known as amylases. These are enzymes that help in the breakdown of starches into sugars. The presence of diastases in honey is one of the factors used to assess the quality and authenticity of honey. Therefore, the answer to the question is yes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is HbA1c an ideal biomarker of well-controlled diabetes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"HbA1c is a commonly used biomarker to assess long-term glucose control in individuals with diabetes. It reflects the average blood glucose levels over the past two to three months. While it is a useful indicator for assessing diabetes management, it is not without limitations. Factors such as hemoglobin variants, anemia, and certain medical conditions can affect HbA1c levels, potentially leading to misleading results. Therefore, while HbA1c is a valuable tool, it may not be ideal in all situations for assessing well-controlled diabetes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is erabutoxin b usually found in plants?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Erabutoxin b is a type of neurotoxin that is typically found in the venom of sea snakes, specifically the Laticauda genus. It is not associated with plants. Therefore, erabutoxin b is not usually found in plants.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is autism thought to be related to the  Arginine Vasopressin Peptide (AVP)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Autism is a complex neurodevelopmental disorder with a variety of genetic and environmental factors contributing to its development. Research has explored various biological pathways and molecules that might be involved in autism. Arginine Vasopressin Peptide (AVP) is a neuropeptide that has been studied in relation to social behaviors and social cognition, which are areas often affected in autism. Some studies have suggested that AVP might play a role in the social deficits observed in autism, indicating a potential link. However, the relationship is not fully understood and more research is needed to establish a definitive connection.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ixodes a species of tick?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ixodes is not a single species of tick, but rather a genus that includes many species of ticks. Therefore, Ixodes itself is not a species, but it is a classification that contains multiple species within it.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are mucins glycosylated proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mucins are a type of protein that are heavily glycosylated. This means that they have a large number of sugar molecules attached to them. Glycosylation is a common post-translational modification of proteins, and in the case of mucins, it is essential for their function. The glycosylation of mucins contributes to their gel-like properties and their role in forming protective mucus barriers in various parts of the body, such as the respiratory and gastrointestinal tracts.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are mucin overexpression associated with disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mucin overexpression is often associated with various diseases, particularly certain types of cancer and inflammatory conditions. Mucins are glycoproteins that play a crucial role in protecting and lubricating surfaces in the body. However, when they are overexpressed, it can lead to pathological conditions. For example, in cancer, mucin overexpression can contribute to tumor growth and metastasis. Similarly, in diseases like cystic fibrosis and chronic obstructive pulmonary disease (COPD), mucin overexpression can exacerbate symptoms and disease progression. Therefore, there is a significant association between mucin overexpression and disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are interferons defensive proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. They are part of the immune response and help to inhibit viral replication within host cells. Therefore, they can be considered as defensive proteins because they play a crucial role in the body's defense mechanism against viral infections.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is YKL-40 used as a biomarker for Alzheimer's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"YKL-40 is a glycoprotein that has been studied as a potential biomarker for various inflammatory conditions and diseases, including Alzheimer's disease. Research has shown that elevated levels of YKL-40 may be associated with neuroinflammation and neurodegeneration, which are key features of Alzheimer's disease. Therefore, it is considered as a potential biomarker for Alzheimer's disease in scientific studies.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is G3BP1 found in stress granules?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"G3BP1 is a protein that is known to be a key component of stress granules. Stress granules are aggregates of proteins and RNAs that form in response to cellular stress. G3BP1 plays a crucial role in the assembly and dynamics of these granules, making it a well-established marker for stress granules in cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has FTY720  been considered for the treatment of stroke?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"FTY720, also known as fingolimod, is primarily known as a medication for multiple sclerosis. However, there has been research into its potential use for other conditions, including stroke. Some studies have explored its effects on stroke due to its immunomodulatory properties and potential neuroprotective effects. Therefore, it can be said that FTY720 has been considered for the treatment of stroke in research contexts.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is FTY720 FDA approved?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"FTY720, also known as fingolimod, is a medication used to treat multiple sclerosis. It was approved by the FDA in 2010 for this purpose.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does the royal jelly contain proteins?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Royal jelly is a secretion produced by honeybees that is used to nourish larvae and the queen bee. It is known to contain a variety of nutrients, including proteins, vitamins, and minerals. Proteins are one of the major components of royal jelly, making up a significant portion of its composition. Therefore, it is accurate to say that royal jelly does contain proteins.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are the major royal jelly proteins similar to the yellow proteins?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking about the similarity between major royal jelly proteins and yellow proteins. Major royal jelly proteins (MRJPs) are a group of proteins found in royal jelly, which is a secretion used in the nutrition of larvae and adult queen bees. Yellow proteins, on the other hand, are a different group of proteins that have been studied in various organisms, including Drosophila (fruit flies). While both groups of proteins are involved in important biological functions, they are not the same and do not share significant similarity in terms of structure or function. Therefore, the answer to the question is 'no'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is the Apis mellifera genome available?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The Apis mellifera, commonly known as the western honeybee, has had its genome sequenced and made available to the public. This sequencing was completed and published in the early 2000s, making the genome accessible for research and study.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has the olive tree pollen proteome been studied?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the proteome of olive tree pollen has been studied. To answer this, we need to consider if there have been scientific studies or research papers published on the proteome of olive tree pollen. Proteomics is a well-established field, and many plant species have had their proteomes studied, including pollen proteomes. Given the importance of olive trees in agriculture and the interest in pollen for allergy research, it is likely that the proteome of olive tree pollen has been studied.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is hemoglobin antimicrobial?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Hemoglobin is primarily known as the protein in red blood cells that carries oxygen from the lungs to the rest of the body and returns carbon dioxide from the body to the lungs. However, there is some evidence suggesting that hemoglobin and its derivatives may have antimicrobial properties. For instance, hemoglobin-derived peptides have been shown to exhibit antimicrobial activity against certain bacteria. Despite this, hemoglobin itself is not primarily classified as an antimicrobial agent.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are there antimicrobial proteins in royal jelly?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Royal jelly is a secretion produced by honeybees that is used to nourish larvae and the queen bee. It is known to contain a variety of proteins, some of which have been studied for their antimicrobial properties. Research has identified specific proteins in royal jelly, such as royalisin, that exhibit antimicrobial activity against certain bacteria and fungi. Therefore, it can be concluded that royal jelly does contain antimicrobial proteins.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does Amblyopia affect the eye?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Amblyopia, also known as lazy eye, is a vision development disorder where an eye fails to achieve normal visual acuity, even with prescription eyeglasses or contact lenses. It typically affects only one eye, but it can affect both. This condition is related to the eye and its ability to see clearly.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is atenolol metabolized by CYP2D6?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Atenolol is a beta-blocker used to treat cardiovascular conditions. It is primarily excreted unchanged in the urine and is not significantly metabolized by the liver. CYP2D6 is a liver enzyme involved in the metabolism of many drugs, but atenolol is not one of them. Therefore, atenolol is not metabolized by CYP2D6.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is cadherin a plasma membrane marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cadherins are a class of type-1 transmembrane proteins that are involved in cell-cell adhesion, forming adherens junctions to bind cells with each other. They are indeed located in the plasma membrane, where they play a crucial role in maintaining the structure and function of tissues. Therefore, cadherins can be considered as markers for the plasma membrane, particularly in the context of cell adhesion and tissue integrity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an upper limit on the functional fraction of the human genome?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether there is an upper limit to the functional fraction of the human genome. The functional fraction refers to the portion of the genome that has a specific biological function, such as coding for proteins or regulating gene expression. While the entire genome is composed of DNA sequences, not all of these sequences have known functions. Research has shown that a significant portion of the human genome is non-coding and may not have a direct functional role. However, the exact proportion of the genome that is functional is still a topic of scientific investigation. Current estimates suggest that a relatively small percentage of the genome is directly involved in coding for proteins, while other parts may have regulatory or unknown functions. Given the complexity of the genome and ongoing research, it is difficult to definitively state an upper limit on the functional fraction. However, based on current understanding, it is unlikely that the entire genome is functional, suggesting there is an upper limit.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are synonymous sites in primates and rodents functionally constrained?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether synonymous sites in primates and rodents are functionally constrained. Synonymous sites are regions in the DNA where a change in the nucleotide sequence does not result in a change in the amino acid sequence of the protein. Traditionally, these sites were thought to be neutral and not subject to functional constraints. However, recent studies suggest that synonymous sites can be subject to selection pressures and may have functional roles, such as in mRNA stability, splicing, or translation efficiency. Therefore, it is possible that synonymous sites in primates and rodents are functionally constrained.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Does IL18 signaling have a role in thymus?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"IL18 is a cytokine that is known to play a role in immune responses. The thymus is an organ where T cells mature, and cytokines can influence this process. IL18 signaling could potentially have a role in the thymus by affecting the development or function of T cells.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is metoprolol metabolized by CYP2D6?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Metoprolol is a beta-blocker that is commonly used to treat high blood pressure and other heart-related conditions. It is known to be metabolized primarily by the liver enzyme CYP2D6. This enzyme is part of the cytochrome P450 family and is responsible for the metabolism of many drugs. Individuals with different genetic variations of CYP2D6 may metabolize metoprolol at different rates, which can affect the drug's efficacy and safety.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the glucocorticoid receptor a transcription factor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The glucocorticoid receptor is a type of nuclear receptor that, upon binding with glucocorticoids, translocates to the cell nucleus where it can bind to specific DNA sequences and regulate the transcription of target genes. This activity classifies it as a transcription factor, as it directly influences the transcription process by modulating gene expression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has dupilumab been FDA approved for atopic dermatitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Dupilumab is a medication that has been developed for the treatment of various inflammatory conditions. One of the conditions it is used to treat is atopic dermatitis, which is a chronic skin condition characterized by itchy and inflamed skin. The FDA, or Food and Drug Administration, is responsible for approving medications for use in the United States. Dupilumab has undergone clinical trials to assess its safety and efficacy for treating atopic dermatitis. Based on the results of these trials, the FDA has granted approval for the use of dupilumab in treating atopic dermatitis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Has the companion diagnostic HercepTest received FDA approval?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The HercepTest is a diagnostic test used to determine the HER2 status in breast cancer patients. It is used to identify patients who may benefit from HER2-targeted therapies. The FDA approval status of such tests is important for their clinical use. The HercepTest has indeed received FDA approval, allowing it to be used as a companion diagnostic for certain cancer treatments.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is FKBP52 encoding a chaperone ?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"FKBP52 is a protein that is known to function as a chaperone. It is part of the immunophilin family and is involved in protein folding and trafficking, particularly in the context of steroid hormone receptors. Therefore, FKBP52 does encode a chaperone protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is colistin an antibiotic?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Colistin is a type of antibiotic that is used to treat certain bacterial infections. It is known as a polymyxin antibiotic and is often used as a last-resort treatment for multidrug-resistant bacteria.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Keutel syndrome a common genetic disorder?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Keutel syndrome is a rare genetic disorder characterized by abnormal cartilage calcification, hearing loss, and other symptoms. It is not commonly found in the general population.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Daprodustat effective for anemia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Daprodustat is a medication used to treat anemia, particularly in patients with chronic kidney disease. It works by stimulating the production of erythropoietin, which in turn increases red blood cell production. Clinical trials and studies have shown that Daprodustat is effective in managing anemia in these patients.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an association between pyostomatitis vegetans and Crohn's disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Pyostomatitis vegetans is a rare condition characterized by pustular lesions in the oral cavity. It is often associated with inflammatory bowel diseases, particularly ulcerative colitis and Crohn's disease. The presence of pyostomatitis vegetans can be an oral manifestation of these underlying conditions. Therefore, there is an association between pyostomatitis vegetans and Crohn's disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Sotrovimab effective for COVID-19?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Sotrovimab is a monoclonal antibody treatment that has been authorized for emergency use in certain cases for the treatment of COVID-19. It has shown effectiveness in reducing the risk of hospitalization and death in patients with mild to moderate COVID-19 who are at high risk of progressing to severe disease. However, its effectiveness can vary depending on the variant of the virus, and ongoing studies are assessing its efficacy against different strains. Therefore, while it has been effective in certain situations, its overall effectiveness can depend on various factors.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ozanimod effective for Ulcerative Colitis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ozanimod is a medication that has been studied for its effectiveness in treating ulcerative colitis, a chronic inflammatory bowel disease. Clinical trials have shown that Ozanimod can be effective in inducing and maintaining remission in patients with moderate to severe ulcerative colitis. It works by modulating the immune system to reduce inflammation in the colon. Based on the available evidence, it is considered an effective treatment option for ulcerative colitis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Cabotegravir effective for HIV prevention?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cabotegravir is a medication used for the prevention of HIV. It is an antiretroviral drug that has been shown to be effective in reducing the risk of HIV infection. Clinical trials have demonstrated its efficacy in preventing HIV transmission, particularly in high-risk populations. Therefore, it is considered an effective option for HIV prevention.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is sacituzumab govitecan effective for breast cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Sacituzumab govitecan is a drug that has been approved for the treatment of certain types of breast cancer, specifically triple-negative breast cancer. Clinical trials have shown that it can be effective in treating this type of cancer, leading to its approval by regulatory agencies such as the FDA. Therefore, it is considered effective for breast cancer, particularly for patients with triple-negative breast cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is rilonacept effective for pericarditis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Rilonacept is a medication that has been studied for its effectiveness in treating recurrent pericarditis. Clinical trials and studies have shown that rilonacept can be effective in reducing the recurrence of pericarditis episodes and alleviating symptoms associated with the condition. The FDA has approved rilonacept for the treatment of recurrent pericarditis, indicating its recognized effectiveness for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Sotatercept effective for Pulmonary Arterial Hypertension?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Sotatercept is a medication that has been studied for its effectiveness in treating Pulmonary Arterial Hypertension (PAH). Clinical trials have shown promising results, indicating that Sotatercept may be effective in improving exercise capacity and reducing pulmonary vascular resistance in patients with PAH. However, as with any medication, the effectiveness can vary among individuals, and it is important to consider the latest clinical trial data and regulatory approvals to determine its current status as an effective treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Belimumab used for lupus nephritis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Belimumab is a medication that is used in the treatment of systemic lupus erythematosus (SLE), which is an autoimmune disease. Lupus nephritis is a serious complication of SLE that affects the kidneys. In recent years, Belimumab has been approved for use in treating lupus nephritis, as it helps in reducing disease activity and preventing flares. Therefore, Belimumab is indeed used for lupus nephritis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there an association between Guillainâ€“BarrÃ© syndrome and covid vaccine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Guillainâ€“BarrÃ© syndrome (GBS) is a rare neurological disorder where the body's immune system mistakenly attacks part of its peripheral nervous system. There have been reports and studies investigating the potential association between GBS and COVID-19 vaccines. Some data suggest a possible link, particularly with certain vaccines like the Johnson & Johnson vaccine, which led to warnings and further investigation by health authorities. However, the occurrence is very rare, and the benefits of vaccination in preventing COVID-19 outweigh the risks. Health authorities continue to monitor and evaluate the safety of vaccines.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do mutations in KCNT2 only cause phenotypes with epilepsy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether mutations in the KCNT2 gene exclusively result in phenotypes that include epilepsy. To answer this, we need to consider whether there are documented cases of KCNT2 mutations leading to other phenotypes without epilepsy. If KCNT2 mutations are known to cause a variety of phenotypes, some of which do not include epilepsy, the answer would be 'no'. If all known phenotypes associated with KCNT2 mutations include epilepsy, the answer would be 'yes'.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do only changes in coding regions of MEF2C cause developmental disorders?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether developmental disorders associated with the MEF2C gene are caused exclusively by changes in its coding regions. Coding regions are parts of the gene that are directly translated into proteins. However, changes in non-coding regions, such as regulatory elements, can also affect gene expression and lead to developmental disorders. Therefore, it is not accurate to say that only changes in coding regions cause these disorders.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Algenpantucel-L effective for pancreatic cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Algenpantucel-L is a therapeutic cancer vaccine that was being developed for the treatment of pancreatic cancer. However, clinical trials, such as the Phase III IMPRESS trial, did not demonstrate a significant improvement in overall survival for patients with resected pancreatic cancer. As a result, the development of Algenpantucel-L was discontinued, and it is not considered an effective treatment for pancreatic cancer based on the available evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is tivantinib effective for MET-high hepatocellular carcinoma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tivantinib is a drug that has been studied for its effectiveness in treating MET-high hepatocellular carcinoma (HCC). Some studies have suggested that tivantinib may have potential benefits for patients with MET-high HCC, as it targets the MET receptor, which is often overexpressed in these tumors. However, clinical trials have shown mixed results, and tivantinib has not been universally accepted as an effective treatment for MET-high HCC. Therefore, while there is some evidence supporting its use, it is not conclusively proven to be effective.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Isradipine slow progression of Early Parkinson Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Isradipine is a medication primarily used to treat high blood pressure. There has been research into its potential effects on Parkinson's disease, particularly in slowing its progression. Some studies have suggested that it might have a neuroprotective effect, which could theoretically slow the progression of Parkinson's disease. However, the results have been mixed, and more research is needed to conclusively determine its effectiveness in this regard. As of now, there is no definitive evidence that Isradipine can slow the progression of early Parkinson's disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is nerinetide effective for ischaemic stroke?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nerinetide is a neuroprotective agent that has been studied for its potential effectiveness in treating ischemic stroke. Clinical trials, such as the ESCAPE-NA1 trial, have investigated its efficacy. However, the results have been mixed, with some studies showing no significant benefit in improving outcomes for ischemic stroke patients. Therefore, based on current evidence, nerinetide is not considered effective for ischemic stroke treatment.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should perampanel be used for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Perampanel is an antiepileptic drug primarily used to treat seizures. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons. While there is ongoing research into various treatments for ALS, perampanel is not specifically indicated for ALS treatment. Therefore, it is not typically used for ALS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are variants in FHF2 (also known as FGF13) associated with encephalopathy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"FHF2, also known as FGF13, is a gene that encodes a member of the fibroblast growth factor (FGF) family. Variants in this gene have been studied in relation to various neurological conditions. Encephalopathy is a broad term that refers to any diffuse disease of the brain that alters brain function or structure. To determine if variants in FHF2 are associated with encephalopathy, one would need to look at scientific studies or genetic databases that report such associations. Based on current knowledge, there is no widely recognized direct association between FHF2 variants and encephalopathy.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is Adamts18 deficiency associated with cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Adamts18 is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family, which is involved in various biological processes including tissue remodeling and angiogenesis. Research has shown that deficiencies or mutations in certain ADAMTS genes, including Adamts18, can be associated with cancer development. Studies have indicated that Adamts18 may function as a tumor suppressor, and its deficiency or downregulation has been linked to increased cancer risk in some contexts. Therefore, it is reasonable to conclude that Adamts18 deficiency is associated with cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Erythropoietin effective for neuroprotection of Preterm Infants.",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Erythropoietin (EPO) is a hormone that is primarily known for its role in red blood cell production. However, it has been studied for its potential neuroprotective effects, particularly in preterm infants who are at risk for brain injury. Some studies have suggested that EPO may have neuroprotective benefits in this population, potentially improving outcomes related to brain development and function. However, the effectiveness of EPO for neuroprotection in preterm infants is still a subject of ongoing research, and while there is promising evidence, it is not yet universally accepted or implemented as a standard treatment. Therefore, the answer to whether EPO is definitively effective for neuroprotection in preterm infants is not straightforward and may depend on the specific context and criteria being considered.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should Intepirdine be used for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Intepirdine was a drug that was investigated for the treatment of Alzheimer's disease. However, clinical trials did not show significant benefits for patients with Alzheimer's, leading to the discontinuation of its development for this purpose. Therefore, it is not recommended for use in treating Alzheimer's disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should istiratumab be used for Pancreatic Cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Istiratumab is a drug that may be under investigation for various types of cancer. However, the use of any drug for a specific condition like pancreatic cancer depends on clinical trial results, regulatory approvals, and medical guidelines. As of the latest information, there is no widely recognized approval or recommendation for the use of istiratumab specifically for pancreatic cancer. Therefore, without specific evidence or approval, it should not be used for this condition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is vocimagene amiretrorepvec effective for recurrent high-grade glioma?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Vocimagene amiretrorepvec, also known as Toca 511, is an investigational gene therapy that has been studied for the treatment of recurrent high-grade glioma. Clinical trials have been conducted to evaluate its efficacy. However, as of the latest updates, the results have been mixed, with some studies not showing significant improvement in overall survival compared to standard treatments. Therefore, while it has shown some promise, it is not conclusively proven to be effective for recurrent high-grade glioma based on current evidence.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Was ALVAC-HIV effective for HIV prevention in the HVTN 702 trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The HVTN 702 trial was a large-scale clinical trial conducted to test the effectiveness of the ALVAC-HIV vaccine in preventing HIV infection. The trial was stopped early because interim results showed that the vaccine did not prevent HIV infection. Therefore, the ALVAC-HIV vaccine was not effective in the HVTN 702 trial.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does Î±CGRP have amyloidogenic properties?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Î±CGRP, or alpha Calcitonin Gene-Related Peptide, is a neuropeptide that is primarily involved in vasodilation and pain transmission. It is not typically associated with amyloidogenic properties, which refer to the ability of a protein to form amyloid fibrils, a characteristic of certain diseases like Alzheimer's. Amyloidogenic properties are more commonly linked to proteins like amyloid-beta or tau. Therefore, Î±CGRP is not known for having amyloidogenic properties.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Do SETD1A mutations predispose to schizophrenia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SETD1A is a gene that has been studied in relation to various mental health conditions, including schizophrenia. Research has shown that mutations in the SETD1A gene are associated with an increased risk of developing schizophrenia. This suggests that there is a genetic predisposition linked to SETD1A mutations for this mental health disorder.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is covid-19 induced anosmia caused by disruption of nuclear architecture?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the loss of smell (anosmia) caused by COVID-19 is due to the disruption of nuclear architecture. COVID-19 can cause anosmia, but the exact mechanisms are complex and not fully understood. While there are studies exploring various cellular and molecular disruptions caused by the virus, including potential impacts on nuclear architecture, it is not definitively established that anosmia is directly caused by such disruptions. Therefore, the answer is not straightforward and requires more specific scientific evidence linking nuclear architecture disruption directly to anosmia in COVID-19 cases.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there any role of the 'Greek islands' in olfactory receptor choice?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks if the 'Greek islands' have any role in olfactory receptor choice. Olfactory receptors are proteins involved in the sense of smell, and their choice is typically determined by genetic and biological factors. The 'Greek islands' are a geographical location and do not have a direct role in biological processes such as olfactory receptor choice. Therefore, the answer is no.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is HDAC1 required for GATA-1 transcriptional activity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if HDAC1 is required for GATA-1 transcriptional activity, we need to consider the role of HDAC1 and GATA-1 in gene expression. HDAC1 is a histone deacetylase that generally represses transcription by removing acetyl groups from histones, leading to chromatin condensation. GATA-1 is a transcription factor involved in erythroid differentiation and gene expression. The relationship between HDAC1 and GATA-1 could involve HDAC1 modulating the activity of GATA-1, either by direct interaction or through chromatin remodeling. However, whether HDAC1 is strictly required for GATA-1's transcriptional activity would depend on specific experimental evidence showing that GATA-1 cannot function without HDAC1. Without such evidence, the answer would be 'no'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there a dependence between chromatin organization and dorsoventral gene expression in Drosophila?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\n  \"draft\": \"The question is asking whether there is a relationship between the organization of chromatin and the expression of genes that determine the dorsoventral axis in Drosophila. Chromatin organization can influence gene expression by regulating the accessibility of DNA to transcription factors and other regulatory proteins. In Drosophila, dorsoventral patterning is a crucial developmental process, and it is possible that chromatin organization plays a role in regulating the expression of genes involved in this process. Therefore, it is reasonable to consider that there might be a dependence between chromatin organization and dorsoventral gene expression in Drosophila.\",\n  \"answer\": \"yes\"\n}",
    "correct": false
  },
  {
    "question": "Does atemoya juice inhibit the CYP1A2 enzyme?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Atemoya is a hybrid fruit, and its juice may contain various compounds. The CYP1A2 enzyme is involved in the metabolism of certain drugs in the liver. There is no widely known or documented evidence that specifically states atemoya juice inhibits the CYP1A2 enzyme. Without specific scientific studies or evidence, it is not possible to definitively say that atemoya juice inhibits this enzyme.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does atemoya juice inhibit tye CYP3A4 enzyme?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if atemoya juice inhibits the CYP3A4 enzyme, we need to consider scientific studies or pharmacological data on the interaction between atemoya and CYP3A4. CYP3A4 is a key enzyme in the metabolism of many drugs, and certain substances can inhibit its activity, leading to altered drug metabolism. However, there is limited information available on atemoya specifically in relation to CYP3A4 inhibition. Without specific studies or evidence indicating that atemoya juice inhibits CYP3A4, the answer would be no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does daily atemoya juice intake change the pharmacokinetics of CYP1A2 substrates?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether consuming atemoya juice daily affects the pharmacokinetics of substances metabolized by the enzyme CYP1A2. The pharmacokinetics of a drug refers to how it is absorbed, distributed, metabolized, and excreted in the body. CYP1A2 is an enzyme that metabolizes various drugs. Some fruit juices are known to interact with drug metabolism, but there is no specific evidence or studies indicating that atemoya juice has an effect on CYP1A2 substrates. Without specific scientific evidence, it is not possible to definitively say that atemoya juice affects the pharmacokinetics of CYP1A2 substrates.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can bergapten cross the blood-brain barrier?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Bergapten, also known as 5-methoxypsoralen, is a furanocoumarin compound found in certain plants. The ability of a compound to cross the blood-brain barrier (BBB) depends on several factors, including its molecular size, lipophilicity, and the presence of specific transport mechanisms. While bergapten is relatively small and lipophilic, which are favorable properties for crossing the BBB, there is limited specific research or evidence directly confirming its ability to do so. Without concrete studies or data, it is difficult to definitively say whether bergapten can cross the blood-brain barrier.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can bergapten cause phototoxicity?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bergapten is a furanocoumarin compound found in certain plants, such as bergamot oil. Furanocoumarins are known for their ability to cause phototoxic reactions when exposed to ultraviolet (UV) light. Phototoxicity occurs when a chemical compound absorbs UV light and causes damage to the skin, leading to symptoms like redness, blistering, and hyperpigmentation. Bergapten, being a furanocoumarin, has the potential to cause phototoxicity when the skin is exposed to sunlight or other sources of UV light after application or ingestion of products containing this compound.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can whole genome sequencing be used for diagnosis of mitochondrial disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Whole genome sequencing (WGS) is a comprehensive method for analyzing the entire genome, including nuclear DNA and mitochondrial DNA. Mitochondrial diseases are often caused by mutations in mitochondrial DNA or nuclear genes that affect mitochondrial function. WGS can identify mutations in both nuclear and mitochondrial DNA, making it a useful tool for diagnosing mitochondrial diseases. Therefore, WGS can indeed be used for the diagnosis of mitochondrial diseases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is AGO2 related to cytokinesis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"AGO2, or Argonaute 2, is a protein that is primarily known for its role in the RNA-induced silencing complex (RISC) and is involved in gene silencing processes such as RNA interference. Cytokinesis is the process during cell division where the cytoplasm of a single eukaryotic cell is divided to form two daughter cells. While AGO2 is not directly involved in the mechanical process of cytokinesis, there is some research suggesting that it may have indirect roles in cell cycle regulation, which could potentially influence cytokinesis. However, the direct relationship between AGO2 and cytokinesis is not well-established or commonly recognized in the scientific literature.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does TIMELESS-TIPIN participate in replisome disassembly?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether TIMELESS-TIPIN is involved in the process of replisome disassembly. The replisome is a complex of proteins responsible for DNA replication. TIMELESS-TIPIN is known to be a part of the replication fork protection complex, which stabilizes the replisome and ensures efficient DNA replication. However, its primary role is not directly associated with the disassembly of the replisome. Instead, it is more involved in stabilizing the replisome during replication stress and ensuring proper replication fork progression. Therefore, based on current scientific understanding, TIMELESS-TIPIN does not directly participate in replisome disassembly.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is METTL1 overexpression associated with better patient survival?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if METTL1 overexpression is associated with better patient survival, we need to consider existing research and studies on the topic. METTL1 is a gene that encodes an enzyme involved in RNA modification, and its role in cancer and patient survival can vary depending on the type of cancer and other factors. Some studies may suggest that METTL1 overexpression is linked to poor prognosis in certain cancers, while others may not find a significant association. Therefore, without specific context or study results, it is not possible to definitively say that METTL1 overexpression is associated with better patient survival.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has CPX-351 been approved by the FDA and the EMA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CPX-351, also known as Vyxeos, is a liposomal formulation of cytarabine and daunorubicin. It has been approved by the FDA for the treatment of certain types of acute myeloid leukemia (AML). Additionally, the European Medicines Agency (EMA) has also granted approval for CPX-351 for similar indications. Therefore, CPX-351 has received approval from both the FDA and the EMA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is REGN5458 a single-targeted antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"REGN5458 is a bispecific antibody, which means it is designed to target two different antigens or epitopes. Specifically, it targets both BCMA (B-cell maturation antigen) on multiple myeloma cells and CD3 on T cells. Therefore, it is not a single-targeted antibody.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is MEDI2228 a bispecific antibody?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if MEDI2228 is a bispecific antibody, we need to understand what MEDI2228 is. A bispecific antibody is designed to bind to two different antigens or epitopes simultaneously. MEDI2228 is actually an antibody-drug conjugate (ADC) targeting BCMA (B-cell maturation antigen) for the treatment of multiple myeloma. It is not a bispecific antibody because it is designed to target a single antigen, BCMA, and deliver a cytotoxic drug to the cancer cells. Therefore, MEDI2228 does not fit the definition of a bispecific antibody.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is there a role for CADM1 in Myelodysplastic syndrome (MDS)?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"CADM1, also known as Cell Adhesion Molecule 1, is a protein that has been studied in various contexts, including cancer and immune system function. Myelodysplastic syndromes (MDS) are a group of disorders caused by poorly formed or dysfunctional blood cells. Research has explored the role of various genes and proteins in MDS, including those involved in cell adhesion and signaling pathways. While CADM1 is primarily known for its role in cell adhesion and tumor suppression, its specific involvement in MDS is not well-established in the literature. Therefore, based on current knowledge, there is no direct evidence to suggest a significant role for CADM1 in MDS.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does UBE4B promote renal cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"UBE4B is a gene that encodes a ubiquitin-conjugating enzyme involved in protein degradation. Research has shown that UBE4B can play a role in various cancers, including renal cancer. Studies suggest that UBE4B may promote tumor growth and progression in renal cancer by affecting protein degradation pathways and cellular processes. Therefore, it is likely that UBE4B does promote renal cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can IFNg induce the expression of IDO?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Interferon gamma (IFNg) is known to play a role in immune response regulation. One of the pathways it influences is the expression of indoleamine 2,3-dioxygenase (IDO), an enzyme involved in tryptophan metabolism. IFNg can induce the expression of IDO in various cell types, contributing to its immunoregulatory functions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Mycobacterium abscessus a human pathogen?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Mycobacterium abscessus is a type of bacteria that can cause infections in humans, particularly in individuals with weakened immune systems or underlying lung conditions. It is known to cause skin, soft tissue, and lung infections, and is considered a human pathogen.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do we find bacteriophages in the gut?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Bacteriophages, which are viruses that infect bacteria, are indeed found in the human gut. They play a role in the gut microbiome by influencing bacterial populations and dynamics. Studies have shown that bacteriophages are abundant in the gut environment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is NfL (neurofilament light chain) a biomarker of neurodegeneration?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Neurofilament light chain (NfL) is a protein found in neurons and is released into the cerebrospinal fluid and blood when neurons are damaged. It has been studied extensively as a potential biomarker for neurodegenerative diseases because its levels tend to increase in conditions where there is neuronal damage or degeneration, such as Alzheimer's disease, multiple sclerosis, and other neurodegenerative disorders. Therefore, NfL is considered a biomarker of neurodegeneration.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do the proteins Talin and Amot interact?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if the proteins Talin and Amot interact, we need to consider existing scientific literature and experimental data. Protein-protein interactions are often studied using techniques such as co-immunoprecipitation, yeast two-hybrid screening, or mass spectrometry. If there is documented evidence of interaction between Talin and Amot in peer-reviewed studies, the answer would be 'yes'. If no such evidence exists, the answer would be 'no'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is serotonin transported by platelets?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Serotonin is a neurotransmitter that is known to be stored and transported by platelets in the bloodstream. Platelets take up serotonin from the plasma and store it in dense granules. Upon activation, platelets release serotonin, which can then act on various receptors in the body. This process is part of the role platelets play in hemostasis and thrombosis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Otolin-1 a matrix protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Otolin-1 is a protein that is known to be involved in the formation of the otoconial matrix in the inner ear. It is considered a matrix protein because it plays a role in the structural framework of the otoconia, which are calcium carbonate crystals in the vestibular system. Therefore, Otolin-1 is indeed classified as a matrix protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the protein HOXA11 associated with endometrial disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"HOXA11 is a gene that encodes a protein involved in the regulation of gene expression, morphogenesis, and differentiation. It is part of the homeobox gene family, which plays a critical role in the development of the reproductive tract. There is scientific literature that suggests a link between HOXA11 and endometrial function, and alterations in its expression have been associated with endometrial diseases, such as endometriosis and infertility. Therefore, it is reasonable to conclude that HOXA11 is associated with endometrial disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Lysozyme abundant in human tears?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lysozyme is an enzyme that is known to be present in various secretions in the human body, including saliva, mucus, and tears. It plays a role in the immune system by breaking down the cell walls of certain bacteria, thus acting as an antibacterial agent. In human tears, lysozyme is indeed one of the components that contribute to the protective functions of tears. It is considered to be abundant in tears, which helps in protecting the eyes from bacterial infections.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SMOC2 expressed during wound healing?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\n  \"draft\": \"SMOC2, or SPARC-related modular calcium-binding protein 2, is a protein that has been studied in various biological processes. To determine if SMOC2 is expressed during wound healing, one would need to look at scientific literature or experimental data that specifically investigates the expression of SMOC2 in the context of wound healing. If such studies indicate that SMOC2 is indeed expressed during the wound healing process, the answer would be 'yes'. Conversely, if there is no evidence of its expression during wound healing, the answer would be 'no'.\",\n  \"answer\": \"yes\"\n}",
    "correct": true
  },
  {
    "question": "Is esophageal adenocarcinoma associated with aberrant glycosylation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Esophageal adenocarcinoma is a type of cancer that affects the esophagus. Aberrant glycosylation refers to abnormal changes in the glycosylation patterns of proteins and lipids, which is a common feature in many cancers. Aberrant glycosylation can affect cell signaling, adhesion, and immune recognition, contributing to cancer progression and metastasis. Research has shown that aberrant glycosylation is indeed associated with various types of cancers, including esophageal adenocarcinoma. Therefore, it is reasonable to conclude that esophageal adenocarcinoma is associated with aberrant glycosylation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is cytokeratin a tumor marker?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cytokeratins are proteins found in the cytoskeleton of epithelial cells. They are often used as tumor markers in the diagnosis of certain types of cancers, particularly epithelial tumors. The presence of specific cytokeratins can help in identifying the origin of a tumor and in distinguishing between different types of cancer. Therefore, cytokeratins are indeed used as tumor markers in clinical settings.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there any R packages that help with visualizing data on spirals?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if there are R packages that help with visualizing data on spirals, we need to consider the availability of packages that offer spiral visualization functions or tools. R is a comprehensive statistical programming language with a vast ecosystem of packages for data visualization. Packages like 'ggplot2' provide extensive customization options and can be extended with additional packages for specific visualization needs. Additionally, there are specialized packages like 'ggspiral' that are specifically designed for creating spiral plots. Therefore, it is likely that there are R packages available for visualizing data on spirals.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are there roles for cohesin mutations in AML?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Cohesin is a protein complex that plays a crucial role in chromosome segregation during cell division, DNA repair, and regulation of gene expression. Mutations in cohesin components have been implicated in various cancers, including acute myeloid leukemia (AML). Research has shown that cohesin mutations can contribute to the pathogenesis of AML by affecting chromosomal stability and gene expression. Therefore, there is evidence supporting the role of cohesin mutations in AML.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Epoxyeicosatrienoic acids (EETs) synthesized by cytochrome P450 epoxygenases from arachidonic acid?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Epoxyeicosatrienoic acids (EETs) are indeed synthesized by the action of cytochrome P450 epoxygenases on arachidonic acid. This process involves the conversion of arachidonic acid into EETs through the enzymatic activity of cytochrome P450 enzymes, which are a group of enzymes involved in the metabolism of various substances within the body.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Epistaxis associated with dental implant placement?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Epistaxis, or nosebleed, is typically associated with nasal or sinus issues, trauma, or certain medical conditions. Dental implant placement is a procedure that involves the jawbone and oral cavity, not the nasal passages. While there could be indirect or rare cases where dental procedures might affect the sinuses, epistaxis is not commonly associated with dental implant placement.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Are Tregs CD4(+)CD25(+) regulatory T cells a positive regulator of the immune response?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Regulatory T cells (Tregs), specifically CD4(+)CD25(+) Tregs, are known for their role in maintaining immune tolerance and preventing autoimmune responses. They generally act as suppressors of the immune response rather than positive regulators. Their primary function is to inhibit the activation and proliferation of other immune cells, thereby preventing excessive immune reactions and maintaining immune homeostasis. Therefore, they are not considered positive regulators of the immune response.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Unlike DNA, RNA is not methylated, yes or no?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether RNA is methylated or not, in contrast to DNA. DNA methylation is a well-known process where methyl groups are added to the DNA molecule, typically at cytosine bases. RNA methylation, on the other hand, is also a known process. Various types of RNA, including mRNA, tRNA, and rRNA, can undergo methylation. This process is important for the regulation of RNA stability, translation, and other functions. Therefore, the statement that RNA is not methylated is incorrect.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do RNA binding Proteins  that bind to adenine uridine (AU)-rich elements (AREs) in the 5' untranslated region (UTR) of mRNAs (AU-RBPs) regulate the DNA Damage Response?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether RNA binding proteins that bind to adenine uridine-rich elements in the 5' untranslated region of mRNAs are involved in regulating the DNA Damage Response. Typically, AU-rich elements are found in the 3' UTR, not the 5' UTR, and are known to influence mRNA stability and translation. However, the role of AU-RBPs in the DNA Damage Response is not well-established in the context of the 5' UTR. Therefore, based on current knowledge, the answer would be no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are G-quadruplexes(G4) possible drug targets for glioblastoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"G-quadruplexes (G4) are nucleic acid structures formed in guanine-rich regions of DNA or RNA. They have been studied for their potential role in various biological processes, including the regulation of gene expression. Glioblastoma is a highly aggressive type of brain cancer, and finding effective drug targets is crucial for treatment. Research has suggested that G-quadruplexes may be involved in the regulation of oncogenes and other pathways relevant to cancer, making them potential targets for drug development. Therefore, it is plausible that G-quadruplexes could be considered as possible drug targets for glioblastoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is CircRNA produced by back splicing of exon, intron or both, forming exon or intron circRNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CircRNA, or circular RNA, is a type of RNA which, unlike linear RNA, forms a covalently closed continuous loop. It is produced by a process called back-splicing. During back-splicing, a downstream splice donor site is joined to an upstream splice acceptor site, which can involve exons, introns, or both. This results in the formation of different types of circRNAs, including exon circRNAs and intron circRNAs. Therefore, circRNA can be produced by back-splicing of exons, introns, or both, forming exon or intron circRNA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are circRNAs susceptible to degradation by RNase R?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Circular RNAs (circRNAs) are generally resistant to degradation by exonucleases like RNase R due to their covalently closed loop structure, which lacks free ends that exonucleases typically require to initiate degradation. RNase R is an exonuclease that degrades linear RNAs by targeting their ends, but it is not effective against circular RNAs. Therefore, circRNAs are not susceptible to degradation by RNase R.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is RUNX1T1 associate with obesity?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"RUNX1T1 is a gene that is primarily known for its role in hematopoiesis and its involvement in certain types of leukemia. There is no well-established or direct association between RUNX1T1 and obesity in the scientific literature. Obesity is a complex condition influenced by multiple genetic, environmental, and lifestyle factors, and while many genes have been studied in relation to obesity, RUNX1T1 is not commonly cited among them.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can FTO promote pancreatic cancer development?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"FTO, or Fat Mass and Obesity-associated protein, is an enzyme that has been studied for its role in various biological processes, including obesity and metabolic disorders. Recent research has also explored its potential involvement in cancer development, including pancreatic cancer. Some studies suggest that FTO may play a role in promoting cancer cell proliferation and survival, possibly through its involvement in RNA modification processes. However, the exact mechanisms and the extent of FTO's influence on pancreatic cancer development are still under investigation. Therefore, while there is some evidence to suggest a link, it is not yet definitively established that FTO promotes pancreatic cancer development.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is Ameloblastoma (AB) a common benign tumor occurring in the brain?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ameloblastoma is a benign tumor that originates from the odontogenic epithelium, which is related to tooth development. It is most commonly found in the jaw, particularly the mandible (lower jaw), and not in the brain. Therefore, it is not common for ameloblastoma to occur in the brain.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is disruption of immune regulation mechanisms associated with adverse pregnancy outcomes, including preeclampsia (PE)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether disruption of immune regulation mechanisms is linked to adverse pregnancy outcomes, specifically mentioning preeclampsia (PE). Preeclampsia is a condition characterized by high blood pressure and often proteinuria during pregnancy, and it is known to have various contributing factors, including immune system dysregulation. Research indicates that immune system imbalances can indeed contribute to the development of preeclampsia and other adverse pregnancy outcomes. Therefore, the disruption of immune regulation mechanisms is associated with these conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can METTL3 methylate long noncoding RNAs?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"METTL3 is a well-known methyltransferase that is part of the m6A methylation complex. It is primarily known for adding methyl groups to mRNA, but research has shown that it can also methylate other types of RNA, including long noncoding RNAs (lncRNAs). This methylation can affect the stability, localization, and function of lncRNAs, similar to its effects on mRNA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is PCAT6 a microRNA?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if PCAT6 is a microRNA, we need to understand what PCAT6 is. PCAT6 is known as a long non-coding RNA (lncRNA), not a microRNA. MicroRNAs are small non-coding RNA molecules that play a role in regulating gene expression, while lncRNAs are longer RNA molecules that also have regulatory functions but are distinct from microRNAs. Therefore, PCAT6 is not classified as a microRNA.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can autophagy related lncRNAs be used for colorectal cancer prognosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Autophagy-related long non-coding RNAs (lncRNAs) have been studied for their potential role in various cancers, including colorectal cancer. Research suggests that these lncRNAs can influence cancer progression and patient outcomes. Therefore, they may serve as biomarkers for prognosis in colorectal cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are circular RNAs implicated in diseases of the eye?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Circular RNAs (circRNAs) are a type of non-coding RNA that have been implicated in various diseases, including those affecting the eye. Research has shown that circRNAs can play roles in the regulation of gene expression and may be involved in the pathogenesis of ocular diseases. Studies have identified specific circRNAs that are associated with conditions such as age-related macular degeneration, diabetic retinopathy, and glaucoma. Therefore, it is accurate to say that circular RNAs are implicated in diseases of the eye.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Ameloblastoma (AB) a benign tumor that never metastasizes?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Ameloblastoma is generally considered a benign tumor, meaning it is not cancerous and does not typically spread to other parts of the body like malignant tumors do. However, while it is primarily benign, there are rare cases where ameloblastoma can metastasize, meaning it can spread to other parts of the body. Therefore, it is not entirely accurate to say that it never metastasizes, as there are exceptions.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Acute Necrotizing Encephalopathy (ANE) which typically affects young, healthy children usually triggered by exposure to air pollution?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Acute Necrotizing Encephalopathy (ANE) is a rare type of brain disease that is often associated with viral infections, such as influenza or other respiratory viruses. It is not typically linked to environmental factors like air pollution. The condition is characterized by rapid onset of fever, seizures, and altered mental status, and it primarily affects young, healthy children. The exact cause of ANE is not fully understood, but it is believed to involve an abnormal immune response to viral infections rather than environmental triggers like air pollution.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is retinol binding protein 4 an adipokine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Retinol binding protein 4 (RBP4) is a protein that is known to transport vitamin A (retinol) in the blood. It is also recognized as an adipokine, which is a type of cytokine secreted by adipose tissue. Adipokines are involved in various metabolic processes, including insulin sensitivity and inflammation. Therefore, RBP4 is indeed classified as an adipokine.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do Afamin bind Vitamin E?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Afamin is a protein that is known to bind vitamin E. It is part of the albumin gene family and is involved in the transport of vitamin E in the bloodstream. Therefore, the answer to the question is yes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is HYDIN (Hydrocephalus-inducing protein homolog) an axonemal protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"HYDIN is a protein that is known to be involved in the structure and function of cilia and flagella, which are structures that contain axonemes. Axonemal proteins are typically those that are part of the axoneme, the central shaft of cilia and flagella. Given that HYDIN is associated with ciliary function, it is considered an axonemal protein.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is ASF1 phopshorylated by  the Tousled-like kinases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether ASF1 is phosphorylated by the Tousled-like kinases. ASF1 is a histone chaperone involved in chromatin assembly and disassembly. Tousled-like kinases (TLKs) are a family of serine/threonine protein kinases involved in DNA replication and repair. Research indicates that ASF1 can indeed be phosphorylated by TLKs, which is important for its function in chromatin dynamics and DNA repair processes. Therefore, the answer to the question is 'yes'.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is paxillin affected by RANKL?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if paxillin is affected by RANKL, we need to consider the biological pathways and interactions involved. RANKL (Receptor Activator of Nuclear Factor Kappa-Î’ Ligand) is a protein that plays a crucial role in bone metabolism by promoting the formation, function, and survival of osteoclasts. Paxillin is a cytoskeletal protein involved in the regulation of cell adhesion and movement. Research indicates that RANKL can influence signaling pathways that may involve paxillin, particularly in the context of osteoclast activity and bone resorption. Therefore, it is plausible that paxillin could be affected by RANKL through these pathways.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is taxilin a cancer marker?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if taxilin is a cancer marker, we need to understand what taxilin is and its role in cancer. Taxilin is a protein that has been studied in various biological contexts. Cancer markers, also known as tumor markers, are substances that are often produced by cancer cells or by the body in response to cancer. These markers are used in the diagnosis and monitoring of cancer. If taxilin is specifically associated with cancer cells or their activity, it could be considered a cancer marker. However, based on the current knowledge and research, taxilin is not widely recognized or used as a cancer marker in clinical practice.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can parasite infections by Schistosoma japonicum prevent or improve asthma?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question is asking whether infections by the parasite Schistosoma japonicum can have a preventive or improving effect on asthma. Schistosoma japonicum is a parasitic worm that causes schistosomiasis, a disease that can lead to various health issues. Some studies have suggested that certain parasitic infections might modulate the immune system in a way that could potentially reduce the incidence or severity of autoimmune diseases, including asthma. However, the relationship is complex and not fully understood, and the potential benefits of such infections must be weighed against the significant health risks they pose. Therefore, while there might be some evidence suggesting a possible effect, it is not conclusive enough to say that Schistosoma japonicum infections can definitively prevent or improve asthma.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does sphingosine-1 phosphoate suppress epiregulin?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if sphingosine-1 phosphate suppresses epiregulin, one would need to look into scientific studies or literature that specifically investigate the interaction between these two molecules. Sphingosine-1 phosphate (S1P) is a signaling lipid that can influence various cellular processes, while epiregulin is a member of the epidermal growth factor (EGF) family involved in cell proliferation. The relationship between them is not commonly discussed in general literature, so without specific studies or evidence, it is not possible to definitively say whether S1P suppresses epiregulin.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is telomestatin, a novel statin drug used to treat high cholesterol?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Telomestatin is not a statin drug used to treat high cholesterol. It is actually a compound known for its ability to bind to G-quadruplex structures in DNA, which is related to cancer research. Statins, on the other hand, are a class of drugs used to lower cholesterol levels in the blood by inhibiting the enzyme HMG-CoA reductase. Therefore, telomestatin is not used for treating high cholesterol.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Satb1 a transcription factor?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Satb1 is known to be a transcription factor. It is a protein that binds to specific DNA sequences, thereby controlling the rate of transcription of genetic information from DNA to messenger RNA. Transcription factors are crucial in regulating gene expression, and Satb1 is involved in this process.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is the 22-item sino-nasal outcome test (SNOT-22) a widely used measure for Health-Related Quality-of-Life (HRQOL) associated with chronic rhinosinusitis (CRS)?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The 22-item sino-nasal outcome test (SNOT-22) is indeed a widely used measure for assessing Health-Related Quality-of-Life (HRQOL) in patients with chronic rhinosinusitis (CRS). It is a validated tool that helps in evaluating the impact of CRS on a patient's quality of life by measuring symptoms and their effects on daily activities.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is SOX10 expressed in melanoma cells?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SOX10 is a transcription factor that is known to be expressed in neural crest-derived cells, including melanocytes. Melanoma, a type of skin cancer, originates from melanocytes. Therefore, it is reasonable to consider whether SOX10 is expressed in melanoma cells. Research indicates that SOX10 is indeed expressed in melanoma cells and is often used as a marker in the diagnosis of melanoma.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is EuroQol 5-Dimension Health Assessment (EQ-5D) [a widely used, simple instrument that monitors the general health-related quality of life (HRQoL) in chronic disease] a 5 question assessment?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The EuroQol 5-Dimension Health Assessment (EQ-5D) is indeed a tool used to measure health-related quality of life. It consists of 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has one question, making it a 5-question assessment.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is neurofilament light marker for disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Neurofilament light chain (NfL) is a biomarker that is used in the context of various neurological diseases. It is a protein found in neurons, and elevated levels in the blood or cerebrospinal fluid can indicate neuronal damage or degeneration. NfL is used as a marker for diseases such as multiple sclerosis, Alzheimer's disease, and other neurodegenerative conditions. Therefore, it is indeed considered a marker for disease, particularly in the field of neurology.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Phospholemman a membrane protein?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Phospholemman is known to be a membrane protein. It is a small protein that is associated with the plasma membrane of cells, particularly in cardiac and skeletal muscle tissues. It plays a role in regulating ion transport across the membrane, particularly sodium and potassium ions, which is characteristic of membrane proteins.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Mical an oxidoreductase?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"To determine if Mical is an oxidoreductase, we need to understand what Mical is and what an oxidoreductase is. Mical is a family of proteins known for their role in actin filament disassembly and cellular signaling. Oxidoreductases are enzymes that catalyze oxidation-reduction reactions, where the transfer of electrons occurs. Mical proteins have been shown to have oxidoreductase activity, as they can catalyze the oxidation of actin, leading to its disassembly. Therefore, Mical can be classified as an oxidoreductase based on its enzymatic activity.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is resistance training usually associated with increasing muscle hypertrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Resistance training is a form of exercise that involves working against a force to increase muscle strength and endurance. It is commonly associated with muscle hypertrophy, which is the increase in muscle size. This type of training typically includes activities such as weight lifting, bodyweight exercises, and using resistance bands. The primary goal of resistance training is often to enhance muscle mass, strength, and endurance, making it a popular choice for those looking to increase muscle hypertrophy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is periampullary carcinoma (PAC) a relatively rare genitourinary malignancy",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Periampullary carcinoma (PAC) refers to a group of cancers that originate in the area where the bile duct and pancreatic duct join and empty into the small intestine. This area is near the ampulla of Vater. It is not classified as a genitourinary malignancy, which pertains to cancers of the urinary system and the male reproductive organs. Therefore, PAC is not considered a genitourinary malignancy, rare or otherwise.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is pRETRO-SUPER an adenoviral vector?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if pRETRO-SUPER is an adenoviral vector, we need to understand what pRETRO-SUPER is. pRETRO-SUPER is a type of retroviral vector used for RNA interference and gene silencing. It is based on retrovirus technology, not adenovirus. Adenoviral vectors are derived from adenoviruses, which are different from retroviruses. Therefore, pRETRO-SUPER is not an adenoviral vector.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can epigenetic modifications be heritable?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Epigenetic modifications refer to changes in gene expression that do not involve alterations to the underlying DNA sequence. These modifications can include DNA methylation, histone modification, and non-coding RNA molecules. There is evidence that some epigenetic modifications can be passed from one generation to the next, meaning they can be heritable. This transmission can occur through mechanisms that allow these modifications to be maintained during cell division and passed on to offspring. However, the extent and stability of such heritable epigenetic changes can vary and are a subject of ongoing research.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) increase the likelihood of severe COVID-19?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether ACE inhibitors and ARBs increase the likelihood of severe COVID-19. There has been research on this topic, especially early in the pandemic, due to concerns about the role of the renin-angiotensin system in COVID-19. However, current evidence suggests that these medications do not increase the risk of severe COVID-19. In fact, many health organizations recommend continuing these medications in patients who are already prescribed them, as they do not appear to worsen COVID-19 outcomes.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does p85Î± homodimerize?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether p85Î±, a regulatory subunit of phosphoinositide 3-kinase (PI3K), can form homodimers. Homodimerization refers to the ability of two identical protein molecules to bind together to form a dimer. In the context of p85Î±, it is known to interact with other proteins, including forming heterodimers with the p110 catalytic subunit of PI3K. However, whether p85Î± specifically forms homodimers is a distinct question. Based on available scientific literature, p85Î± is not typically characterized by forming homodimers, as its primary role is in forming heterodimers with p110. Therefore, the answer to whether p85Î± homodimerizes is 'no'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is thalidomide used as an immunomodulatory drug nowadays?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Thalidomide, originally developed as a sedative, was found to cause severe birth defects and was withdrawn from the market. However, it was later discovered to have immunomodulatory and anti-inflammatory properties. Today, thalidomide is used as an immunomodulatory drug, particularly in the treatment of certain cancers like multiple myeloma and complications of leprosy.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are functional tests a good biomarker for Duchenne Muscular Dystrophy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Functional tests are used to assess the physical capabilities and limitations of individuals with Duchenne Muscular Dystrophy (DMD). These tests can provide valuable information about the progression of the disease and the effectiveness of treatments. However, biomarkers are typically biological indicators, such as proteins or genes, that can be measured to assess the presence or progression of a disease. While functional tests are important for evaluating the impact of DMD on a patient's abilities, they are not biological indicators. Therefore, functional tests are not considered biomarkers in the traditional sense.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, particularly influenza?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks if COVID-19 can be clinically distinguished from other respiratory illnesses like influenza. Clinically, both COVID-19 and influenza share similar symptoms such as fever, cough, and fatigue, making it difficult to distinguish between them based solely on symptoms. However, specific diagnostic tests, such as PCR tests for COVID-19 and influenza, can accurately identify the virus causing the illness. Therefore, while clinical symptoms alone may not be sufficient to distinguish between COVID-19 and influenza, diagnostic testing can provide a clear distinction.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is lumbar puncture the first test that should be performed on a patient with increased intracranial pressure?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"A lumbar puncture is not typically the first test performed on a patient with increased intracranial pressure. Performing a lumbar puncture in such cases can be dangerous as it may lead to brain herniation. Usually, imaging studies like a CT or MRI scan are done first to assess the cause of the increased pressure and to ensure it is safe to proceed with a lumbar puncture if needed.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does mutation of ARTEMIS gene causes severe combined immunodeficiency?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The ARTEMIS gene is known to be involved in the repair of DNA double-strand breaks and is crucial for the development of the immune system. Mutations in the ARTEMIS gene can lead to a form of severe combined immunodeficiency (SCID), which is characterized by a lack of functional T and B lymphocytes. This condition is often referred to as radiosensitive SCID due to the increased sensitivity to ionizing radiation observed in affected individuals. Therefore, a mutation in the ARTEMIS gene is indeed associated with severe combined immunodeficiency.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Cinpanemab effective for Parkinsonâ€™s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Cinpanemab is a monoclonal antibody that was being investigated for the treatment of Parkinson's Disease. However, clinical trials did not show significant efficacy in improving symptoms or slowing disease progression. Therefore, it is not considered effective for Parkinson's Disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Prasinezumab effective for Parkinsonâ€™s Disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Prasinezumab is a monoclonal antibody that targets alpha-synuclein, a protein associated with Parkinson's disease. Clinical trials have been conducted to evaluate its effectiveness in treating Parkinson's disease. While some studies have shown potential benefits, the overall evidence is not conclusive enough to definitively state that Prasinezumab is effective for Parkinsonâ€™s Disease. The results from ongoing and future studies will be crucial in determining its efficacy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does CIDEB mutation protect from liver disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The CIDEB gene is associated with lipid metabolism and its mutations have been studied in relation to liver disease. Some studies suggest that certain mutations in the CIDEB gene may confer protection against liver diseases such as non-alcoholic fatty liver disease (NAFLD). However, the protective effect can vary depending on the specific mutation and the population studied. Therefore, while there is evidence suggesting a protective role, it is not definitive for all CIDEB mutations or all types of liver disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there any association between Tripe palms and cancer?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tripe palms, also known as acanthosis palmaris, is a skin condition characterized by thickened, velvety palms with a texture similar to tripe, the lining of a cow's stomach. This condition is often associated with internal malignancies, particularly gastric and lung cancers. The presence of tripe palms can be a paraneoplastic syndrome, which means it is a skin manifestation that occurs in association with cancer. Therefore, there is a recognized association between tripe palms and cancer.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Was AAVS3 developed for hemophilia A?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"AAVS3 is a type of adeno-associated virus vector used in gene therapy. It is designed to deliver genetic material into cells. Hemophilia A is a genetic disorder caused by missing or defective factor VIII, a clotting protein. Gene therapy approaches for hemophilia A often involve using viral vectors to deliver a functional copy of the factor VIII gene to the patient's cells. AAVS3 could potentially be used for this purpose, but the question asks specifically if it was developed for hemophilia A. To answer this, we need to determine if AAVS3 was specifically designed with hemophilia A in mind or if it is a more general tool for gene therapy that could be applied to various conditions, including hemophilia A.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Was DNX-2401 tested for treatment of Diffuse Intrinsic Pontine Glioma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"DNX-2401 is an oncolytic virus that has been tested for various types of cancers, including gliomas. Diffuse Intrinsic Pontine Glioma (DIPG) is a type of brain tumor that is notoriously difficult to treat. Clinical trials and research studies often explore new treatments for DIPG due to its aggressive nature and poor prognosis. DNX-2401 has been investigated in the context of brain tumors, and there is evidence that it has been tested for DIPG treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Baricitinib effective for Alopecia Areata?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Baricitinib is a medication that has been studied for its effectiveness in treating Alopecia Areata, an autoimmune condition that causes hair loss. Clinical trials and studies have shown that Baricitinib can be effective in promoting hair regrowth in patients with this condition. The FDA has also approved Baricitinib for the treatment of Alopecia Areata, indicating its recognized effectiveness.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is erenumab effective for trigeminal neuralgia?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Erenumab is a medication primarily used for the prevention of migraine headaches. It works by blocking the activity of a protein called calcitonin gene-related peptide (CGRP), which is involved in migraine attacks. Trigeminal neuralgia is a different condition characterized by severe facial pain due to irritation of the trigeminal nerve. While erenumab is effective for migraines, there is limited evidence to support its effectiveness for trigeminal neuralgia. Current treatments for trigeminal neuralgia typically include anticonvulsants and other medications specifically targeting nerve pain. Therefore, based on current evidence, erenumab is not considered effective for treating trigeminal neuralgia.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is alternative splicing associated with heart disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Alternative splicing is a process that allows a single gene to code for multiple proteins. It is known to play a role in various biological processes and diseases, including heart disease. Research has shown that alternative splicing can affect the expression of genes involved in heart function and contribute to the development of heart disease.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is PRP-40 involved in microexon splicing?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"PRP-40 is a protein that is part of the spliceosome complex, which is responsible for splicing pre-mRNA. Microexon splicing is a specific type of splicing that involves very small exons. While PRP-40 is involved in the general splicing process, it is not specifically known to be involved in microexon splicing.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does microexon alternative splicing of small GTPase regulators have implication in central nervous system diseases?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Microexon alternative splicing is a process that can affect the function of proteins by including or excluding very small exons in the final mRNA. Small GTPase regulators are involved in various cellular processes, including those in the central nervous system (CNS). Alterations in splicing patterns, including those involving microexons, can lead to changes in protein function and have been implicated in various diseases. Research has shown that alternative splicing, including that of microexons, can play a role in the development and function of the CNS and may be linked to CNS diseases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Does silencing of SRRM4 promote microexon inclusion?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the silencing of SRRM4 leads to the inclusion of microexons. SRRM4 is known to be involved in the regulation of alternative splicing, particularly in the inclusion of microexons. Silencing SRRM4 would likely lead to a decrease in microexon inclusion, rather than promoting it.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does silencing of SRRM4 inhibit tumor growth across cancers?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the silencing of SRRM4 inhibits tumor growth across various types of cancers. To answer this, we need to consider if there is evidence or studies that show SRRM4 silencing has a broad effect on tumor growth in multiple cancer types. If such evidence exists, the answer would be 'yes'. If not, or if the effect is limited to specific cancers, the answer would be 'no'.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Does SRRM4 regulate neuronal-specific microexon splicing of TAF1 mRNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"SRRM4 is known to be involved in the regulation of neuronal-specific microexon splicing. TAF1 mRNA is a target for microexon splicing in neurons. Therefore, it is likely that SRRM4 plays a role in the splicing of TAF1 mRNA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is PRP-40 regulation of microexons a conserved phenomenon?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\n  \"draft\": \"To determine if PRP-40 regulation of microexons is a conserved phenomenon, we need to consider whether this regulatory mechanism is observed across different species. Conservation in biological terms usually implies that a particular gene, protein, or regulatory mechanism is preserved through evolution in different organisms. If PRP-40's role in regulating microexons is found in multiple species, it would suggest that this is a conserved phenomenon. However, without specific evidence or studies indicating that PRP-40 regulation of microexons is conserved across various species, it is difficult to definitively say 'yes'. Therefore, based on the information available, the answer would likely be 'no'.\",\n  \"answer\": \"no\"\n}",
    "correct": false
  },
  {
    "question": "Does nintedanib improve response rate in patients with bladder cancer?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Nintedanib is a tyrosine kinase inhibitor that targets multiple pathways involved in angiogenesis and tumor growth. It has been studied in various types of cancer, including lung cancer and idiopathic pulmonary fibrosis. However, there is limited evidence or clinical trial data specifically addressing its efficacy in improving response rates in patients with bladder cancer. Without specific studies or data supporting its use in bladder cancer, it is not possible to definitively say that nintedanib improves response rates in these patients.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Was prehospital transdermal glyceryl trinitrate effective for stroke in the RIGHT-2 trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The RIGHT-2 trial investigated the use of transdermal glyceryl trinitrate (GTN) in the prehospital setting for patients with suspected stroke. The trial aimed to determine if GTN could improve outcomes for these patients. The results of the RIGHT-2 trial indicated that prehospital transdermal GTN did not improve functional outcomes at 90 days for patients with acute stroke. Therefore, it was not found to be effective in this context.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Was erythropoietin effective for optic neuritis in the TONE trial?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The TONE trial investigated the effectiveness of erythropoietin in treating optic neuritis. The results of the trial indicated that erythropoietin was not effective in improving outcomes for patients with optic neuritis.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can losartan reduce brain atrophy in Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Losartan is primarily known as an angiotensin II receptor blocker used to treat high blood pressure. There is some research suggesting that it may have neuroprotective effects, potentially impacting conditions like Alzheimer's disease. However, the evidence is not conclusive, and it is not specifically approved for reducing brain atrophy in Alzheimer's disease. More research is needed to establish its efficacy in this area.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is levosimendan effective for amyotrophic lateral sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Levosimendan is a calcium sensitizer and inodilator primarily used for heart failure treatment. Its effectiveness for amyotrophic lateral sclerosis (ALS) is not well-established. While some studies may explore its potential benefits for ALS, there is no conclusive evidence supporting its effectiveness for this condition as of the latest research.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Should be used bexarotene for relapsing-remitting multiple sclerosis?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Bexarotene is primarily used as a treatment for cutaneous T-cell lymphoma and is not a standard treatment for relapsing-remitting multiple sclerosis (RRMS). While there may be ongoing research into its potential effects on MS, it is not currently approved or commonly used for this condition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Efgartigimod be used for myasthenia gravis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Efgartigimod is a medication that has been approved for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive. It works by reducing the levels of pathogenic antibodies that contribute to the symptoms of myasthenia gravis. Therefore, it can indeed be used for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Based on clinical trial data, can pioglitazone delay cognitive impairment for people at risk for Alzheimer's disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks if pioglitazone, based on clinical trial data, can delay cognitive impairment in individuals at risk for Alzheimer's disease. Pioglitazone is a medication primarily used to treat type 2 diabetes, but there has been interest in its potential effects on cognitive function. Clinical trials would provide evidence on its efficacy in delaying cognitive impairment. However, as of the latest data, there is no conclusive evidence from clinical trials that pioglitazone can delay cognitive impairment in people at risk for Alzheimer's disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is Tilavonemab effective for progressive supranuclear palsy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Tilavonemab is an investigational drug that has been studied for its potential effectiveness in treating progressive supranuclear palsy (PSP). However, clinical trials have not demonstrated significant efficacy in improving the symptoms or progression of PSP. Therefore, it is not considered an effective treatment for this condition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is ocrelizumab effective for primary progressive multiple sclerosis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Ocrelizumab is a medication that has been studied for its effectiveness in treating primary progressive multiple sclerosis (PPMS). Clinical trials and studies have shown that ocrelizumab can slow the progression of disability in patients with PPMS. It is one of the few treatments approved for this form of multiple sclerosis, indicating its effectiveness in managing the condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is deucravacitinib effective for psoriasis?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Deucravacitinib is a medication that has been studied for its effectiveness in treating psoriasis. Clinical trials and studies have shown that deucravacitinib can be effective in reducing the symptoms of psoriasis, leading to its approval for use in treating this condition. Therefore, based on available evidence, it can be considered effective for psoriasis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is daridorexant effective for insomnia?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Daridorexant is a medication that has been studied for its effectiveness in treating insomnia. Clinical trials have shown that it can help improve sleep onset and maintenance, making it an effective treatment option for individuals with insomnia.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is tebentafusp effective for uveal melanoma?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Tebentafusp is a bispecific protein that has been studied for its effectiveness in treating uveal melanoma, a rare and aggressive form of eye cancer. Clinical trials have shown that tebentafusp can improve overall survival in patients with metastatic uveal melanoma compared to other treatments. The FDA has also approved tebentafusp for this indication, suggesting that it is considered effective for this condition.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can lenacapavir be used for HIV?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Lenacapavir is an antiretroviral medication that is used in the treatment of HIV. It is a capsid inhibitor and has been developed to be part of the treatment regimen for people living with HIV. The drug works by interfering with the HIV capsid, which is essential for the virus's replication process. Lenacapavir has been studied and approved for use in certain cases of HIV treatment, particularly for individuals who have multi-drug resistant HIV or have limited treatment options. Therefore, lenacapavir can indeed be used for HIV treatment.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Wilson's disease described as an iron storage disease?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Wilson's disease is not described as an iron storage disease. It is actually a genetic disorder that leads to excessive accumulation of copper in the body, particularly in the liver and brain. Iron storage diseases, on the other hand, typically refer to conditions like hemochromatosis, where there is excessive accumulation of iron in the body. Therefore, Wilson's disease is not categorized as an iron storage disease.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is medical hydrology the same as Spa therapy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Medical hydrology and spa therapy are related fields but not exactly the same. Medical hydrology involves the study and use of water for therapeutic purposes, often focusing on the medicinal properties of mineral waters. Spa therapy, on the other hand, is a broader term that includes various treatments and therapies offered at spas, which may or may not involve the use of water. While there is overlap, as both can involve water-based treatments, they are not identical concepts.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is North Star Ambulatory Assessment score a reliable clinical outcome for disease progression assessment in Duchenne Muscular Dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The North Star Ambulatory Assessment (NSAA) is a tool used to measure motor abilities in individuals with Duchenne Muscular Dystrophy (DMD). It is commonly used in clinical settings to assess disease progression and response to treatment. The NSAA is considered a reliable and validated measure for this purpose, as it provides a standardized way to evaluate motor function over time. However, like any clinical tool, its reliability can depend on factors such as the consistency of administration and the specific context in which it is used.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can modulation of KCNQ1 splicing prevent arrhythmias?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks if modulation of KCNQ1 splicing can prevent arrhythmias. KCNQ1 is a gene that encodes a potassium channel involved in cardiac electrical activity. Abnormal splicing of KCNQ1 can lead to arrhythmias, so theoretically, correcting or modulating its splicing could help prevent these conditions. However, whether this approach is effective would depend on scientific evidence and research outcomes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can the concept of digital twins be applied in Precision Nutrition?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Digital twins refer to the digital representation of a physical object or system, allowing for real-time monitoring and analysis. In Precision Nutrition, the goal is to tailor dietary recommendations to individual needs based on various factors such as genetics, lifestyle, and health status. By using digital twins, it is possible to create a virtual model of an individual's nutritional needs and responses, enabling more precise and personalized dietary interventions. Therefore, the concept of digital twins can indeed be applied in Precision Nutrition to enhance the personalization and effectiveness of nutritional guidance.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is prosopagnosia also known as lack of auditory recognition?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Prosopagnosia is a neurological condition characterized by the inability to recognize faces. It is not related to auditory recognition, which involves the ability to recognize sounds or voices. Therefore, prosopagnosia is not known as lack of auditory recognition.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do cells undergoing necroptosis show disruption of their cell membranes?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Necroptosis is a form of programmed cell death that is distinct from apoptosis. Unlike apoptosis, which is characterized by cell shrinkage and membrane blebbing without loss of membrane integrity, necroptosis involves the rupture of the cell membrane. This rupture leads to the release of cellular contents into the surrounding tissue, which can trigger an inflammatory response. Therefore, cells undergoing necroptosis do show disruption of their cell membranes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Iron deficiency anemia a common complication of chronic kidney disease?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Iron deficiency anemia is indeed a common complication of chronic kidney disease. This is because the kidneys play a crucial role in producing erythropoietin, a hormone that stimulates the production of red blood cells. In chronic kidney disease, the production of erythropoietin is often reduced, leading to anemia. Additionally, patients with chronic kidney disease may have reduced iron absorption or increased iron loss, contributing to iron deficiency anemia.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Anemia is not associated with chronic kidney failure",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Anemia is commonly associated with chronic kidney failure because the kidneys produce erythropoietin, a hormone that stimulates red blood cell production. When the kidneys are not functioning properly, they produce less erythropoietin, leading to anemia. Therefore, anemia is indeed associated with chronic kidney failure.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is anaphylaxis a results of mast cell activation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Anaphylaxis is a severe, potentially life-threatening allergic reaction that can occur rapidly. It is indeed a result of mast cell activation. When an allergen enters the body, it can trigger the immune system to release chemicals, including histamines, from mast cells. This release causes the symptoms associated with anaphylaxis, such as swelling, difficulty breathing, and a drop in blood pressure. Therefore, mast cell activation is a key component in the development of anaphylaxis.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is trichotillomania encountered with equali frequency in males and females?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Trichotillomania is a condition characterized by an irresistible urge to pull out one's hair. Research indicates that trichotillomania is more commonly diagnosed in females than in males. This suggests that the condition is not encountered with equal frequency in both genders.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can skin picking phenotype present following methylphenidate treatment?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Methylphenidate is a medication commonly used to treat ADHD and narcolepsy. It is known to have various side effects, including potential behavioral changes. Skin picking, also known as dermatillomania, is a compulsive behavior that can sometimes be associated with stimulant medications like methylphenidate. While not extremely common, there are reports and studies that suggest skin picking can emerge as a side effect of methylphenidate treatment in some individuals.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Optogenetics refers to the study of gene expression optimization",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Optogenetics is a biological technique that involves the use of light to control cells within living tissue, typically neurons, that have been genetically modified to express light-sensitive ion channels. It is not specifically about the study of gene expression optimization, but rather about controlling cell activity using light.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Have chimeric antigen receptor (CAR)-T cell therapies been approved for the treatment of B cell malignancies?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Chimeric antigen receptor (CAR)-T cell therapies are a type of immunotherapy where T cells are genetically engineered to target specific cancer cells. These therapies have been developed and tested for various types of cancers, including B cell malignancies. Over the years, several CAR-T cell therapies have received regulatory approval for the treatment of B cell malignancies, such as certain types of leukemia and lymphoma. This indicates that CAR-T cell therapies have indeed been approved for these conditions.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is deflazacort more efficient than prednisone/prednisolone for the treatment of Duchenne muscular dystrophy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Deflazacort and prednisone/prednisolone are both corticosteroids used in the treatment of Duchenne muscular dystrophy (DMD). Studies have shown that deflazacort may have a more favorable side effect profile compared to prednisone, particularly in terms of weight gain and bone health. However, the efficacy in terms of muscle strength and function is generally considered to be similar between the two. Therefore, while deflazacort might be preferred by some due to its side effect profile, it is not necessarily more efficient in terms of treatment efficacy.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is casimersen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Casimersen is a medication that has been approved by the FDA for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45 skipping. This approval suggests that casimersen is considered effective for this specific subset of DMD patients. However, the effectiveness of casimersen for the broader DMD population or for mutations not amenable to exon 45 skipping is not established. Therefore, while casimersen is effective for certain patients, it is not universally effective for all DMD cases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is viltolarsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Viltolarsen is a medication that has been approved for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. Clinical trials have shown that viltolarsen can increase dystrophin production in these patients, which is a key protein missing in individuals with DMD. While it is not a cure, it is considered an effective treatment option for those specific cases.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is golodirsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Golodirsen is a medication that has been developed to treat Duchenne muscular dystrophy (DMD), specifically for patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. The effectiveness of golodirsen has been a subject of study and debate. While it has received accelerated approval by the FDA based on its ability to increase dystrophin production in skeletal muscle, the clinical benefit, such as improved motor function, has not been conclusively demonstrated in large-scale studies. Therefore, while it shows promise in terms of its mechanism of action, the overall effectiveness in improving clinical outcomes for patients with DMD remains uncertain.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is eteplirsen effective for the treatment of Duchenne muscular dystrophy?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Eteplirsen is a drug that has been developed for the treatment of Duchenne muscular dystrophy (DMD), specifically for patients with a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. The effectiveness of eteplirsen has been a subject of debate. The FDA granted accelerated approval for eteplirsen in 2016 based on the surrogate endpoint of increased dystrophin production in skeletal muscle observed in some patients. However, the clinical benefit of eteplirsen, such as improved motor function or slowed disease progression, has not been conclusively demonstrated in large, well-controlled clinical trials. The approval was controversial, with some experts questioning the strength of the evidence supporting its efficacy. Therefore, while eteplirsen is approved for use, its effectiveness in altering the course of DMD remains uncertain.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is SARS-CoV-2 transmitted through breast milk?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether the SARS-CoV-2 virus, responsible for COVID-19, can be transmitted through breast milk. According to current scientific understanding and guidelines from health organizations like the CDC and WHO, there is no evidence that the virus is transmitted through breast milk. Studies have shown that breast milk from infected mothers does not contain the virus, although antibodies against the virus have been found in the milk. Therefore, breastfeeding is generally considered safe, and the benefits of breastfeeding outweigh the potential risks of transmission through breast milk.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do machine learning-based methods outperform statistical methods for survival analysis?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine whether machine learning-based methods outperform statistical methods for survival analysis, we need to consider various factors. Machine learning methods, such as random survival forests or deep learning models, can capture complex patterns and interactions in data that traditional statistical methods, like the Cox proportional hazards model, might miss. However, the performance of these methods can depend on the specific dataset, the complexity of the relationships within the data, and the expertise of the user in tuning and interpreting the models. In some cases, machine learning methods may outperform statistical methods, especially with large and complex datasets. In other cases, traditional statistical methods may be more interpretable and sufficient for the task at hand. Thus, the answer is not straightforward and can vary depending on the context.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Does iron regulate oligodendrocyte maturation?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Oligodendrocytes are a type of glial cell in the central nervous system responsible for the formation of myelin sheaths around neurons. Iron is an essential element that plays a crucial role in various biological processes, including the development and functioning of the nervous system. It is known that iron is important for the maturation and function of oligodendrocytes, as it is involved in the synthesis of myelin. Therefore, iron does regulate oligodendrocyte maturation.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are LOQ and LOD the same?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"LOQ (Limit of Quantification) and LOD (Limit of Detection) are terms used in analytical chemistry to describe different thresholds in measurement. LOD refers to the lowest concentration of an analyte that can be detected but not necessarily quantified as an exact value. LOQ, on the other hand, is the lowest concentration at which the analyte can not only be reliably detected but also quantified with acceptable precision and accuracy. Therefore, LOQ and LOD are not the same, as they serve different purposes in analytical measurement.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can Amyotrophic Lateral Sclerosis (ALS) be associated with a mutation of the Super Oxide Dismutase 1 (SOD) gene?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that affects nerve cells in the brain and spinal cord. Research has shown that mutations in the Super Oxide Dismutase 1 (SOD1) gene are associated with familial forms of ALS. These mutations can lead to the production of a misfolded protein that is toxic to motor neurons, contributing to the development of the disease. Therefore, there is a well-established link between SOD1 gene mutations and ALS.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Have Quercetin-biapigenin nanoparticles been shown to be effective in penetrating the blood-brain barrier",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if Quercetin-biapigenin nanoparticles have been shown to be effective in penetrating the blood-brain barrier, we need to consider existing scientific research and studies. The blood-brain barrier is a selective barrier that prevents most substances from entering the brain from the bloodstream. Nanoparticles are often studied for their potential to deliver drugs across this barrier. If there is specific research or studies that have demonstrated the effectiveness of Quercetin-biapigenin nanoparticles in penetrating the blood-brain barrier, then the answer would be 'yes'. Otherwise, the answer would be 'no'.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Is OXLUMO (lumasiran) used for the treatment of primary hyperoxaluria?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"OXLUMO, also known as lumasiran, is a medication that is specifically designed for the treatment of primary hyperoxaluria type 1 (PH1). Primary hyperoxaluria is a rare genetic disorder characterized by the overproduction of oxalate, which can lead to kidney stones and kidney damage. Lumasiran works by reducing the production of oxalate, thereby helping to manage the condition. Therefore, OXLUMO is indeed used for the treatment of primary hyperoxaluria.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can untranslated regions (UTRs) regulate gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Untranslated regions (UTRs) are segments of mRNA that are not translated into protein. They are located at the 5' and 3' ends of the mRNA. UTRs play a crucial role in the regulation of gene expression. They can influence the stability, localization, and translation efficiency of the mRNA. For example, the 5' UTR can affect the initiation of translation, while the 3' UTR can influence mRNA stability and degradation. Therefore, UTRs are indeed involved in the regulation of gene expression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can the epigenetic status of introns affect gene expression?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether the epigenetic status of introns can influence gene expression. Epigenetics refers to changes in gene activity that do not involve alterations to the genetic code itself but rather involve modifications such as DNA methylation and histone modification. Introns are non-coding regions within a gene that are removed during RNA splicing. While traditionally considered non-functional, recent research suggests that introns can play roles in gene regulation. Epigenetic modifications in introns could potentially influence how genes are expressed by affecting the splicing process or the chromatin structure, which in turn could impact transcription. Therefore, it is plausible that the epigenetic status of introns could affect gene expression.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, such as influenza?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Distinguishing COVID-19 from other respiratory illnesses like influenza based solely on clinical symptoms can be challenging because they share many similar symptoms such as fever, cough, and fatigue. However, certain symptoms like loss of taste or smell are more specific to COVID-19. Despite this, clinical symptoms alone are not sufficient for a definitive diagnosis. Laboratory tests, such as PCR tests for COVID-19 and specific tests for influenza, are necessary to accurately distinguish between these illnesses.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is COVID-19 caused by the Omicron variant less severe than infection caused by other variants?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The Omicron variant of COVID-19 has been reported to cause less severe disease compared to some previous variants, such as the Delta variant. However, severity can vary based on individual health conditions, vaccination status, and other factors. Overall, while Omicron is generally considered less severe, it is still important to take precautions and follow public health guidelines.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Should patients using inhaled glucocorticoids for asthma or COPD be advised to stop these medications to prevent COVID-19?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether patients using inhaled glucocorticoids for asthma or COPD should stop these medications to prevent COVID-19. Inhaled glucocorticoids are commonly used to manage asthma and COPD by reducing inflammation in the airways. Stopping these medications could lead to worsening of asthma or COPD symptoms, which could be more harmful to the patient. Current guidelines and expert recommendations generally advise against stopping these medications as a preventive measure against COVID-19, as there is no evidence that inhaled glucocorticoids increase the risk of contracting COVID-19. Instead, maintaining good control of asthma or COPD is important for overall health and may help in managing any potential respiratory infections, including COVID-19.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is adenosine methylation an epigenetic modification?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Adenosine methylation, specifically N6-methyladenosine (m6A), is a chemical modification of RNA that affects gene expression without altering the underlying DNA sequence. This type of modification is considered an epigenetic change because it can regulate gene expression and influence cellular processes in a heritable manner, similar to other well-known epigenetic modifications like DNA methylation and histone modification.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can analgesics or antipyretics be taken for side effects following COVID-19 vaccination?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether analgesics or antipyretics can be used to manage side effects after receiving a COVID-19 vaccine. Analgesics are medications that relieve pain, while antipyretics are used to reduce fever. Common side effects of COVID-19 vaccines include pain at the injection site, fever, and body aches. Health authorities like the CDC have stated that it is generally safe to take these medications after vaccination to alleviate symptoms, but they do not recommend taking them preemptively before vaccination as it might affect the immune response. Therefore, the answer to the question is 'yes'.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Are Luminopsins a fusion proteins of luminol and Rhodopsin ?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Luminopsins are indeed fusion proteins, but they are not a fusion of luminol and rhodopsin. Instead, they are a fusion of luciferase and opsin proteins. The luciferase component allows for bioluminescence, while the opsin component is a light-sensitive receptor. This combination allows for the control of neuronal activity using light. Therefore, the statement in the question is incorrect.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "In twin-twin transfusion syndrome, are the twins identical?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Twin-twin transfusion syndrome (TTTS) occurs in identical twins, specifically monochorionic twins, where they share a single placenta. This condition arises due to an imbalance in the blood flow between the twins through shared placental vessels. Since TTTS is a condition that occurs in monochorionic twins, which are a type of identical twins, the answer is yes.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Zanubrutinib a first-generation BTK inhibitor approved by US Food and Drug Administration (FDA)?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Zanubrutinib is a BTK inhibitor, but it is not a first-generation one. Ibrutinib is considered the first-generation BTK inhibitor. Zanubrutinib is a second-generation BTK inhibitor. It has been approved by the US FDA for certain conditions, but it is not classified as a first-generation BTK inhibitor.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can CRISPR/Cas12a be used for the detection of EGFR mutations in circulating DNA?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"CRISPR/Cas12a is a gene-editing technology that can be used for various applications, including the detection of specific DNA sequences. EGFR mutations are specific genetic alterations that can be present in circulating DNA, such as in blood samples. The CRISPR/Cas12a system can be designed to target and identify these specific mutations due to its ability to recognize and bind to specific DNA sequences. Therefore, it is feasible to use CRISPR/Cas12a for the detection of EGFR mutations in circulating DNA.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is Functional Neurological Disorder (FND) classified as a psychosomatic disorder?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Functional Neurological Disorder (FND) is a condition where patients experience neurological symptoms such as weakness, movement disorders, sensory symptoms, and blackouts. These symptoms are not explained by traditional neurological diseases. FND is often considered a psychosomatic disorder because it involves both psychological and physical components. The symptoms are real and can cause significant distress and impairment, but they are thought to arise from a problem with the functioning of the nervous system rather than a structural or organic disease. Therefore, FND is classified as a psychosomatic disorder.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Are any medications available to prevent COVID-19 following exposure?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"The question asks whether there are medications available that can prevent COVID-19 after someone has been exposed to the virus. As of the latest information, there are no medications specifically approved to prevent COVID-19 after exposure. Vaccines are available to prevent infection, but they are not considered medications for post-exposure prevention. Treatments like monoclonal antibodies have been used to reduce the severity of the disease after infection, but they are not preventive measures. Therefore, the answer is no.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Can reinfection occur after SARS-CoV-2 infection?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Reinfection with SARS-CoV-2, the virus that causes COVID-19, is possible. While initial infection with the virus typically leads to the development of antibodies and some level of immunity, this immunity may not be complete or long-lasting. There have been documented cases of individuals being infected with SARS-CoV-2 more than once, indicating that reinfection can occur. Factors such as the emergence of new variants, waning immunity over time, and individual differences in immune response can contribute to the possibility of reinfection.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can other vaccines be given with COVID-19 vaccine?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"The question asks whether it is possible to administer other vaccines alongside the COVID-19 vaccine. According to health guidelines and studies, it is generally considered safe to receive other vaccines at the same time as the COVID-19 vaccine. This includes vaccines such as the flu shot and others that may be part of routine immunization schedules. Co-administration of vaccines can help ensure individuals are protected against multiple diseases without unnecessary delays.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is omaveloxolone a suppressor of Nrf2?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Omaveloxolone is not a suppressor of Nrf2. In fact, it is known to activate the Nrf2 pathway. Nrf2 is a transcription factor that regulates the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation. Omaveloxolone is designed to activate Nrf2, thereby enhancing the body's ability to combat oxidative stress.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Is omaveloxolone an activator of NFkB?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Omaveloxolone is a synthetic triterpenoid and an activator of the Nrf2 pathway, not NFkB. It is known for its role in reducing oxidative stress and inflammation by activating Nrf2, which leads to the expression of antioxidant proteins. NFkB is a different pathway involved in inflammatory responses, and omaveloxolone does not activate it.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Has RTA 408 received FDA approval?",
    "answer": "yes",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"RTA 408, also known as omaveloxolone, is a drug developed by Reata Pharmaceuticals. As of the latest information available up to October 2023, RTA 408 has not received FDA approval. The drug has been under investigation for the treatment of various conditions, including Friedreich's ataxia, but it has not yet been approved by the FDA for any indication.\",\"answer\":\"no\"}",
    "correct": false
  },
  {
    "question": "Can salivary cortisol be used to evaluate pain in neonates?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Salivary cortisol is a biomarker that can be used to assess stress levels, and it has been studied in various contexts, including neonatal care. Pain in neonates is a significant concern, and non-invasive methods to evaluate pain are preferred. Salivary cortisol has been considered as a potential indicator of pain because stress and pain can lead to increased cortisol levels. However, the use of salivary cortisol specifically for evaluating pain in neonates would depend on the reliability and validity of this measure in reflecting pain rather than other stressors. Research has explored this possibility, suggesting that salivary cortisol can be a useful tool in assessing neonatal pain, although it may not be the sole indicator used in clinical practice.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Can breastfeeding be used to alleviate the procedural pain in neonates?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Breastfeeding has been studied as a method to alleviate procedural pain in neonates. Research indicates that breastfeeding can have analgesic effects due to the combination of skin-to-skin contact, the act of sucking, and the presence of sweet-tasting breast milk. These factors can help reduce pain perception in neonates during procedures. Therefore, it is generally accepted that breastfeeding can be an effective method for pain relief in newborns during medical procedures.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Is music therapy effective for pain management in neonates?",
    "answer": "no",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Music therapy has been studied as a non-pharmacological intervention for pain management in neonates. Various studies have shown that music therapy can have a calming effect and may reduce pain perception in neonates during medical procedures. The soothing nature of music can help in reducing stress and pain responses in newborns. Therefore, music therapy is considered an effective method for pain management in neonates.\",\"answer\":\"yes\"}",
    "correct": false
  },
  {
    "question": "Is there any treatment for the Facioscapulohumeral Muscular Dystrophy?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetic muscle disorder characterized by progressive muscle weakness. As of the latest information available, there is no cure for FSHD. However, there are treatments and management strategies that can help alleviate symptoms and improve quality of life. These may include physical therapy, pain management, and surgical interventions for specific complications. Research is ongoing to find more effective treatments and potential cures.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are there any other types of Spinal Muscular Atrophy except for types 1-4?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Spinal Muscular Atrophy (SMA) is traditionally classified into types 1 through 4 based on the age of onset and severity of symptoms. However, there are other forms of SMA that are not classified within these traditional types. For example, SMA with respiratory distress type 1 (SMARD1) and distal SMA are considered different forms of the disease. Additionally, there are rare genetic variants and subtypes that may not fit neatly into the types 1-4 classification.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do all proteins start with methionine?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Proteins are synthesized from mRNA templates in a process called translation. In eukaryotes and archaea, the first amino acid incorporated into a nascent polypeptide chain is typically methionine, which is encoded by the start codon AUG. In bacteria, the first amino acid is formylmethionine, a modified form of methionine. However, not all mature proteins start with methionine because the initial methionine can be removed during post-translational modification. Therefore, while the synthesis of proteins often begins with methionine, not all mature proteins retain methionine at the start.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Do epigenetic changes change the DNA sequence?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Epigenetic changes refer to modifications that affect gene expression without altering the DNA sequence itself. These changes can include the addition of chemical groups to DNA or histone proteins, which can influence how genes are turned on or off. However, the underlying DNA sequence remains unchanged during epigenetic modifications.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are epigenetic changes heritable?",
    "answer": "yes",
    "llm_answer": "yes",
    "llm_response": "{\"draft\":\"Epigenetic changes refer to modifications on DNA or associated proteins that affect gene expression without altering the DNA sequence itself. These changes can be influenced by environmental factors, lifestyle, and other external conditions. One of the key aspects of epigenetics is its potential for heritability, meaning that these changes can be passed down from one generation to the next. Research has shown that some epigenetic modifications can indeed be inherited, although the mechanisms and extent of this inheritance can vary. Therefore, the question of whether epigenetic changes are heritable can be answered affirmatively based on current scientific understanding.\",\"answer\":\"yes\"}",
    "correct": true
  },
  {
    "question": "Do enhancers have to be close to their gene targets?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"Enhancers are DNA sequences that can increase the transcription of genes. They do not have to be close to their gene targets; they can be located thousands of base pairs away, either upstream or downstream of the gene they regulate. Enhancers can even be located within introns of other genes. They can influence gene expression from a distance by looping the DNA to bring the enhancer in proximity to the promoter of the target gene.\",\"answer\":\"no\"}",
    "correct": true
  },
  {
    "question": "Are accessible enhancers necessarily active?",
    "answer": "no",
    "llm_answer": "no",
    "llm_response": "{\"draft\":\"To determine if accessible enhancers are necessarily active, we need to understand the definitions of 'accessible' and 'active' in the context of enhancers. An enhancer is a DNA sequence that can increase the transcription of genes. 'Accessible' typically means that the chromatin structure is open, allowing transcription factors and other proteins to bind to the DNA. 'Active' implies that the enhancer is not only accessible but also actively participating in the transcription process, often marked by specific histone modifications and the presence of transcription machinery. However, accessibility alone does not guarantee activity, as some accessible enhancers may not be actively driving transcription at a given time. Therefore, accessible enhancers are not necessarily active.\",\"answer\":\"no\"}",
    "correct": true
  }
]